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Abstract 
Exogenous Stimulation of Meniscus Cells for the Purposes of Tissue Engineering 
the Knee Meniscus 
by 
Najmuddin Juzer Gunja 
Injuries to avascular regions of menisci do not heal and result in significant 
discomfort to patients. Current treatments, such as partial meniscectomy, 
alleviate the symptoms, but lead to premature osteoarthritis due to reduced 
stability and changes in knee biomechanics. An alternative treatment to 
overcome these problems involves functional tissue engineering. This thesis 
examined several exogenous factors to enhance the capability of meniscus cells 
(MCs) to synthesize relevant ECM markers and improve the functionality of 
constructs in vitro. First, the effect of passage on the phenotype of MCs in 
monolayer was investigated, and rapid changes were observed in collagen I, 
collagen II, and COMP expression. Collagen I and aggrecan protein coatings 
assisted in reversing expression levels of certain ECM markers; however, 
collagen II expression could not be reversed. Next, 3D tissue engineering studies 
were conducted using a cell-scaffold approach with MCs seeded on PLLA 
meshes. Anabolic stimuli that aided in meniscus regeneration included 1) 
hypoxia and bFGF, which resulted in synergistic increases in the total 
glycosaminoglycan content and compressive properties of constructs; 2) 10 MPa 
static hydrostatic pressure (HP), which resulted in increases in collagen content 
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and the relaxation modulus of constructs; and 3) 10 MPa static HP and TGF-f31, 
which resulted in additive increases in collagen content, and synergistic 
increases in the compressive moduli of constructs. Finally, a self-assembly, 
scaffoldless approach was employed for meniscus regeneration using co-
cultures of MCs and articular chondrocytes (ACs). A high density of cells were 
seeded on non-adherent agarose molds and allowed to coalesce into a construct 
without a scaffold. Different co-culture ratios of MCs and ACs resulted in a 
spectrum of fibrocartilages that recapitulated some biochemical and 
biomechanical properties of the rabbit meniscus. Cell culturing conditions were 
optimized with the identification of a smooth 1% agarose mold that resulted in 
geometrically-mimetic meniscus constructs. In conclusion, this thesis quantified 
phenotypic changes in MCs over passage, and used scaffold-based and 
scaffoldless approaches to regenerate constructs with biochemical and 
biomechanical properties in the range of native tissue values. Successful 
replacement of a damaged meniscus will improve the quality of patient life and 
reduce the risk of osteoarthritis. 
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Introduction 
The overall objective of this thesis is to identify exogenous stimuli that can 
enhance the biochemical and biomechanical properties of tissue engineered 
meniscus constructs. To achieve this objective, the thesis is divided into three 
sections. The first section addresses the effects of monolayer culture on 
meniscus cell phenotype. The second section involves the use of exogenous 
stimuli to enhance extracellular matrix (ECM) and biomechanical properties of 
meniscus cell-seeded poly-l-lactic acid (PLLA) scaffolds. The third section 
enhances a novel scaffoldless approach, developed in our laboratory, for 
meniscus tissue engineering. The primary hypotheses of this investigation are 
that 1) meniscus cells will experience rapid phenotypic changes during culture, 
but these changes can be modulated by controlling the culturing conditions; 2) 
exogenous factors, individually or in combination, will allow for the formation of 
meniscus constructs resembling native tissue; and 3) a scaffoldless approach 
can be used to recreate the heterogeneities of the knee meniscus. To test these 
hypotheses, three specific aims were employed: 
1) To investigate the phenotypic changes in meniscus cells with 
passage and examine gene expression reversal techniques. Meniscus 
cells synthesize several ECM molecules including collagen I, collagen II 
and aggrecan that are essential for the function of the tissue. It has been 
shown that cell expansion in monolayer causes rapid phenotypic changes 
in other cartilaginous cells with variations in gene expression profiles for 
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important ECM markers. Corresponding studies with meniscus cells in 
monolayer are absent. Thus, the goal of this aim is two-fold: 1) to 
determine the effects of passage on important meniscus ECM markers. 
The hypothesis is that, much like other cartilaginous cells, meniscus cells 
would exhibit phenotypic changes in monolayer, and 2) to reverse any 
changes in gene expression incurred during passage by plating meniscus 
cells on either an aggrecan or collagen I protein coating. The hypothesis is 
that, both aggrecan and collagen I will modulate the matrix forming 
phenotype of meniscus cells. In this aim, meniscus cell gene expression 
will be studied using quantitative reverse transcription polymerase chain 
reaction (qRT-PCR). 
2) To determine the effect of exogenous stimuli on meniscus cell-
seeded PLLA constructs. Prior studies in our laboratory and in the 
literature have shown the benefit of using exogenous stimuli such as 
hypoxia, bFGF, TGF-(31 and hydrostatic pressure for articular cartilage 
tissue engineering. Thus, the purpose of this aim is to examine these 
exogenous factors individually or in combination for meniscus tissue 
engineering and identify stimuli that enhance ECM and biomechanical 
properties of meniscus cell-seeded PLLA constructs. The hypotheses of 
this aim are that 1) each exogenous stimulus will improve the quality of the 
meniscus cell-seeded PLLA constructs and 2) combinations of particular 
stimuli will result in additive and synergistic effects. Several qualitative and 
quantitative tools will be utilized to examine the contents of the constructs 
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including histology, immunohistochemistry and biochemistry. The 
biomechanical properties of the constructs will be characterized using 
unconfined compression and uniaxial tension tests. 
3) To optimize cell and tissue culture conditions for scaffoldless 
meniscus constructs. Previous work in our laboratory has shown that 
meniscus cells coalesce into scaffoldless constructs when seeded on non-
adherent agarose wells. The purpose of this aim is to advance this 
process by investigating strategies to recreate the heterogeneities of the 
knee meniscus with the use of meniscus cell and articular chondrocyte co-
cultures and to form geometrically mimetic meniscus-shaped constructs 
by altering the topology and compliance of agarose wells. The hypotheses 
of this aim are that 1) co-cultures of meniscus cells and articular 
chondrocytes will result in a spectrum of biochemical and biomechanical 
properties that span the range of the inner and outer meniscus and 2) 
rough high compliance agarose wells will favor the formation of meniscus 
shaped constructs. Constructs will be evaluated for their biochemical 
composition using quantitative and qualitative measurements including 
histology, immunohistochemistry and biochemistry. The biomechanical 
properties of the constructs will be evaluated using creep indentation and 
uniaxial tension tests. 
Chapter 1 delivers an overview of the field of meniscus tissue engineering. 
Chapter 2 discusses a study investigating the effects of passage on gene 
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expression of meniscus cells and examines gene expression reversal 
techniques. Chapter 3 focuses on characterizing the biomechanical and 
degradation properties of PLLA scaffolds used in our tissue engineering studies. 
Chapters 4 to 7 discuss the effects of several exogenous stimuli on meniscus 
cell-seeded PLLA constructs. Chapter 8 and 9 discuss scaffoldless approaches 
for meniscus tissue engineering. Appendix A, B and C are review articles on 
salient biodegradable materials used in soft tissue fixation. 
Chapter 1 reviews meniscus structure and function and current tissue 
engineering strategies. Special emphasis is placed on exogenous stimuli used to 
regenerate the meniscus. This chapter motivates the use of various culturing 
conditions, growth factors and mechanical stimuli used in this thesis. 
Chapter 2 addresses work performed toward the completion of specific aim 1 of 
this thesis. It describes the effects of passage on the gene expression of 
meniscus cells. In addition, also two different protein coatings are examined to 
reverse these changes in gene expression. 
Chapters 3-7 address work performed toward completion of specific aim 2. 
Chapter 3 includes a characterization study of PLLA scaffolds where the 
biomechanical and degradation properties are tracked over a period of three 
months in different medium formulations. Chapter 4 identifies a beneficial 
hydrostatic pressure regimen to enhance the biochemical and biomechanical 
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properties of meniscus cell-seeded PLLA constructs. Chapter 5 describes the 
beneficial effect of TGF-(31 on meniscus cell-seeded PLLA constructs and the 
synergistic and additive effects of combining TGF-B1 and hydrostatic pressure. 
Chapter 6 details the synergistic and additive effects of a combination of hypoxia 
and bFGF for meniscus tissue engineering. Chapter 7 investigates strategies to 
recreate portions of the knee meniscus via co-cultures of meniscus cells and 
articular chondrocytes seeded on PLLA scaffolds. 
Chapters 8 and 9 address work performed toward completion of specific aim 3. 
Chapter 8 identifies meniscus cell and articular chondrocyte co-culture ratios 
most closely resembling the inner and outer meniscus. Chapter 9 investigates 
techniques to form meniscus shaped constructs by varying the topology and 
concentration of agarose wells. 
Appendix A, B and C review the state-of-the-art in soft-tissue fixation devices. 
Appendix A provides a general overview of salient biodegradable polymers used 
in arthroscopic soft-tissue fixation. Appendix B reviews novel biodegradable 
polymers that are under investigation as musculoskeletal implants. Appendix C 
provides a comprehensive review of polymers and osteoconductive materials 
used in ACL fixation. 
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Chapter 1: Knee meniscus structure, function, and 
tissue engineering 
Najmuddin J. Gunja and Kyriacos A. Athanasiou 
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Introduction 
the knee menisci are fibrocartilaginous tissues specialized to protect the 
underlying articular cartilage of the femur and the tibia via load distribution and 
shock absorption.1"5 Intrinsic repair capacity is limited to the peripheral region of 
the tissue, and injuries to other portions result in a loss of tissue functionality 
leading to osteoarthritic changes in the underlying articular cartilage.6 Methods 
aimed at restoring native meniscus function need to be developed to prevent 
these long-term degenerative changes. 
Meniscus composition 
The knee meniscus exhibits stark regional variation in cell morphology, ECM, 
and biomechanical properties. For the meniscus, this variation manifests itself in 
the transition from a ligamentous outer region to a cartilaginous inner region.1 
Cells and extracellular matrix 
The term fibrochondrocyte or fibrocartilage cell has often been used to describe 
the cells of the meniscus.7"10 However, recent characterization studies have led 
to the identification of different cell populations within the tissue.1,11 McDevitt et 
a/.11 divided the meniscal cell population into three distinct groups; 
fibrochondrocytes, fibroblast-like cells, and cells of the superficial zone. 
Fibrochondrocytes, as defined by the authors, are cells that are localized in the 
middle and inner meniscus and express both collagen I and collagen II. They can 
be identified by their round or oval shape and presence of a pericellular matrix. 
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The ECM in this region consists mainly of collagens I and II, in a 2:3 ratio, that 
are responsible for providing structural and tensile properties to the tissue.12'13 
Fibroblast-like cells are found mainly in the outer 1/3rd of the tissue and lack a 
pericellular matrix. The ECM in this region is predominantly collagen I.1,14 Cells 
of the superficial zone are located below the surface of the tissue and can be 
identified by their fusiform shape and lack of cytoplasmic projections. In addition 
to the presence of collagen I and II in the inner 2/3rd of the meniscus, several 
other proteoglycans and glycoproteins can also be found. The major meniscal 
proteoglycan is aggrecan and its main function is to provide compressive 
properties of the meniscus, especially to the inner 1/3rd which is predominantly 
under compressive load.15 COMP, a pentameric glycoprotein that influences 
collagen fibril formation is also present in the inner 2/3rd of the meniscus.16 Small 
leucine rich proteoglycans such as biglycan and decorin, that interact with growth 
factors as well as influence fibrillogenesis, are present in smaller quantities as 
well.10 
BiomechanJcal properties 
Due to meniscal geometrical properties and attachments via meniscal horns, an 
applied physiological load not only compresses the tissue but also places it under 
a circumferential tensile strain. Finite element models have been used to 
describe the distribution of both compressive and tensile forces throughout the 
tissue during a loading event.17 Results of finite element analyses have shown 
the inner region to be subjected to higher levels of compressive strains while 
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circumferential tensile strains are concentrated in the outer region. This 
regionally variant loading is consistent with the overall cartilaginous to 
fibrocartilaginous gradient present in the tissue. The biomechanical properties 
would be expected to correlate with this tissue gradient, suggesting that the inner 
region is stiffer in compression and the outer region is stiffer in circumferentially 
oriented tension. Characteristic of a fibrous tissue, the meniscus exhibits 
anisotropic tensile properties due to the large diameter, circumferentially oriented 
collagen fibers. Previous work has characterized both the tensile and 
compressive properties of leporine menisci.18, 19 It was found that the femoral-
anterior portion of the medial meniscus exhibited the highest indentation stiffness 
(350 ± 110 kPa), aggregate modulus (270 ± 90 kPa), and shear modulus (140 ± 
40 kPa), while the tibial-posterior region exhibited the lowest indentation stiffness 
(170 ± 40 kPa), aggregate modulus (130 ± 30 kPa), and shear modulus (60 ± 20 
kPa). Circumferential tensile tests showed that the Young's modulus was 156.6 ± 
48.9 MPa, and the UTS was 21.6 ± 7.0 MPa. 
Meniscus injuries 
The avascularity in the inner region of the meniscus means that it is unable to 
intrinsically heal. The most common type of injury, a meniscal tear, can occur 
due to trauma to the joint or wear and tear. There are a variety of meniscal tears 
that have been classified depending on their location in the meniscus. For 
example, a split in the meniscus from the lateral to the medial rim across the 
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radius is known as a radial tear while tears along the length of the meniscus are 
called circumferential tears. 
Several methods have been used to repair tears in the meniscus. In the past, 
menisci were considered to be functionless remains of leg muscle and were often 
completely removed when damaged. This technique, known as complete 
meniscectomy, has now been abandoned as a treatment modality as it has been 
shown to result in joint instability, joint damage and osteoarthritis.20, 21 These 
findings led to a procedure known as partial meniscectomy where torn portions of 
the meniscus were removed via arthroscopic intervention. Recent research, 
however, has shown that this technique may also result in impaired mechanical 
function of articular cartilage, leading to degenerative changes and 
osteoarthritis.22, 23 Biodegradable polymer materials are currently successfully 
used to treat meniscal tears; however, their applicability is limited only to the 
vascular region of the meniscus.1 Meniscal allografts and prostheses have also 
been tried as replacements for the meniscus. Allografts have shown positive 
short-term results but there is concern regarding the possibility of disease 
transmission and host rejection in the joint.24 Prostheses have been found to 
exhibit inferior mechanical properties when compared to native tissue.25 In light of 
these problems, there has been a tremendous push down a tissue engineering 
pathway to develop a biological meniscal substitute that will restore normal 
function to the joint. 
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Meniscus tissue engineering 
Successful tissue engineering of the meniscus will require the identification of an 
appropriate cell source, scaffold material and culturing condition. The following 
section details prior work conducted in these areas pertaining to the meniscus. 
Cell source 
Selection of an appropriate cell source weighs heavily on the eventual clinical 
translatability of a tissue engineering approach. Considering this, differentiated 
cells are currently used in FDA approved autologous chondrocyte 
transplantation, while stem cells are in the process of gaining wider clinical use 
for cartilage repair. Studies in our laboratory 26, 27 and others 28 have used MCs 
and ACs to form fibrocartilaginous tissue constructs. Another consideration for 
cell source selection, especially in studies culminating in an in vivo assessment, 
is the animal species from which the cells are isolated. Currently, meniscus 
tissue engineering in vivo studies have only employed an allogenic or autologous 
cell source as it has been traditionally believed that xenogenic constructs would 
elicit an immune response.29"31 However, it has been suggested that 
cartilaginous tissues like the meniscus are immunoprivileged due to the dense 
ECM shielding the immunoreactive cells from both humoral and cell-mediated 
responses.32"34 The successful application of a xenogenic tissue engineered 
meniscus replacement would have significant benefits over allogenic or 
autologous approaches, as issues associated with the low quality and quantity of 
donor tissues would be avoided. By using a xenogenic approach, the age of the 
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donor animal could be minimized, as it has been shown that aging adversely 
affects the ability of the cells to express mRNA corresponding to relevant ECM 
and produce robust fibrocartilaginous tissue.35"37 Also, the cell expansion phase 
required for allogenic or autologous approaches would be avoided using a 
xenogenic source because of the amount of available donor tissue. 
Scaffolds 
Numerous studies have shown that 3-D culture is necessary for redifferentiation 
of expanded chondrocytes and dually functions as a means to form a tissue 
engineered construct. Different kinds of scaffolds have been used to tissue 
engineer the knee meniscus that can be broadly divided into two categories, 
natural and synthetic scaffolds. 
Natural scaffolds that have shown the most promising results are collagen gels. 
Studies on these gels by Mueller et a/.38 have yielded encouraging results in 
vitro. However, no mechanical tests were performed to determine the integrity of 
the scaffolds. Several in vivo experiments in animal models have also been 
performed with collagen implants.30,39,40 One particular implant collagen implant 
is currently in clinical trials in humans.41"43 In spite of the relative success of these 
implants, insufficient tissue to host integration and inferior mechanical properties 
of these scaffolds are issues that remain unaddressed. 
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Numerous synthetic scaffolds have been used in meniscus tissue engineering 
experiments. One of the most popular scaffold choices in the literature is poly-
glycolic add (PGA). Non-woven PGA meshes are frequently used in tissue 
engineering studies.44, 45 It has been shown that fibroblasts as well as 
chondrocytes readily attach and proliferate on PGA scaffolds.46 In addition, an 
upregulation of protein synthesis and mechanical properties has also been 
observed.46, 47 In our laboratory, knee meniscus cells produced more collagen 
and GAG while maintaining a higher cell number on PGA scaffolds than on 
agarose scaffolds.45 Recent studies with TMJ disc fibrochondrocytes and 
meniscal cells have shown that seeding these cells on PGA scaffolds causes 
them to contract significantly within four to eight wks losing 50% of their original 
volume.48"50 Furthermore, the rapid degradation of PGA is also a concern in long-
term tissue engineering studies.49, 50 Hence, a polymer with greater structural 
integrity and slower degradation time may be beneficial for tissue engineering 
studies involving fibrocartilage. One such polymer that is now gaining popularity 
is poly-l-lactic acid (PLLA). In recent tissue engineering pilot studies with TMJ 
disc fibrochondrocytes and meniscus cells in our lab, PLLA scaffolds were 
compared to PGA scaffolds. Over 4 wks, it was found that PLLA maintained its 
mechanical integrity and shape while the PGA constructs rapidly contracted and 
lost mechanical integrity. The PGA scaffolds could not be tested under 
compression or tension due to their weak structural network. In addition, both 
scaffolds maintained cellularity throughout the culture period while neither 
scaffold exhibited a significant advantage over the other in terms of collagen or 
14 
GAG content.51 Hence, the use of PLLA in fibrocartilage tissue engineering 
needs to be further investigated to fully verify its potential as a scaffold material. 
Scaffoldless tissue engineering 
In addition to a scaffold-based approach, a novel scaffoldless approach, 
developed in our laboratory for articular cartilage, has been used for meniscus 
tissue engineering.27,52,53 In this technique, a high density of cells are seeded in 
a non-adherent agarose mold. The cells coalesce by cadherin-mediated cell 
interactions as dictated by the differential adhesion hypothesis.54"56 Overtime, 
the cells migrate apart and secrete extracellular matrix, With this approach, 
anisotropic, inhomogeneous constructs mimicking the native meniscus can be 
created without the need for a scaffold. This approach addresses two major 
limitations with scaffold-based constructs: 1) scaffolds are susceptible to early or 
delayed degradation in vivo, a phenomenon which may interfere with ECM 
production and maturation and long-term mechanical properties 57, and 2) the 
random arrangements of non-woven scaffold meshes introduce a formidable 
challenge in producing constructs that are anisotropic like the native meniscus. 
Cell culturing conditions 
Current cellular approaches for meniscus tissue engineering usually involve 
autologous meniscus cells.29,30 However, primary cells from one animal are too 
low in number to seed on a scaffold. To overcome this, an approach often 
employed is to expand autologous cells in monolayer until the cell number is 
15 
sufficient for the study. A caveat with this technique is that primary cells may 
dedifferentiate in vitro in monolayer culture. This, for example, has been shown 
consistently with articular cartilage.58, 59 Gene expression studies with primary 
chondrocytes show that they express predominantly collagen II. However after 
one passage, the collagen II expression drops, and the cells begin to express 
collagen I which is indicative of a fibroblastic phenotype.60, 61 In an effort to 
reverse lost gene expression in articular cartilage and temporomandibular joint 
(TMJ) disc fibrochondrocytes, several growth factors, surface protein coatings 
and 3-D scaffolds have been investigated.60, 62"64 However, corresponding 
passage and gene expression reversal studies for the meniscus are absent. 
Hence, understanding the state of expanded meniscal fibrochondrocytes prior to 
embarking on long-term tissue engineering studies may be prudent. 
Recent work has suggested that low oxygen tension (hypoxia) may aid in 
meniscus cell (MC) and articular chondrocyte (AC) phenotype maintenance and 
enhancement during cell culture 65"68, with increases in expression of hypoxia 
inducible factoMalpha (HIF-1a) and SOX-9. These transcription factors play 
important roles in collagen II synthesis.69, 70 Furthermore, in vivo, cartilaginous 
tissues reside in hypoxic conditions where the lack of the blood supply creates a 
low oxygen environment (1 to 8%) for cartilage cells.71,72 
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Growth factors 
Many different growth factors have been investigated in our laboratory and others 
including TGFP-1, IGF-1, PDGF-AB, bFGF, and BMP-2. 73'82 IGF-1 has been 
used extensively with articular chondrocytes and has been shown to increase 
proteoglycan synthesis.74, 79, 81 PDGF-AB has been shown to stimulate the 
migration of fibrochondrocytes from the inner, middle, and outer thirds of the 
bovine meniscus. In addition, increased DNA synthesis was observed in cells of 
all three regions.73 Of the growth factors previously investigated, TGF(3-1 has 
exhibited the greatest capability to enhance both collagen and GAG production, 
and tensile and compressive biomechanical properties. Based on previous 
studies using this growth factor, a concentration of 10-30 ng/mL is sufficient to 
obtain the maximal effects. While the results of solely applying bFGF on tissue 
constructs may be insufficient to warrant future usage, studies in which bFGF 
has been combined with other stimuli, such as hypoxia, report increases in GAG 
deposition and compressive properties.65 
Mechanical stimuli 
In vitro studies with meniscus explants and cells have shown that mechanical 
stimuli such as direct compression, tension and HP can increase extracellular 
matrix (ECM) expression and synthesis.83"91 The use of HP is of particular 
interest in meniscus tissue engineering as it causes no macro-scale deformation 
to the construct, yet is responsible in stimulating cells to increase ECM synthesis, 
possibly by altering intracellular ion flux.92 Such a stimulus may be favorable in 
17 
the early stages of a tissue engineering study where cells seeded on scaffolds 
are still in the proliferation and migration stages and are vulnerable to external 
stimuli. 
HP studies can be broadly divided into three categories, a) 2-D monolayer 
studies, b) 3-D explant studies, and c) 3-D tissue engineering studies. Results 
from experiments in the first category are often reported in terms of gene 
expression. Studies on articular chondrocytes and Achilles tendon fibroblasts 
have shown an upregulation of aggrecan and collagen II expression in cells 
immediately after intermittent hydrostatic pressurization.87, 93"95 Further 
upregulation of collagen and aggrecan expression was observed when the 
samples were tested 24 hrs post-stimulation suggesting that rest time might be 
an important factor to consider in long-term tissue engineering studies. TMJ disc 
cells have been shown to increase collagen I expression under static HP of 10 
MPa and increase collagen II expression during intermittent HP stimulation of 10 
MPa, 1 Hz.96 Studies with explants have investigated the effects of HP on 
proteoglycan synthesis as well as MMP regulation. An experiment with articular 
cartilage explants showed that cyclic HP at physiological magnitudes caused an 
upregulation of sulfate incorporation into the explants.97 Cyclic HP on meniscus 
explants has been shown to inhibit upregulation of potent effector molecules 
such as MMP-1, MMP-3, and COX-2.86 Tissue engineering studies have been 
performed by encapsulating cells in alginate beads, using pellet cultures, seeding 
cells on scaffolds or using scaffoldless self-assembly techniques.96,98"102 Results 
18 
from these studies have varied significantly among research groups, often even 
when using similar cell sources. For example, although intermittent HP 
application has been shown to consistently increase GAG production by 
chondrocytes on PGA and PLGA scaffolds, as well as in pellet cultures, this has 
not been observed in self-assembled articular chondrocyte constructs.98, 100, 101 
Static HP has been shown to increase both collagen and aggrecan synthesis in 
intervertebral disc cells while only increasing collagen content in TMJ disc 
cells.96,99 Thus, specific regimens of both static and intermittent HP stimuli exhibit 
beneficial effects for tissue engineering purposes, even though the underlying 
mechanisms are still unclear. 
Conclusions 
Successful knee meniscus tissue engineering would be an important step toward 
the treatment of meniscal defects, but much work needs to be accomplished 
before this state can be reached. In this thesis, a variety of exogenous stimuli, 
reviewed above, were investigated for their abilities to enhance the biochemical 
and biomechanical properties of meniscus cell-seeded constructs. The ensuing 
chapters provide a comprehensive synopsis of the effects of these stimuli and 
their benefits for meniscus tissue engineering. 
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Chapter 2: Passage and reversal effects on gene 
expression of bovine meniscal fibrochondrocytes 
Najmuddin J. Gunja and Kyriacos A. Athanasiou 
Chapter published as: Gunja NJ and Athanasiou KA. Passage and reversal 
effects on gene expression of bovine meniscal fibrochondrocytes. Arthritis Res 
Ther. 2007;9(5):R93. 
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Abstract 
The knee meniscus contains a mixed population of cells that exhibit fibroblastic 
as well as chondrocytic characteristics. Tissue engineering studies and future 
therapies for the meniscus require a large population of cells that are seeded on 
scaffolds. To achieve this, monolayer expansion is often used as a technique to 
increase cell number. However, the phehotype of these cells may be significantly 
different from that of the primary population. The objective of this study was to 
investigate changes in meniseal fibrochondrocytes at the gene expression level 
over four passages using quantitative real-time reverse transcriptase polymerase 
chain reaction. Cells from the inner two-thirds of bovine medial menisci were 
used. Four extracellular matrix (ECM) molecules, commonly found in the 
meniscus, were investigated, namely collagen I, collagen II, aggrecan and 
cartilage oligomeric matrix protein (COMP). In addition, primary and passaged 
meniscus fibrochondrocytes were placed on surfaces coated with collagen I or 
aggrecan protein to investigate whether any gene expression changes resulting 
from passage could be reversed. Collagen I expression was found to increase 
with the number of passages, whereas collagen II and COMP expression 
decreased. Collagen I and aggrecan surface coatings were shown to 
downregulate and upregulate collagen I and COMP expression levels, 
respectively, in passaged cells. However, decreases in collagen II expression 
could not be reversed by either protein coating. These results indicate that 
although monolayer expansion results in significant changes in gene expression 
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in meniscal fibrochondrocytes, protein coatings may be used to regain the 
primary cell expression of several ECM molecules. 
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Introduction 
The meniscus is a wedge-shaped fibrocartilaginous tissue located in the knee 
joint. As reviewed elsewhere, it serves several mechanical functions including 
shock absorption, load transmission, joint stability and joint lubrication.1, 103 
Injuries to the meniscus can result in significant pain and discomfort to the 
patient, as well as in increasing the average stress in the knee joint, causing 
damage to the articular cartilage on the femoral and tibial surfaces.2 The ability of 
the meniscus to heal intrinsically is limited to the vascular regions of the tissue. 
Thus, tissue engineering is a promising treatment modality to replace avascular 
sections of the meniscus.1 
The term fibrochondrocyte or fibrocartilage cell has often been used to describe 
the cells of the meniscus.7"10. However, recent characterization studies have led 
to the identification of different cell populations within the tissue.1,11 McDevitt et 
al. divided the meniscal cell population into three distinct groups; 
fibrochondrocytes, fibroblast-like cells, and cells of the superficial zone.11 
Fibrochondrocytes, as defined by the authors, are cells that are localized in the 
middle and inner meniscus and express both collagen I and collagen II. They can 
be identified by their round or oval shape and presence of a pericellular matrix. 
The ECM in this region consists mainly of collagens I and II, in a 2:3 ratio, that 
are responsible for providing structural and tensile properties to the tissue.12,13 
Fibroblast-like cells are found mainly in the outer 1/3rd of the tissue and lack a 
pericellular matrix. The ECM in this region is predominantly collagen I.1,14 Cells 
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of the superficial zone are located below the surface of the tissue and can be 
identified by their fusiform shape and lack cytoplasmic projections. In this 
experiment, we utilize cells from the inner 2/3rd of the meniscus; thus, the 
majority of cells present are fibrochondrocytes. In addition to the presence of 
collagen I and II in the inner 2/3rd of the meniscus, several other proteoglycans 
and glycoproteins can also be found. The major meniscal proteoglycan is 
aggrecan and its main function is to provide compressive properties of the 
meniscus, especially to the inner 1/3rd which is predominantly under compressive 
load.15 COMP, a pentameric glycoprotein that influences collagen fibril formation 
can also be identified in the inner 2/3rd of the meniscus.16 Also present, in smaller 
quantities, are small leucine rich proteoglycans, biglycan and decorin, that 
interact with growth factors as well as influence fibrillogenesis.10 
Current cellular approaches for meniscus tissue engineering usually involve 
autologous meniscus cells.29, 30 However, primary cells from one animal are too 
low in number to seed on a scaffold. To overcome this, an approach often 
employed is to expand autologous cells in monolayer until the cell number is 
sufficient for the study. A caveat with this technique is that primary cells may 
dedifferentiate in vitro in monolayer culture. This, for example, has been shown 
consistently with articular cartilage.58, 59 Gene expression studies with primary 
chondrocytes show that they express predominantly collagen II. However after 
one passage, the collagen II expression drops, and the cells begin to express 
collagen I which is indicative of a fibroblastic phenotype.60, 61 In an effort to 
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reverse lost gene expression in articular cartilage and temporomandibular joint 
(TMJ) disc fibrochondrocytes, several growth factors, surface protein coatings 
and 3-D scaffolds have been investigated.60, 62~64 However, corresponding 
passage and gene expression reversal studies for the meniscus are absent. 
Hence, understanding the state of expanded meniscal fibrochondrocytes prior to 
embarking on long-term tissue engineering studies may be prudent. 
Thus, the goal of this experiment was two-fold. The first was to determine the 
effects of passage on the gene expression of important ECM molecules (collagen 
I, collagen II, aggrecan and COMP) produced by meniscal fibrochondrocytes. 
The hypothesis was that, much like articular chondrocytes, meniscal 
fibrochondrocytes would exhibit phenotypic changes in monolayer. The second 
was to reverse any changes in gene expression incurred during passage by 
plating passaged meniscus cells on either an aggrecan or a collagen I protein 
coating. 
Materials and methods 
Cell harvesting 
Medial menisci were isolated from six one wk old calf knees (Research 87 Inc.) 
by exposing the knee joint under aseptic conditions using scalpel blades. The 
procedures used were in strict accordance with the National Institutes of Health 
Guidelines on the Care and Use of Laboratory Animals. Ethics approval was 
obtained from Rice University before commencement of the study. 
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Each meniscus was taken to a cell culture hood, washed with autoclaved 
phosphate buffered saline (PBS) and transferred to a solution containing 2% 
penicillin-streptomycin-fungizone (PSF) (Cambrex) and culture medium. The 
culture medium contained 50:50 Dulbecco's modified Eagle's medium (DMEM)-
F12 (GIBCO), 10% fetal bovine serum (FBS) (Mediatech), 1% non-essential 
amino acids (NEAA) (GlBCO), 25 ug of i-ascorbic acid (Sigma) and 1% PSF. The 
outer 1/3 of each meniscus was removed and the remainder was minced into 
small fragments (<1mm3). Each minced meniscus was then placed in 30 ml_ of 2 
mg/mL collagenase type II (Worthington Biochemical) and transferred to an 
orbital shaker to be digested overnight at 37°C. Post-digestion, an equal volume 
of PBS was added to the mixture and centrifuged at 200 X g. The bulk of the 
supernatant was removed and more PBS was added and the mixture was 
centrifuged again. This process was repeated until all the collagenase was 
removed from the mixture leaving behind a white pellet of meniscal cells. Cell 
counts from each meniscus were obtained using a hemocytometer. Cell viability 
was assessed using a Trypan blue exclusion test and was found to be greater 
than 95%. 
Cell culture, passage and expansion 
From each meniscus, 1.3 million cells were obtained of which 0.2 million cells 
were placed in 1 mL of TriZol reagent (Invitrogen), 0.5 million cells were plated 
on T-75 flasks at approximately 25% confluence and the remaining 0.6 million 
cells were divided into three equal groups and placed in a 24-well non-tissue 
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culture plastic plate coating with either collagen 1 (Sigma), aggrecan (Sigma) or 
a no protein control for 24 h. Collagen I was dissolved in 0.1 M acetic acid and 
then diluted in water to a final concentration of 10 ug/cm2 per 24 well plate. 
Aggrecan was soluble in water and was reconstituted to the same concentration. 
Post-plating, the 24-well plates were kept open in the cell culture hood and 
allowed to dry overnight. The cells were allowed to settle on the coatings for one 
day, and were then scraped off the bottom using a cell scraper and placed in 1 
mL TriZol reagent. The cells in the T-75 flask were allowed to expand till 100% 
confluence and then passaged using trypsin/EDTA (GIBCO). The cells were 
counted using a hemocytometer and labeled as passage 1 (Pi) cells. From this 
cell population, 0.2 million cells were placed in 1 mL TriZol reagent, 0.5 million 
cells were plated on T-75 flasks and 0.6 million cells were divided into three 
equal groups and placed in a 24-well non-tissue culture plastic plate. This 
process was repeated until the fourth passage. The experimental design is 
shown in Figure 1. 
RNA isolation 
Gene expression abundance of these cells was measured via qRT-PCR. In the 
first step, RNA was isolated from each sample that was previously placed in 
TriZol. Chloroform was added to each sample. The samples were then 
centrifuged at 12,000 rpm for 15 min. Isopropyl alcohol was added to the 
supernatant and the sample was centrifuged again. The RNA precipitate was 
washed with 75% ethanol, and dissolved in diethylpryocarbonate (DEPC) water. 
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The concentration and purity of RNA was determined using a spectrophotometer 
(Nanodrop). 
Reverse transcriptase 
Post-RNA isolation, the samples were normalized to 200 ng of RNA per sample 
suspended in DEPC water. Prior to reverse transcription, the RNA was DNase 
treated to eliminate any DNA contamination in our samples. The RNA was then 
reverse transcribed to cDNA using a Stratascript™ First Stand Synthesis System 
(Stratagene) following the protocol set by the manufacturer. Briefly, random 
hexamers were added to each sample and the mixture was incubated at 65°C for 
5 min and then cooled to room temperature for 10 min. Finally to each sample, 
10X buffer, RNase block, dNTPs, and Stratascript enzyme was added. The 
samples were incubated at different temperatures starting at 25°C for 10 min, 
followed by 42°C for 60 min and finally 70°C for 15 min to terminate the reaction. 
Polymerase chain reaction 
The cDNA obtained from the previous step was then amplified using a Rotor-
gene 3000 real-time PCR machine (Corbett Research). Briefly, DEPC water, 10X 
buffer, MgCfe dNTP, HotStar Taq, and gene-specific primers and probes were 
added to the cDNA sample. The samples were heated to 95°C for 50 cycles, at 
15 s per cycle to denature and separate the strands of cDNA. The mix was then 
cooled to 60°C to allow the forward and reverse primers to anneal to the DNA 
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strand and the HotStar Taq to elongate both primers in the direction of the target 
sequence. 
Fluorescence measurements on FAM, Cy5 and ROX channels were taken every 
cycle at 60°C to provide a quantitative, real-time analysis of the PCR reaction for 
specific genes. The genes of interest included collagen I, collagen II, aggrecan, 
COMP, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The forward 
and reverse primers and probe sequences for the above mentioned genes are 
shown in Table 1. The primers and probes were optimized into triplexes such that 
(collagen I, COMP and GAPDH) and (collagen II, aggrecan and GAPDH) genes 
could be detected simultaneously. 
Gene expression efficiency and abundance 
The efficiency of the PCR reactions was determined by taking dilutions of 
standard samples run in duplicate (1X, 10X, 100X and 1000X). The take off cycle 
(Ct) of the standard's slope was plotted against the log standards to determine 
the slope (S). The efficiency (E) was then determined using the following 
formula.104 
E = \0S 
The abundance (A) of the gene was calculated using the determined efficiency 
for the reaction, as well as the take off cycle for the particular sample.105 
A = (l + E)-Q 
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Statistical analyses 
Statistical analysis was performed using JMP IN™ software. A one-way analysis 
of variance (ANOVA) was run with five treatment groups (PO, P1, P2, P3 and P4) 
with passage number as a factor. To compare the effects of coating, a two-way 
ANOVA was run with coating and passage treated as factors. Coating had four 
treatment groups (collagen I coating, aggrecan coating, no coating control and no 
coating passage) while passage had five treatment groups (PO to P4). If 
significance was observed with the ANOVAs, a post-hoc Tukey's HSD test was 
run to pinpoint any specific differences among groups. The significant groups 
were further analyzed by crossing coating and passage factors to test for any 
specific differences observed between passages of different coating groups. A p 
value of less than 0,05 was considered significant for all statistical tests. All 
results are shown as mean ± standard deviation. 
Results 
GAPDH as a verification gene 
For clarity, the convention mentioned in Table 2 will be used throughout the 
results and the discussion sections. GAPDH expression was observed in over 
98% of the samples that were tested and was, thus, used as a verification gene. 
Samples with undetectable levels of GAPDH were not processed and considered 
to be part of a failed reaction. No significant difference was observed in GAPDH 
expression among groups over passage. 
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Gene expression with passage 
The gene expression abundances for primary and passaged fibrochondrocytes 
are reported normalized to the amount of RNA per sample and are plotted for the 
genes of interest. These baseline passage values are shown in the upper left 
panels of Figure 2 (collagen I), Figure 3 (collagen II), Figure 4 (COMP) and 
Figure 5 (aggrecan). Over four passages, a sharp 5800-fold increase in gene 
expression was observed in collagen I levels [1.1 x 10~09 ± 1.2 x 10"09 (P0) -> 6.4 
x 10"06 ± 2.5 x10"06 (P4)] while a 70-fold decrease was observed with collagen II 
expression [1.2 x 10"08 ± 2.8 x 1009 (P0) -» 1.8 x 1010 ± 1.6 x.10:10 (P4)]. COMP 
levels decreased by 7-fold after the first passage [6.2 x 10~10 ± 4.6 x 10"10 (P0) -* 
1.2 x 10"10 ± 1.2 x 10"10 (P1)] and then stayed relatively constant over the next 
three passages. Aggrecan abundance with passage did not seem to follow any 
particular trend. A 5-fold decrease in gene expression was observed after the 
first passage [1.22 x 10"06 ± 4.17 x 10"07 (P0) -* 2.32 x 10"07 ± 1.20 x 10"07 (P1)]. 
Gene expression was then up-regulated in the second passage by approximately 
25-fold [2.3 x 10"07 (P1) ±1.20 x 10"07 -* 5.9 x 10"06 ± 2.45 x 10"06 (P2)] and then 
dipped again over the next few passages by about 1.5-fold [5.93 x 10"06 ± 2.45 x 
10-06 (P2) ^ 4.76 x 10-°6 ± 2.17 x 10-06 (P4)]. 
Reversal attempts with protein coatings 
Collagen I and aggrecan coatings were used to determine if any changes in gene 
expression occurring as a result of monolayer passage could be reversed. The 
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upper right and lower left panels of Figure 2, Figure 3, Figure 4, and Figure 5 
represent the reversal behavior exhibited by these protein coatings. 
Collagen I 
Cells placed on collagen I and aggrecan coatings showed significantly different 
gene expression profiles for collagen I over passage compared to the baseline 
passage and the ho coating groups. Both protein coatings were found to lower 
collagen I expression in the cells from the second to the fourth passage by 50% 
or greater. In addition, the gene expression in the coating groups for all passages 
was within 20% of the P0 baseline abundance values. 
Collagen II 
Contrary to expectations, the drop in collagen II expression observed over four 
passages was not reversed by either the collagen I or the aggrecan protein 
coating. In fact, both protein coatings induced a further down-regulation of 
collagen II expression by approximately 50% or more at most passage time 
points. Interestingly, even the no-coat control group showed a drop in collagen II 
expression as was observed with the protein coatings. 
Cartilage Oligomeric Matrix Protein 
Significant differences were observed between the baseline passage group and 
the two coating groups. COMP expression in cells plated on collagen I protein 
coating was up-regulated at each passage time point and had returned to 
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baseline PO levels by the third passage. In contrast, the aggrecan coating group 
showed some signs of reversal over passage, however, the effect was not as 
pronounced as the collagen I coating group. 
Aggrecan 
None of the protein coating groups were found to have an effect on the 
expression of aggrecan in the passaged cells. Cells plated on the aggrecan 
protein coating tended to decrease aggrecan expression at all passages by at 
most 2-fold when compared to baseline values, however, the groups were not 
significantly different. 
Discussion 
Cartilage tissue engineering studies generally require large numbers of cells that 
can be attained through expansion in monolayer. However, several experiments 
with articular chondrocytes and TMJ disc fibrochondrocytes have shown that 
phenotypic changes are common when dealing with passaged cartilaginous 
cells.59,60,67,106 Further, gene expression reversal back to baseline (PO) passage 
values post-expansion has been met with minimal success.60, 63 Since similar 
studies have not been performed for meniscal fibrochondrocytes, in this study the 
degree of dedifferentiation and subsequent phenotype reversal via protein 
coatings were investigated by observing gene expression changes over passage. 
Significant differences in gene expression were observed over four passages for 
collagen I, collagen II, and COMP, the first two being sensitive markers for the 
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differentiation state of primary meniscal fibrochondrocytes.107 In the gene 
expression reversal experiments, aggrecan and collagen I protein coatings aided 
in reversing collagen I and COMP expression back to primary values; however, 
collagen II expression could not be reversed. 
The morphology and phenotype of cartilaginous cells may be modulated by 
altering the culturing conditions. Meniscus cells cultured on alginate beads for 
three to four wks were found to resemble chondrocytes in morphology as well as 
upregulate collagen II expression.107 Similar results have been observed with 
dedifferentiated chondrocytes placed in 3-D hydrogels such as agarose or 
alginate.62,67 On the other hand, meniscus cells seeded for one day in monolayer 
appeared to be either rounded like chondrocytes or spindle-shaped like 
fibroblasts. However, after one wk in monolayer, all cells spread and proliferated, 
exhibiting a morphology characteristic of fibroblasts.107 It has been consistently 
shown in the literature that cartilaginous cells exhibiting a fibroblastic morphology 
express high levels of collagen I, with a down-regulation in collagen II 
expression.60,106,108,109 A similar result was observed in this experiment, where 
collagen I expression increased by 5800-fold over four passages while collagen II 
expression decreased by 70-fold. This observation may be attributed to 
dedifferentiation of meniscus cells in monolayer, analogous to dedifferentiation 
observed by Darling and Athanasiou.60 However, the presence of multiple cell 
populations in the inner two thirds of the meniscus that can proliferate at different 
rates must also considered as a potential contributor to the observed 
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phenomenon. For instance, the rapid upregulation in collagen I expression, as 
normalized to total cells/sample, may be achieved by an increase in collagen I 
expression per cell, or in the case of multiple cell populations, an increase in the 
number of collagen I producing cells, or by a combination of the above.10,106,107 
Similarly, the observed down-regulation of collagen II may be a direct 
consequence of a decrease in the ratio of chondrocyte-like cells to fibroblast-like 
cells. Unfortunately, it is difficult to ascertain whether the passaged meniscus 
cells are composed of two cell populations or just one cell population expressing 
mainly fibroblastic genes. In future experiments examining gene expression, it 
will be imperative to identify whether cell populations can be clearly distinguished 
prior to passage and if so, isolate the different cell types and analyze their 
proliferative, morphological and phenotypic properties separately to gain a better 
understanding of their individual contributions to the observed results. 
Gene expression profiles of COMP, a pentameric glycoprotein found 
preferentially in the pericellular and territorial matrices of meniscus cells, were 
found to decrease significantly with passage.16,11° Disruptions or mutations in the 
COMP structure have been linked with skeletal development disorders such as 
pseudochondroplasia and multiple epiphyseal dysplasia, underlining the 
importance of COMP in the tissue.111,112 A recent study with chondrocytes has 
shown that collagen II down-regulation (the most common chondrocyte 
dedifferentiatioh marker) during monolayer passage is accompanied by a quicker 
down-regulation of COMP.59 Similar, results were obtained in this experiment, 
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where COMP expression dropped 7-fold after the first passage, albeit slower 
than collagen II expression drop (15-fold post first passage). These results are in 
agreement with previous studies that have determined the function of COMP to 
be that of maintaining the integrity and properties of the collagen II network by 
bridging collagen II and collagen IX fibrils.59,113 
In addition to culturing conditions, the effect of aging on meniscus cells is a 
relevant topic of interest. Behavioral differences between immature and adult 
animals on the level of primary cells exist, and passaged adult cells may 
dedifferentiate to a different phenotype when compared to the cells examined in 
this study. Combining the results of this study with previous literature, such 
differences are expected to be small and the same trends are expected to hold. 
For instance, a protein expression study using skeletally mature and immature 
rabbit fibrochondrocytes expanded in primary and secondary monolayer culture 
showed no significant differences in sulfated proteoglycans and cell number.114 
With respect to the increased collagen I expression and decreased collagen II 
expression seen in this study as a result of passaging, a more recent gene 
expression study by Hellio Le Graverand and associates showed that, when 
compared to cells from immature tissue, adult primary cells expressed higher 
collagen I and lower collagen II.37 This observation, taken together with past 
literature on the dedifferentiation of chondrocytes and the results of this study, 
would indicate that adult cells are unlikely to be able to reverse this trend (i.e. 
begin to express more collagen II and less collagen I).60 The practical result of 
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this study is thus that, as with cells from immature tissue, with adult cells, the 
already scarce collagen II expression is likely to be even lower with passage. 
The rapid changes in gene expression of meniscus cells over passage are 
concerning as this has important implications for future tissue engineering 
studies involving passaged meniscus cells. Several techniques have been used 
in the past to promote gene expression reversal of passaged chondrocytes and 
TMJ disc fibrochondrocytes back to primary cell values. These techniques have 
included utilizing growth factors, 3-D hydrogels and protein coatings.60, 62, 64, 67 
For meniscus cells, experiments have focused mainly on preventing 
dedifferentiation and stabilizing phenotype. For example, human meniscus cells 
cultured in alginate beads have been shown to obtain a round chondrocytic 
shape as well as maintain expression of collagen II over 3 to 4 wks.107 For most 
tissue engineering studies, however, the cell population needs to be expanded. 
Culturing cells in 3-D environments, such as alginate, has been shown to 
promote protein synthesis while suppressing cell proliferation.60, 109 Unless an 
alternate medium that promotes both cell proliferation and phenotype retention is 
identified, gene expression reversal back to primary cell values of expanded 
meniscus cells in monolayer remains the most viable option. 
We hypothesized that exposing passaged meniscus cells for 24 h to collagen I or 
aggrecan, proteins abundantly present in the meniscus, would mimic the in vivo 
environment and be conducive to reversing lost phenotype. It is known that cells 
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plated in monolayer interact with proteins present in FBS that are adsorbed to the 
cell culture flask.115,116 This results in stimuli not generally encountered in vivo, 
prompting changes in cell morphology and surface marker expression.117. An 
interesting result of the reversal study was that aggrecan coating lowered 
collagen I gene expression back to PO baseline passage values. Previous 
studies in our laboratory have shown that insulin-like growth factor-l (IGF-I) 
treated dermal fibroblasts plated on an aggrecan surface coating adopted a 
chondrocytic phenotype and morphology, thus, initiating expression of collagen II 
with a down-regulation of collagen I.118 Passaged meniscus cells contain a high 
population of fibroblast-like cells, thus, the observed decrease in collagen I 
expression was not surprising.107 The absence of IGF-I in the culture medium, 
however, may have contributed to the lack of collagen II expression reversal. It is 
plausible that IGF-I or other growth factors are essential for the expression of 
collagen II on fibroblast-like cells placed on an aggrecan protein coating.118 
However, the results of this study could also be a consequence of insufficient 
exposure time (i.e., 24 h) to the aggrecan protein coating. 
Collagen I protein coating was found to down-regulate collagen I expression and 
up-regulate COMP expression. The down-regulation of collagen I expression 
may be attributed to a collagen I saturation effect experienced by the cells via 
integrins on the cell surface. It is known cell-surface integrins can attach to region 
1 (e.g., G2 l-domain) of collagen I surfaces with a similar homology to the von 
Willebrand factor.119 In addition, integrins also aid in transmission of intracellular 
38 
signals that can regulate cell growth, differentiation and motility.120 Thus, it is 
likely that similar integrins on passaged meniscus cells can sense the presence 
of excess collagen I in the vicinity and relay messages to the nucleus to down-
regulate collagen I expression. Proliferative rates of cells may affect gene 
expression as well, as is commonly observed in growth plate chondrocytes.121 It 
has been shown that fibroblastic cells on 3-D collagen I matrices have slower 
proliferative rates than chondrocytic cells on the same surface; although, the 
opposite is true in monolayer culture.122,123 As passaged meniscal cells exhibit 
mainly fibroblastic properties, the down-regulation of collagen I may, perhaps, be 
attributed to the slower proliferation rate of these fibroblast-like cells. The 
upregulation of COMP gene expression back to primary fibrochondrocyte levels 
by the third passage was another exciting finding. COMP is an important marker 
for the dedifferentiation state of articular chondrocytes and its upregulation may, 
thus, signal a resurgence of the chondrocytic population in the meniscus.59 
In this experiment, GADPH expression stayed relatively constant with passage 
and may be used as a housekeeping gene for future meniscus tissue 
engineering studies. GAPDH has often been employed as a useful housekeeping 
gene in RT-PCR studies not involving other standardization techniques. It is 
commonly believed that within the same tissue sample, GADPH mRNA 
expression levels are relatively constant while they can vary considerably 
between tissue types.124 Recent studies with fibrochondrocytes from the TMJ 
disc suggest that even though GADPH may be constant in different regions of 
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the disc, there is a definite change in abundance with passage, a phenomenon 
not observed in passaged meniscal fibrochondrocytes.106 
Conclusions 
In summary, these data indicate that the cells of the inner 2/3rd of the meniscus 
undergo significant changes during monolayer expansion and passage. They 
experience losses in major chondrocyte markers (collagen II and COMP) while 
simultaneously experiencing gains in fibroblastic markers (collagen I). Reversal 
efforts to regain lost phenotype in passaged meniscus cells via protein coatings 
were successful for collagen I and COMP via collagen I and aggrecan coatings. 
However, collagen II gene expression reversal proved to be unsuccessful. A lack 
of collagen II could result in structural breakdown of the tissue as well as preempt 
osteoarthritis;14,125,126 Hence, it will be important to investigate alternate vehicles 
to reverse losses in collagen II expression in passaged meniscus cells. These 
could include studying alternate protein coatings such as collagen II and decorin, 
adding growth factors such as transforming growth factor-pi (TGF-pl), fibroblast 
growth factor-ll (FGF-II), and IGF-I to the culture medium or culturing the cells in 
novel 2-D or 3-D environments that support proliferation while maintaining 
morphology.60'64'65-67'127"130 
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Figure 1. Experimental design 
In brief, bovine meniscus cells were expanded through four passages in 
monolayer culture; 0.5 * 106 cells were expanded in a T-75 flask to confluence. 
At each passage time point, 0.2 * 106 cells were collected for RT-PCR, and 0.2 * 
106 cells were plated on an aggrecan or collagen I two-dimensional surface 
coating or on a no coating control for 24 hrs and then subsequently processed for 
RT-PCR. The gene expression profiles with passage and on the different protein 
coatings were then determined, n = 6 was used for all gene expression 
abundance evaluations. 
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Figure 2. Collagen I gene expression profiles 
The x-axis refers to the passage number, and the y-axis to the gene expression 
abundance (in the exponent notation used, 'E-ri stands for '* 10"'). Small letters 
denote significant differences with passage, using a one-way analysis of variance 
(top left). Capital letters denote significant differences between levels (passage, 
collagen I coating, aggrecan coating and no coating), using a two-way analysis of 
variance. Stars denote groups that are not significantly different from values of 
the primary cells (that is, the P0 value in the top left panel), using an interaction 
term between the two factors. 
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Figure 3. Collagen II gene expression profiles 
The x-axis refers to the passage number, and the y-axis to the gene expression 
abundance (in the exponent notation used, 'E-n' stands for '* 10""'). Small letters 
denote significant differences with passage, using a one-way analysis of variance 
(top left). Capital letters denote significant differences between levels (passage, 
collagen I coating, aggrecan coating and no coating), using a two-way analysis of 
variance. 
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Figure 4. COMP gene expression profiles 
The x-axis refers to the passage number, and the y-axis to the gene expression 
abundance (in the exponent notation used, 'E-n' stands for '* 10""'). Small letters 
denote significant differences with passage, using a one-way analysis of variance 
(top left). Capital letters denote significant differences between levels (passage, 
collagen I coating, aggrecan coating and no coating), using a two-way analysis of 
variance. Stars denote groups that are not significantly different from values of 
the primary cells (that is, the P0 value in the top left panel), using an interaction 
term between the two factors. 
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Figure 5. Aggrecan gene expression profiles 
The x-axis refers to the passage number, and the y-axis to the gene expression 
abundance (in the exponent notation used, 'E-n' stands for '* lO""'). Small letters 
denote significant differences with passage, using a one-way analysis of variance 
(top left). Capital letters denote significant differences between levels (passage, 
collagen I coating, aggrecan coating and no coating), using a two-way analysis of 
variance. Stars denote groups that are not significantly different from values of 
the primary cells (that is, the PO value in the top left panel), using an interaction 
term between the two factors. 
Table 1: Primer and probe sequences of desired genes 
Target gene 
(GenBank 
accession number, 
product size) 
Collagen I 
(NM-174520, 97bp) 
Collagen II 
(X02420, 76bp) 
Aggrecan 
(U76615, 76bp) 
COMP 
(X74326, 72bp) 
GAPDH 
(U85042, 86bp) 
Forward primer (5' - 3') 
CATTAGGGGTCACAATGGTC 
AACGGTGGCTTCCACTTC 
GCTACCCTGACCCTTCATC 
TCAGAAGAGCAACGCAGAC 
ACCCTCAAGATTGTCAGCAA 
Reverse primer(5' - 3') 
TGGAGTTCCAI I I ICACCAG 
GCAGGAAGGTCATCTGGA 
AAGCTTTCTGGGATGTCCAC 
TCTTGGTCGCTGTCACAA 
ACGATGCCAAAGTGGTCA 
Target gene 
(GenBank 
accession number, 
product size) 
Collagen I 
(NM-174520, 97bp) 
Collagen II 
(X02420, 76bp) 
Aggrecan 
(U76615, 76bp) 
COMP 
(X74326, 72bp) 
GAPDH 
(U85042, 86bp) 
Probe (5' - 3') 
ATGGATTTGAAGGGACAGCCTTGG 
ATGACAACCTGGCTCCCAACACC 
TGACGCCATCTGCTACACAGGTGA 
CAGAGGGATGTGGACCACGACTTC 
CCTCCTGCACCACCAACTGCTT 
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Table 2. Explanation of different passage numbers and surface coating 
groups 
Passage 
PO 
P1 
P2 
P3 
P4 
Unpassaged cells 
Cells undergone one 
passage 
Cells undergone two 
passages 
Cells undergone three 
passages 
Cells undergone four 
passages 
Coating 
Baseline passage 
COM coat 
Age coat 
No coat 
Cells from POto P4 
on T-75 flasks 
Cells from PO to P4 
on collagen I coat 
Cells from PO to P4 
on aggrecan coat 
Cells from PO to P4 
on a no coat control 
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Chapter 3: Temporal effects of culture media on 
unseeded non-woven PLLA meshes for meniscus tissue 
engineering 
Najmuddin J. Gunja and Kyriacos A. Athanasiou 
I would like to acknowledge Dr. Elizabeth Christenson and Sue Anne Chew for 
assisting with the GPC and 1H-NMR assays, respectively 
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Abstract 
A variety of scaffolds are currently used for meniscus tissue engineering 
including agarose, alginate and PLLA. Of these, PLLA has shown particular 
promise in supporting meniscus cell adhesion and proliferation on the construct, 
as well as ECM deposition on the construct. However, the temporal effects of 
aqueous medium on the mechanical and degradation properties of PLLA 
scaffolds used in our tissue engineering approach have not been studied. In this 
experiment, three culturing conditions were examined (PBS, medium + 10% FBS 
and serum free medium) and scaffolds were cultured for 0, 4, 8, or 12 wks. 
Compressive biomechanical and tensile tests were performed at each time point 
for each culturing condition. In addition, GPC and proton NMR-spectroscopy 
were performed to examine molecular weight (MW) and ester degradation over 
time. No significant differences were observed for compressive and tensile 
properties among culturing conditions at each time point and over time. GPC 
results showed that the MW of our scaffolds ranged from 108 kDa ± 12 kDa at t = 
0 wks to 95 ± 15 kDa at 12 wks, although this drop was not significant. Proton-
NMR spectroscopy analyses showed a typical PLLA curve with consistent peaks 
between culturing conditions and between time points suggesting that 
degradation did not take place over the 12 wk culture period. Overall, these 
results confirm that unseeded PLLA scaffolds do not degrade substantially or 
lose mechanical properties over 12 wks in culture. 
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Introduction 
Tissue engineering of the meniscus requires consideration of several factors 
including cell source, culturing conditions and animal model. Of particular 
importance is the scaffold material where the cells can proliferate and secrete 
extracellular matrix (ECM). Natural scaffolds such as collagen, small intestinal 
submucosa, perichondria! tissue and the periosteum have been studied for 
meniscus tissue engineering and a summary of the results obtained with these 
scaffolds has been reviewed elsewhere.131 Synthetic polymer scaffolds, such as 
poly-urethane, poly-l-lactic acid (PLLA), poly-glycolic acid (PGA), poly-
caprolactone (PCL) are also gaining popularity.131 The mechanical and 
degradation properties of these scaffolds can be tailored depending on the 
manufacturing or fabrication process.57 Of these synthetic materials, some 
warrant no further research, while others such as PLLA which are amenable to 
cell attachment and proliferation and support ECM production need to be further 
characterized. 
In the present study, we sought to characterize the degradation and mechanical 
properties of unseeded non-woven PLLA scaffolds used in the laboratory for 
meniscus and tempormandibular joint (TMJ) disc tissue engineering. Cells can 
quicken the degradation of polymers such as PLLA by releasing factors and 
enzymes that can quicken ester hydrolysis, the mechanism known to degrade 
PLLA.57 PLLA itself undergoes bulk degradation over time in aqueous medium 
which results in a loss of molecular weight.132 Bulk degradation is the 
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predominant process of degradation in poly-lactides and glycolides. A recent 
study has shown that bovine serum albumin, an important component of fetal 
bovine serum, can quicken PLLA degradation.133 Several tissue engineering 
studies utilize FBS as an important component of the culture medium and, thus, 
its effect of PLLA degradation may influence construct properties. 
The objective of this study was to ascertain that the scaffold used in our 
meniscus tissue engineering studies does not degrade prematurely, potentially 
impeding ECM production. To isolate the effects of culture medium and time, we 
examined unseeded PLLA constructs at multiple time points ranging from 0 to 12 
wks. In addition, three different culture media were utilized, phosphate buffered 
saline (PBS), medium with FBS and serum free medium. It was hypothesized 
that: a) scaffolds cultured in medium with FBS would degrade to a greater extent 
than those cultured in other groups; and b) the mechanical properties and MW of 
the scaffolds would decrease over time in aqueous solution but not substantially. 
Materials arid methods 
Scaffold culture 
Cylindrical 2 mm thick and 3 mm wide non-woven PLLA scaffolds (Biomedical 
structures) were obtained from a PLLA sheet using a 3 mm dermal punch. The 
porosity of the scaffolds was over 90% with fiber diameters approximately 25 urn. 
The scaffolds were sterilized using ethylene oxide. They were then pre-wetted 
with 70% ethyl alcohol, and subsequently washed twice with phosphate buffered 
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saline (PBS). The scaffolds were housed in individual wells of 12 well plates that 
were previously coated with 0.5 ml of 2% sterile molten agarose and incubated 
overnight in culture medium. 60 scaffolds per group were cultured in one of three 
aqueous conditions: a) PBS b) Dulbecco's Modified Eagle's Medium (DMEM) 
and c) DMEM and 10% FBS. The culture medium was changed once every 3 
days for a period of 12 wks. At 0, 4, 8 and 12 wks, 15 scaffolds from each group 
were removed and processed for biomechanical testing, proton-nuclear magnetic 
resonance (H-NMR) and gel permeation chromatography (GPC). 
Compressive tests 
The viscoelastic compressive properties of samples from each group (n = 5) 
were tested at t = 4 wks using a set up described previously.134 Briefly, an 
incremental stress relaxation test at 10%, 20% and 30% strain was designed and 
implemented after determining the height of the construct. Each sample was held 
at the chosen strain level for 20 min with a 10% strain step. The strain rate was 
kept constant throughout at 0.5 mm/s. Data obtained from each test were fitted 
using MATLAB to an incremental stepwise viscoelastic stress relaxation solution 
for a standard linear solid.135 The parameters obtained were converted to 
instantaneous modulus (Ej), relaxation modulus (Er) and coefficient of viscosity 
(u) for each strain level. 
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Tensile tests 
Five samples were used for tensile tests at t = 4 wks. Tests were performed 
using an Instron 5565 with a 50 N load cell. To ensure testability, samples were 
carefully carved into a dog-bone shape with a 2 mm gauge length. The ends of 
the samples were glued to paper tabs using cyanoacrylate. After a 0.05 N tare 
load was applied, the constructs were pulled to failure at a constant strain rate of 
0.02 s"1. Stress-strain curves generated from the test yielded the tensile stiffness 
and the ultimate tensile strength (UTS) of each construct. 
Proton - NMR spectroscopy 
Post-compression, two PLLA samples from each group were processed for 1H-
NMR spectroscopy to analyze chemical structure and to probe for potential ester 
degradation to the polymer. Samples were dissolved in CDCI3 and NMR spectra 
were acquired on a Bruker AC-250 spectrophotometer. 
Gel permeation chromatography 
Three samples from each group were combined and weighed at each time point. 
Chloroform was added to the samples at 20mg/ml. Molecular weight distributions 
were determined using gel permeation chromatography. Phenogel columns and 
guard columns (50x7.8 mm, 5 urn, mixed bed, Phenomenex, Torrance, CA) were 
used to elute samples at 1 ml/min flow rate. Known molecular weights of 
polystyrene were used to form calibration curves. 
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Statistical analyses 
The two factors (culturing condition and time) were compared using a two-way 
analysis of variance (ANOVA). If significant differences were observed, a Tukey's 
post hoc test was performed to determine specific differences among groups. A 
significance level of 95% with a p value of 0.05 was used in all statistical tests 
performed. All values are reported as mean ± standard deviation. 
Results 
Gross morphology 
At all time points, samples appeared to retain their shape and structure with no 
observable signs of degradation. Temporally, no significant differences were 
observed in the thickness and diameter of constructs cultured in the three types 
of media. 
Compressive tests 
Compressive viscoelastic tests were performed at three different strain levels, 
10%, 20% and 30% and the instantaneous modulus/relaxation modulus and 
coefficient of viscosity were determined at each strain level (Figure 6). No 
significant differences were observed among groups for the three tested 
parameters at all strain levels. In addition, no temporal differences were 
observed among groups for the compressive properties. Values for the 
instantaneous modulus ranged from 10-15 kPa, the relaxation modulus ranged 
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from 6-9 kPa and the coefficient of viscosity ranged from 0.4 to 0.55 MPa-s. 
These values persisted at later time points as well. 
Tensile tests 
The highest tensile stiffness and strength values were recorded in the serum free 
medium group at t = 0 with 400 ± 130 kPa and 220 + 120 kPa, respectively 
(Figure 7). The lowest tensile stiffness and strength values were recorded in the 
medium + FBS groups at t = 12 wks with 380 ± 100 kPa and 190 + 100 kPa. 
Although a general downward trend was observed in tensile properties over time, 
the differences among groups and time points were not significant. 
Proton - NMR spectroscopy 
1H-NMR spectra for PLLA scaffolds in all groups and at all time points were 
unremarkable (Figure 8). Specifically, evidence of ester degradation in scaffolds 
cultured for longer time points was not observed with spectra of scaffolds at t = 0 
similar to that of scaffolds cultured at t = 12 wks. In addition, the presence of FBS 
was not found to enhance degradation of ester bonds or interfere with the peaks. 
Gel permeation chromatography 
Molecular weights ranged from 108 ± 12 kDa (t = 0, PBS) to 95 ± 15 kDa (t =12 
wks, medium + FBS), however no significant differences were observed among 
groups for both factors (culturing condition (p = 0.53) and time (p = 0.11) (Table 
3). 
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Discussion 
Scaffold degradation profiles can influence the success of a tissue engineering 
study. The scaffold should be able to retain sufficient mechanical properties early 
on and allow cells to produce relevant ECM. Aliphatic polymeric scaffolds, such 
as PLLA, degrade via ester hydrolysis, which implies that the aqueous nature of 
the culture medium may play a crucial role in degradation. To isolate the effects 
of culture medium, in this experiment, unseeded PLLA scaffolds in three types of 
media (serum free medium, medium with FBS, and PBS) were examined for 0, 4, 
8 and 12 wks. Compressive and tensile properties, and molecular weights of the 
scaffolds were not found to significantly differ among groups cultured in different 
media and over time. 1H-NMR spectra did not indicate ester degradation over 
three months in culture with consistent peaks observed at all time points. Overall, 
the culture medium did not significantly affect PLLA mechanical and degradation 
properties over three months confirming the potentially non-deleterious role of 
the scaffold in tissue engineering studies. 
The mechanical properties of non-woven PLLA meshes were examined at 
various time points with no significant differences observed for the instantaneous 
modulus, the relaxation modulus, and the coefficient of viscosity. In addition, no 
obvious strain dependencies were observed; although, samples compressed at 
30% strain trended towards the highest mechanical properties. Our results agree 
with a prior study showing only minor changes in the tensile properties of PLLA 
fibers cultured in PBS.136 In that study, PLLA was cultured up to 35 wks, 
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approximately three times longer than our culture period. The molecular weight of 
the scaffolds decreased with time; however, the decrease was not significant. 
This was contrary to reports in the literature that suggest molecular weight drops 
consistently with time in culture.132, 136 These differences may be attributed to 
pre-culturing factors such as the fabrication technique, original molecular weight, 
degree of crystallinity, thermal history, inherent viscosity and porosity of the 
polymer that can influence the polymer's overall behavior.132 
FBS contains a variety of growth factors and chemicals that are beneficial for cell 
proliferation and growth. However, a recent study showed that BSA, an important 
component of FBS, enhances the degradation of PLLA films as a result of activity 
resembling the enzyme esterase that is responsible for ester degradation.133 
However, in this experiment we were unable to find any differences in 
degradation profiles of the scaffolds with time using 1H-NMR analysis. 
Conclusions 
Overall, we were able to show that the scaffolds utilized in our tissue engineering 
approach can retain their mechanical properties and MW, and do not degrade up 
to at least 12 wks in serum-free or serum containing media. Future studies will 
have to examine whether the presence of cells accelerates potential degradation 
and subsequent drop in biomechanics properties. 
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Figure 6. Compressive properties of unseeded PLLA constructs 
No significant differences were observed among culturing conditions and time 
points at all strain levels for the compressive properties of the constructs. All 
values are reported mean ± SD. 
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Figure 7. Tensile properties of unseeded PLLA constructs 
No significant differences were observed among culturing conditions and time 
points for the tensile stiffness and UTS of the constructs. All values are reported 
mean ± SD. 
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Figure 8. Representative 1H-NMR spectra of PLLA 
The structure of PLLA is shown on the top of the PLLA spectrum. A shift in the 
hydrogen peak would represent ester degradation. However, peaks did not shift 
as a result of the culture conditions or over time. 
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Table 3. Weight-average molecular weight of PLLA constructs at different 
time points 
Experimental groups 
Serum-free medium 
Medium + FBS 
PBS 
t = 0 
kDa 
105 ±11 
103 ±15 
108 ±12 
t = 4 wks 
kDa 
103 ±10 
105 ± 11 
104 ±9 
t = 8wks 
kDa 
101 ±8 
97 ±13 
99 ±14 
t=12wks 
kDa 
99 ±11 
95 ± 15 
97 ±18 
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Chapter 4: Effects of hydrostatic pressure on leporine 
meniscus cell-seeded PLLA scaffolds 
Najmuddin J. Gunja and Kyriacos A. Athanasiou 
Chapter accepted as: Gunja NJ and Athanasiou KA. Effects of hydrostatic 
pressure on leporine meniscus cell-seeded PLLA scaffolds. Biomedical Materials 
Research Part A. 
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Abstract 
Hydrostatic pressure (HP) is an important component of the loading environment 
of the knee joint. Studies with articular chondrocytes and TMJ disc 
fibrochondrocytes have identified certain benefits of HP for tissue engineering 
purposes. However, similar studies with meniscus cells are lacking. Thus, in this 
experiment, the effects of applying 10 MPa of HP at three different frequencies 
(0, 0.1 and 1 Hz) to leporine meniscus cell seeded-PLLA scaffolds were 
examined. HP was applied once every 3 days for 1 hr for a period of 28 days. 
Constructs were analyzed for cellular, biochemical and biomechanical properties. 
At t = 4 wks, total collagen/scaffold was found to be significantly higher in the 10 
MPa, 0 Hz group when compared to other groups. This despite the fact that the 
cell numbers/scaffold were found to be lower in all HP groups when compared to 
the culture control. Additionally, the total GAG/scaffold, instantaneous modulus, 
and relaxation modulus were significantly increased in the 10 MPa, 0 Hz group 
when compared to the culture control. In summary, this experiment provides 
evidence for the benefit of a 10 MPa, 0 Hz stimulus, on both biochemical and 
biomechanical aspects, for the purposes of meniscus tissue engineering using 
PLLA scaffolds. 
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Introduction 
The knee menisci, fibrocartilaginous tissues that lie on the tibial plateau, are 
involved in several important biomechanical processes, including load 
transmission, shock absorption, and lubrication of the knee joint.137, 138 The 
menisci are subjected to a variety of forces in vivo, including tension, 
compression, shear, and hydrostatic pressure (HP).15, 86, 137 The ability of the 
meniscus to withstand these forces may, to a large extent, be attributed to the 
unique collagen fiber alignment and orientation within the structure.1, 15 
Abnormalities or complications in the structure of the meniscus can lead to 
degeneration of the tissue as well as precipitate osteoarthritis.22,23 A promising 
modality to overcome this problem is functional tissue engineering which serves 
to replace a damaged meniscus with an engineered construct with desired 
biomechanical and biochemical properties. 
The past decade has seen a marked increase in efforts to engineer the meniscus 
using classical tissue engineering strategies involving cells, growth factors and 
scaffolds. The concept of using mechanical stimulation as an additional element 
to tissue engineer the meniscus is now gaining popularity.15 The importance of 
the mechanical environment for developing musculoskeletal tissues cannot be 
understated, as mechanical forces are known to influence these tissues' 
performance. For example, numerous experiments on disuse of musculoskeletal 
tissues like cartilage, muscle, and bone have been correlated to apoptosis within 
the tissues, followed by their subsequent atrophy.139"141 Additionally, in vitro 
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studies with meniscus explants and cells have shown that mechanical stimuli 
such as direct compression, tension and HP can increase extracellular matrix 
(ECM) expression and synthesis.83"91 The use of HP is of particular interest as it 
causes no macro-scale deformation to the construct, yet is responsible in 
stimulating cells to increase ECM synthesis, possibly by altering intracellular ion 
flux.92 Such a stimulus may be favorable in the early stages of a tissue 
engineering study where cells seeded on scaffolds are still in the proliferation and 
migration stages and are vulnerable to external stimuli. 
HP studies can be broadly divided into three categories, a) 2-D monolayer 
studies, b) 3^ -D explant studies, and c) 3-D tissue engineering studies. Results 
from experiments in the first category are often reported in terms of gene 
expression. Studies on articular chondrocytes and fibrocartilaginous metaplasia 
of Achilles tendon fibroblasts have shown an upregulation of aggrecan and 
collagen II expression in cells immediately after intermittent hydrostatic 
pressurization.87' 93"95 Interestingly, a further upregulation of collagen and 
aggrecan expression was observed in the fibrocartilaginous metaplasia study 
when the samples were tested 24 hrs post-stimulation suggesting that rest time 
might be an important factor to consider in long-term tissue engineering studies. 
TMJ disc cells have been shown to increase collagen I expression under static 
HP of 10 MPa and increase collagen II expression during intermittent HP 
stimulation of 10 MPa, 1 Hz.96 Studies with explants have investigated the effects 
of HP on proteoglycan synthesis as well as MMP regulation. An experiment with 
6 5 
articular cartilage explants showed that cyclic HP at physiological magnitudes 
caused an upregulation of sulfate incorporation into the explants.97 Cyclic HP on 
meniscus explants has been shown to inhibit upregulation of potent effector 
molecules such as MMP-1, MMP-3, and COX-2.86 3-D studies for tissue 
engineering purposes have been performed by encapsulating cells in alginate 
beads, using pellet cultures, seeding cells on scaffolds or using scaffold less self-
assembly techniques.96, 98~102 Results of these studies have varied significantly 
between research groups, often even when using similar cell sources. For 
example, although intermittent HP application has been shown to consistently 
increase GAG production by chondrocytes on PGA and PLGA scaffolds, as well 
as in pellet cultures, this has not been observed in self-assembled articular 
chondrocyte constructs.98, 1d0, 101 Static HP has been shown to increase both 
collagen and aggrecan synthesis in intervertebral disc cells while only increasing 
collagen content in TMJ disc cells.96," Thus, specific regimens of both static and 
intermittent HP stimuli exhibit beneficial effects for tissue engineering purposes, 
even though the underlying mechanisms are still unclear. 
In this experiment, a traditional tissue engineering approach was employed using 
meniscus cells seeded on PLLA scaffolds. Non-woven meshes of high molecular 
weight PLLA (>100kDa) degrade slowly over time and are, thus, advantageous 
for long term applications over the extensively studied PGA, which degrades 
rapidly in aqueous environments.45, 57,142,143 In addition to the longer half-life of 
the polymer, data from our laboratory using meniscus cells and TMJ disc 
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fibrochondrocytes suggest that PLLA scaffolds adequately promote cell 
proliferation and ECM synthesis and are comparable to data published with PGA 
scaffolds.45, 96, 144 Thus, PLLA was chosen as the scaffold material for the 
experiment. 
The objective of this study was to determine the effects of periodic and 
intermittent HP on leporine meniscus cell-seeded PLLA scaffolds. Several 
different loading regimens were tested where the frequency of loading and the 
pressure applied were controlled. The hypothesis was that both intermittent and 
static HP would increase the production of collagen and GAG molecules on the 
scaffolds as well as enhance the mechanical integrity of the scaffolds as a result 
of matrix deposition. 
Materials and methods 
Cell harvesting 
Medial and lateral menisci were isolated under aseptic conditions from 1 to 2 yr 
old New Zealand white rabbits, sacrificed by a local rabbit breeder on the day of 
harvest. Each meniscus was taken to a cell culture hood, washed with 
autoclaved phosphate buffered saline (PBS) and transferred to culture medium 
containing 2% penicillin-streptomycin-fungizone (PSF) (Cambrex). The culture 
medium contained 50:50 Dulbecco's modified Eagle's medium (DMEM)-F12 
(Invitrogen), 10% fetal bovine serum (FBS) (Mediatech), 1% non-essential amino 
acids (NEAA) (Invitrogen), 25 ug of l-ascorbic acid (Sigma) and 1% PSF. The 
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menisci were minced into small fragments (< 1 mm3) and digested overnight at 
37°C in 2 mg/ml collagenase type II (Worthington Biochemical). Vascular portions 
of the meniscus were discarded prior to mincing. Post-digestion, an equal volume 
of PBS was added to the collagenase digest and the mixture was centrifuged at 
200 g. The bulk of the supernatant was removed, more PBS was added, and the 
mixture was centrifuged again to wash the pellet of collagenase. This process 
was repeated twice leaving behind a white pellet of meniscus cells. Cell counts 
were obtained using a hemocytometer. Cell viability was assessed using a 
Trypan blue exclusion test and was found to be greater than 95%. The cells were 
then resuspended in culture medium supplemented with 20% FBS and 10% 
dimethyl sulfoxide (DMSO) and frozen at -80°C for up to a month. 
Cell culture and passage 
Cells from four rabbits were pooled together after thawing, and the viability was 
found to be over 90%. The cells were then plated on T-225 flasks at 25% 
confluence and allowed to expand. At full confluence, the cells were passaged 
using trypsin/EDTA (Invitrogen) and counted with a hemocytometer. 
Scaffold, spinner flask preparation and cell seeding 
High molecular weight (100 kDa) non-woven PLLA scaffold sheets (~90% 
porosity) (Biomedical Structures) were cut into cylinders 1.5 mm in thickness and 
3 mm in diameter using a 3 mm dermal punch. Each scaffold was strung on a 
stainless steel wire, alternating with beads to avoid scaffold-scaffold contact. The 
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scaffolds were sterilized using ethylene oxide. These were then pre-wetted in 
70% isopropyl alcohol, washed twice with PBS, and placed in an autoclaved 
spinner flask filled with regular culture medium. Cells, passaged once, were 
seeded into the spinner flask at a density of 0.7 million cells/scaffold 
corresponding to approximately 50,000 cells/mm3 of scaffold by volume. Stirrer 
bars placed at the bottom of the spinner flask were rotated at 60 RPM post-
seeding for 3 days. The scaffolds were left in the spinner flask for an additional 4 
days without stirring to allow cells to fully adhere to the polymer. After 1 wk, the 
steel wire was removed and the cell-seeded constructs were transferred to 
agarose-coated six-well plates. The agarose coatings on the wells were prepared 
by adding 1.5 ml of 2% sterile molten agarose to each well. Each well housed six 
cell-seeded scaffolds. 
Experimental groups 
Post-static culture, the scaffolds were randomly assigned into HP or control 
groups (n = 6 per group). Three different HP groups (Figure 9) were tested. 
Scaffolds in the first group were exposed to static HP of 10 MPa for 1 hr every 3 
days for 4 wks. Semantically, a static HP regimen implies one continuous 
application throughout the entire culture duration; however, since the application 
occurred repeatedly over a period of 4 wks with non-pressurized rest in between, 
the term periodic HP will be used throughout the results and the discussion 
section to describe this group. The second and third groups were intermittent HP 
groups where 10 MPa at 0.1 Hz or 10 MPa at 1 Hz of HP was applied for the 
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same period as the periodic HP group. These particular regimens were chosen 
based on their benefits observed in prior HP experiments.87, 96,145 Additionally, 
during the 1 hr of stimulation, a duty cycle of 60 s on, 60 s off was employed for 
the intermittent HP groups. This was employed based on a study with 
dynamically stimulated articular cartilage explants where increased radiolabeled 
sulfate uptake was observed if a rest time of 100 s or less was employed 
between each stimulation.146 Two control groups were utilized in this experiment 
(Figure 9). Scaffolds in the first control group remained in six-well plates for the 
duration of the experiment (culture control). The second control group consisted 
of unpressurized scaffolds that underwent the same manipulation as pressurized 
scaffolds including loading into the pressure chamber, except no pressure was 
applied (HP control). 
HP preparation and application 
The cell-seeded scaffolds in the HP groups were placed in histology cassettes 
(Fisher Scientific) that were previously cleaned with 70% isopropyl alcohol and 
sterilized with ethylene oxide. The cartridges were then transferred to individual 
heat sealable sterile bags (Ampac). To each bag, 30 ml of culture medium with 
1% FBS (supplemented with 10mM Hepes) was added, and the bag was tapped 
lightly to remove air bubbles from the medium and from the cartridges. The bag 
was then heat-sealed without any bubbles inside. 
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The HP set-up used in this experiment has been described previously.96, 101 
Briefly, the control specimens were placed in an open unpressurized chamber 
while the pressurized specimens were placed in a water filled stainless steel 
chamber (Parr Instrument Company) that connected to an Instron 8871 via a 
water-driven stainless steel piston (PHD Inc.). Both chambers rested in a water 
bath set at 37°C. Displacement was controlled by an Instron WaveMaker 
program that also recorded pressures. Post-stimulation, the bags containing the 
scaffolds were cleaned with 70% isopropyl alcohol and transferred back into the 
culture hood and unsealed. The scaffolds were then removed from the cartridges 
and placed back into six-well plates with fresh medium. 
Histology 
Post-stimulation (t = 4 wks), one sample from each group was frozen and 
sectioned at 12 urn and placed on adhesive slides (Instrumedics). Ultraviolet light 
was used to crosslink the section to the slide. Harris hematoxylin and eosin 
(H&E) stains were performed to confirm presence of ECM. Safranin-0 / fast 
green stains were performed to examine the distribution of glycosaminoglycans 
in the section.147 Picrosirius red was used to determine the presence of 
collagen.148 
Biomechanics 
The viscoelastic compressive properties of samples from each group (n = 5) 
were tested post-stimulation (t = 4 wks) using an Instron 5565 set-up described 
71 
previously.134 Incremental stress relaxation curves were obtained at 10%, 20%, 
and 30% strain for 5 min each. Data were fitted using MATLAB to an incremental 
stepwise viscoelastic stress relaxation solution for a standard linear solid.135 
Fitted parameters obtained were converted to instantaneous modulus (Ei), 
relaxation modulus (Er) and coefficient of viscosity (u). 
Biochemistry 
Biochemical tests were performed on samples at t = 0 wks and t = 4 wks. The 4 
wk samples were obtained post-biomechanical testing. All samples were 
digested at 65°C overnight with 125 ug/ml papain (Sigma) in 50 mM phosphate 
buffer (pH = 6.5) containing 2 mM N-acetyl cysteine (Sigma) and 2 mM EDTA. A 
picogreen cell proliferation assay kit (Molecular Probes) was used to determine 
total DNA content in each sample. It was assumed that each cell contains 7 
picograms of DNA content, as reported in the literature.149 Samples were also 
tested for total GAG present by a dimethymethlylene blue (DMMB) assay.150 A 
modified hydroxyproline assay was used to determine total collagen in the 
scaffold.151 
Statistical analyses 
The quantitative biochemical and biomechanical data were compared using a 
one-way analysis of variance (ANOVA) where HP was the single factor. If a 
statistical difference was observed, a Tukey's post hoc test was performed to 
determine specific differences among groups. A significance level of 95% with a 
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p value of 0.05 was used in all statistical tests performed. All values are reported 
as mean ± standard deviation (SD). 
Results 
Gross morphology and histology 
Post-seeding, cells on the PLLA scaffold appeared elongated with multiple 
protrusions attached to the PLLA fibers. In addition, clusters of rounded cells 
were also observed lodged between fibers of the non-woven PLLA mesh. At t = 4 
wks, the presence of translucent tissue was observable in all groups (Figure 10), 
however, this was more prominent in the controls and the periodic HP group (10 
MPa, 0 Hz) where holes created by the stainless steel wire through the centers of 
scaffolds prior to seeding were filled with ECM. The holes were still partially 
visible in the intermittent HP groups. Though structural integrity was maintained 
over 4 wks in all constructs, the scaffolds exposed to intermittent HP (10 MPa, 
0.1 and 1 Hz) were less uniform around the periphery; i.e., strands of single or 
multiple fibers projected outwards when compared to the scaffolds in the other 
groups. At t - 4 wks, construct diameter in the culture control and the intermittent 
HP groups was 3.0 ±0.1 mm while in the HP control and the HP 10 MPa 0 Hz 
groups the diameter was higher, 3.1 ± 0.1 mm and 3.1 ± 0.8 mm, respectively. 
The thickness of the constructs varied from 1.4 ± 0.2 mm for the 10 MPa, 1 Hz 
group to 1.7 ± 0.2 for the 10 MPa, 0 Hz group. No significant differences, 
however, were observed among groups for the construct diameter (p = 0.71) and 
thickness (p = 0.27). H&E stains confirmed the presence of ECM in, all groups 
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(Figure 11). Safranin-O / fast green exhibited little staining for proteoglycans, 
correlating with low GAG production observed in all groups (Figure 11). 
Picrosirius red staining was positive, with stronger staining observed on the 
periphery of the scaffolds (Figure 11). 
Biochemistry 
Dry and wet weights of the scaffolds at t = 4 wks are shown in Table 4. The dry 
weight of scaffolds exposed to a pressure of 10 MPa at 1 Hz was approximately 
1.3 ± 0.3 mg, half the weight of scaffolds in other groups (p = 0.009). The wet 
weight of the scaffolds ranged from 12.4 ± 0.5 to 15.7 + 2.9 mg; however, no 
significant difference was observed among groups (p = 0.37). A significant 
difference was observed in cell number/scaffold among groups (p < 0.0001) 
(Table 4). Cells were originally seeded at 0.7 million cells/scaffold. At t = 0, the 
cell count was measured at 0.62 ±0.17 million cells/scaffold (efficiency > 80%) 
and by the 4th wk, the number of cells on the control scaffolds increased to 0.8 
million cells/scaffold, although increase over t = 0 was not significant. However, 
an inter-group comparison showed that the cell numbers on scaffolds in all HP 
groups (<= 0.5 million cells/scaffold) were fewer than in the culture control at t = 4 
wks. No detectable collagen or GAG was observed at t = 0. At t = 4 wks (Figure 
12), the total collagen/scaffold was found to be 2 times higher in the periodic HP 
group (27 ug ± 5 ug) than in all other HP groups and controls (p = 0.0006). At t = 
4 wks, low amounts of GAG (Figure 12) were detected in all groups (< 8 
ug/scaffold, p = 0.03). A significant difference in GAG/scaffold was only observed 
74 
between the 10 MPa, 0 Hz group and the culture control (~1.8 times higher). 
Collagen and GAG data were also normalized to cell number (Figure 12). In both 
cases, all three HP groups (10 MPa 0, 0.1, and 1 Hz) were found to exhibit 
significantly higher collagen levels/cell when compared to the controls. The 
highest collagen content/cell (p = 0.003) was exhibited in the 10 MPa, 0 Hz group 
with collagen values 3 times greater than the culture control. For GAG 
content/cell (p = 0.008), a 3 time greater GAG accumulation was observed in 10 
MPa, 0 Hz and 10 MPa, 1 Hz groups when compared to the culture control. 
Biomechanics 
f he viscoelastic parameters, Er, Ej and u, were determined at 10%, 20%, and 
30% strain via incremental stress relaxation tests. No apparent strain 
dependencies were identified for any of the parameters. Values of Er, Ej, and u at 
30% strain are shown in Figure 13. In general, the instantaneous modulus 
ranged from 31-88 kPa while the relaxation modulus ranged from 8-30 kPa 
among groups. The periodic HP group was found to be significantly stiffer than 
the culture control and 10 MPa, 1 Hz groups for the instantaneous moduli (~ 1.5 
times stiffer, p = 0.005) and relaxation moduli values (~ 1.75 times stiffer, p = 
0.02). The coefficient of viscosity (p = 0.05) was found to be greatest for the 
periodic HP group (730 ± 167 Pa-s) and lowest for the culture control (241 ± 190 
Pa-s). Similar differences were also observed for these parameters at 10% and 
20% strain. 
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Discussion 
HP was used as a mechanical stimulus to coax meniscus cells seeded on PLLA 
constructs to upregulate relevant ECM matrix in vitro, as well as to enhance the 
biomechanical properties of the constructs. The results of this study show that 
HP does, indeed, have a beneficial effect for meniscus tissue engineering 
purposes. It was found that the application of periodic HP (10 MPa, 0 Hz) for 1 hr 
every 3 days resulted in constructs with greater collagen deposition when 
compared to the other examined groups. In addition, the compressive 
mechanical properties of scaffolds in this group were found to be significantly 
higher than scaffolds in the culture control and the 10 MPa, 1 Hz group. 
Physiologic pressures in the knee joint range from 3-18 MPa.152, 153 To our 
knowledge there is scant information about pressures experienced by 
fibrochondrocytes and chondrocytes. Several mechanical tests have shown that 
chondrocytes in articular cartilage experience 7 to 10 MPa of hydrostatic 
pressure during normal activities.154 In addition, a frequency ranging from 0.6 to 
1.09 Hz is observed during normal walking rhythm of an adult human.155 Thus, 
the goal in this experiment was to apply physiologically relevant pressures to 
knee meniscus constructs. Several tissue engineering studies with articular 
chondrocytes and TMJ disc fibrochondrocytes have shown beneficial effects for a 
loading regimen of 10 MPa 94,96,156 and for frequencies between 0 and 1 Hz.96, 
ioi, 157 j^s a f j r s t s t e p w e SQUgnt t0 u s e these beneficial regimens for a meniscus 
tissue engineering strategy. Thus, a pressure of 10 MPa at three frequencies (0, 
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0.1 and 1 Hz) was investigated with clear benefits for the 10 MPa, 0 Hz group. In 
future studies, we will examine alternative loading regimens and frequencies to 
further optimize and enhance the biochemical and biomechanical properties of 
meniscus cell-seeded constructs. 
The cell numbers per scaffold in each group were analyzed to determine whether 
a particular HP stimulus resulted in cell proliferation on the scaffold. Contrary to 
our hypothesis that HP would increase cell proliferation, cells numbers/scaffold in 
all HP groups, including the HP controls, were found to be significantly lower than 
those of the unpressurized culture control at t = 4 wks, as well as lower than the 
original seeding density of approximately 0.7 million cells/scaffold. These results 
are consistent with a previous study using TMJ disc fibrochondrocytes seeded on 
PGA scaffolds where the average cell number/scaffold in pressurized groups was 
four times lower than the day 0 control.96 However, unlike that study, we did not 
observe a drop in cell number in our unpressurized culture control. This leads us 
to believe that the manipulation involved in bagging the constructs was a major 
factor in inducing cell loss. Furthermore, our experiment was conducted over a 
long duration (4 wks), with samples pressurized once every 3 days, thereby 
increasing the probability of cell dislodgment from the scaffolds. In addition to 
manipulation of the constructs for prolonged periods, the HP stimulation itself 
might have contributed to cell dislodgment from the scaffold. Although HP 
stimulation should not cause volumetric changes to the construct, theoretical 
models for the effect of HP on composite polymers, such as PLLA, have shown 
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that increasing HP can increase the bulk modulus and Poisson's ratio of the 
polymer slightly while decreasing its specific volume.158 Thus, these effects might 
result in extremely small displacements on the scaffold causing cells to dislodge. 
Despite observations of cell loss, however, HP was still shown to be beneficial for 
constructs in terms of their biochemical and biomechanical composition. 
Meniscus cells were pooled from medial and lateral menisci which may have 
introduced some variability in our experiment. The meniscus contains two major 
cell types, fibroblast-like cells and fibrochondrocytes, which are capable of 
producing different types of collagens in vivoand in vitro}' 37, 159, 160 Although 
specific collagens present in our Constructs were not examined, it is expected 
that both collagen I and collagen II would be present. A study in the literature has 
Shown that meniscus cells seeded on scaffolds produced both collagen I and 
collagen II as seen by immunohistochemica! analysis.160 The focus of this 
experiment was to identify a hydrostatic pressure regimen that enhanced the 
total collagen and GAG content and improved the mechanical properties of the 
cell-seeded PLLA constructs. In future studies, we will investigate whether 
hydrostatic pressure influences specific collagen levels, akin to a study 
conducted with inner and outer fibrosus cells where significant differences were 
observed in collagen I and collagen II content between inner and outer cells 
exposed to hydrostatic pressure.102 
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Biochemical tests were conducted after 4 wks of pressurization to determine 10 
MPa HP effects at varying frequencies (0, 0.1 and 1 Hz). HP was found to be a 
significant factor, and the 10 MPa, 0 Hz group showed the greatest collagen 
content/scaffold. This result is in agreement with a previous study using TMJ disc 
cells that showed significantly higher levels of collagen/construct under a 10 MPa 
static HP regimen than under an intermittent regimen of 10 MPa, 1 Hz.96 If total 
collagen and GAG content are normalized to cell number, constructs in all three 
HP groups (10 MPa 0, 0.1 and 1 Hz) result in significantly higher collagen and 
GAG deposition per cell than in the controls, suggesting that both intermittent 
and periodic HP increase the cells' capability to synthesize ECM. This finding is 
consistent with gene expression studies on articular chondrocytes where 
intermittent HP results in upregulation of collagen II and aggrecan expression.68' 
87,93,94 Although the mechanism to explain these results remains elusive, several 
theories have been proposed in the literature. In chondrocytes, intracellular ionic 
and osmotic variations as a result of HP stimulus have been shown to alter the 
activity of membrane transport pathways that affect matrix synthesis.92 In 
cultured mouse calvariae and periosteal cells, intermittent HP has been shown to 
stimulate the release of activated TGF-(3.161 TGF-P1 has been shown in several 
experiments to upregulate collagen expression and synthesis in vitro in meniscus 
cells.143,162 HP has also been shown to regulate matrix metalloproteases (MMPs) 
and tissue inhibitors of matrix metalloproteases (TIMPs) in meniscus cells which 
would affect matrix breakdown and accumulation. A recent study showed that 
removing rabbit menisci from the knee joint results in an upregulation of MMP-1 
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and MMP-3 in the explant, which could then be down-regulated by HP.86 Further, 
meniscus cells embedded in alginate beads down-regulated MMP-1 and MMP-
13 when exposed to static HP and upregulated TIMP-1 and TIMP-2 when 
exposed to intermittent HP.163 Thus, we believe that collagen regulation may be 
affected both directly due to HP mechanotransduction on the cells, as well as 
indirectly via the regulation of TGF-(3 and MMP pathways which in turn may 
enhance collagen synthesis or prevent collagen breakdown. 
Some interesting observations can be made about the compressive mechanical 
properties of the scaffolds in relation to their biochemical properties. Constructs 
in the 10 MPa, 0 Hz group were significantly stiffer in compression than the 
culture control and the 10 MPa, 1 Hz group. In addition, the intermittent HP 
regimens were neither detrimental nor beneficial for the formation of robust tissue 
when compared to the controls. In vivo, articular cartilage and, to a lesser extent, 
the knee meniscus exhibit high compressive properties due to the presence of 
highly negatively charged GAGs that attract water and hydrate the tissue.13 A 
significant increase in GAG/scaffold at t = 4 wks for the periodic HP group over 
the culture control correlated well with the biomechanical data and suggested 
that periodic HP stimulation resulted in mechanically superior scaffolds. 
Rest time between HP stimulation may be an important factor to consider in 
tissue engineering studies. A short-term gene expression study with 
fibrochondrocytes showed that ECM gene profiles were upregulated to a greater 
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extent 24 hr post HP stimulation as opposed to directly after pressurization.95 A 
delayed gene expression response for ECM molecules would likely translate to 
delays in ECM synthesis as well. Based on this working hypothesis, we utilized a 
rest time of 2 days after each HP stimulus to allow cells seeded on scaffold to 
upregulate gene expression of important ECM components and provide sufficient 
time for matrix synthesis and organization prior to the next pressurization cycle. 
Other loading regimens of 5 day on, 2 days off or 2 days on, 1 day off have been 
employed in the past by researchers conducting HP tissue engineering studies 
on articular chondrocytes and TMJ disc cells.96,101 However, these studies and 
ours examined only one rest time and so conclusions about their beneficial effect 
may be premature. Nonetheless, it will be prudent in future experiments to 
examine rest time as an experimental factor to determine an optimal condition 
that favors greater ECM synthesis such as the study on dynamically compressed 
articular cartilage explants where the authors discovered that a rest time of 100 s 
or less between stimulation increased the radiolabeled sulfate uptake in the 
explants.146 
Conclusions 
The experimental data provide significant evidence for the benefit of periodic HP 
(10 MPa, 0 Hz) for the purposes of meniscus tissue engineering using PLLA 
scaffolds. The increase in total collagen in the periodic HP constructs, despite the 
drop in cell number, is a significant finding and an investigation on the influence 
of HP on the metabolic pathways of meniscus cells might shed some light on the 
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underlying mechanism for this observation. The compressive stiffness of our 
constructs was found to increase concomitantly with increases in GAG 
deposition; however, the values (31-88 kPa) are still below those of native tissue 
(100-400 kPa).164 To further improve the structural integrity, the use of growth 
factors can be employed. Previous research has shown that growth factors, such 
as TGF-(31 and b-FGF, are responsible for upregulating collagen I, collagen II, 
and proteoglycan synthesis in cartilaginous cell cultures, explants, and cell-
seeded scaffolds.65' 75> 143' 162' 165 Further, static HP alone has been shown to 
upregulate TGF-(31 expression in a characterized human chondrocyte cell-line.166 
Thus, a myriad of possibilities can be investigated to better understand the 
effects of HP at the cellular and tissue level, as well as create cartilaginous tissue 
engineered constructs with biochemical and biomechanical properties 
approaching those of native tissue. 
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Figure 9. Experimental groups 
a) Culture controls b) HP controls c) Periodic HP (10 MPa, 0 Hz) d) Intermittent 
HP (10 MPa, 0.1 Hz) e) Intermittent HP (10 MPa, 1 Hz). Samples were 
stimulated once every three days for one hr for a period of 28 days. 
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10 MPa, 0 Hz 10MPa,0.1 Hz 
Figure 10. Gross morphology of pressurized and unpressurized scaffolds 
Top left and right pictures represent unpressurized controls. Bottom from left to 
right: constructs pressurized at 10 MPa and 0 Hz, 10 MPa and 0.1 Hz, and 10 
MPa and 1 Hz. 
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Figure 11. Histological stains of constructs 
Top from left to right: Picrosirius red stains of unpressurized constructs (original 
magnification, 200X). Middle from left to right: Picrosirius red stains of constructs 
pressurized at 10 MPa and 0 Hz, 10 MPa and 0.1 Hz, and 10 MPa and 1 Hz. 
Bottom from left to right: Representative images of constructs stained with 
Safranin-0 / fast green and H&E. 
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Figure 12. Biochemical data 
At t = 4wks (a) Collagen/scaffold (p = 0.0006) (b) GAG/scaffold (p = 0.03). (c) 
Collagen/million cells (p = 0.003). (d) GAG/million cells (p = 0.008). All values 
reported as mean ± SD. Groups with the same letter are not significantly different 
from each other. 
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Figure 13. Biomechanical data at 30% strain 
At t = 4wks (a) Relaxation modulus (p = 0.02) (b) Instantaneous modulus (p = 
0.005) (c) Coefficient of viscosity (p = 0.05). All values reported as mean ± SD. 
Groups with the same letter are not significantly different from each other. 
Table 4. Dry weight, wet weight and cell number of scaffolds 
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Treatment 
Culture control 
HP control 
10 MPa, 0 Hz 
10 MPa, 0.1 Hz 
10 MPa, 1 Hz 
p value 
Dry weight 
(mg) 
2.2±1.1 
2.8 ±0.2 
2.3 ±0.5 
1.3 ±0.3 
2.9 ±0.8 
0.009 
Wet weight 
(mg) 
15.7 ±2.9 
12.4 ±0.5 
13.8 ±1.4 
13.1 ±2.7 
13.7 ±1.4 
0.37 
Cell number 
(millions) 
0.8 ±0.1 
0.5 ±0.1 
0.5 ±0.1 
0.3 ±0.1 
0.4 ±0.1 
< 0.0001 
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Chapter 5: Effects of TGF-p1 and hydrostatic pressure 
application on meniscus cell-seeded scaffolds 
Najmuddin J. Gunja, Rajesh K. Uthamanthil and Kyriacos A. 
Athanasiou 
Chapter published as: Gunja NJ, Uthamanthil, R.K., and Athanasiou KA. Effects 
of TGF-pi and hydrostatic pressure application on meniscus cell-seeded 
scaffolds. Biomaterials. 30:565-573, 2009 
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Abstract 
The combinatorial effects of TGF-pi and hydrostatic pressure (HP) were 
investigated on meniscus cell-seeded PLLA constructs using a two-phase 
sequential study. The objective was to identify potentially synergistic effects of 
these stimuli toward enhancing the biomechanical and compositional 
characteristics of the engineered constructs. In Phase I, the effects of TGF-01 
were examined on the ability of meniscus cells to produce ECM. In Phase II, 
meniscus cell-seeded PLLA constructs were cultured for 4 wks with a 
combination of TGF-pi and HP (10 MPa, 0 Hz or 10 MPa, 0.1 Hz). TGF-(31 was 
found to increase collagen and GAG deposition in the scaffolds 15-fold and 8-
fold, respectively, in Phase I. In Phase II, the combination of TGF-pi and 10 
MPa, 0 Hz HP resulted in 4-fold higher collagen deposition (additive increase), 3-
fold higher GAG deposition and enhanced compressive properties (additive and 
synergistic increases), when compared to the unpressurized no growth factor 
culture control. Though significant correlations were observed between the 
compressive properties (moduli and viscosity), and the GAG and collagen 
content of the constructs, the correlations were stronger with collagen. This study 
provides robust evidence that growth factors and HP can be used successfully in 
combination to enhance the functional properties of in vitro engineered knee 
meniscus constructs. 
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Introduction 
The knee meniscus is a fibrocartilaginous structure that cushions the tibia and 
the femur.1 Damage to the meniscus can lead to significant pain around the knee 
joint and result in osteoarthritis. Current arthroscopic meniscal treatments, such 
as partial meniscectomy, provide short term relief; however, longer term studies 
have shown that meniscectomy quickens the onset of osteoarthritis.167 Thus, 
Other treatment modalities, such as tissue engineering, are widely researched 
including the use of growth factors and mechanical stimuli, as reviewed 
elsewhere.1 
A wide range of growth factors including transforming growth factor beta-1 (TGF-
(31), insulin-like growth factor-1 (IGF-1), basic fibroblast growth factor (bFGF), 
platelet-derived growth factor-AB (PDGF-AB), epidermal growth factor (EGF), 
and hepatocyte growth factor (HGF) have been studied for their potential use in 
exogenously stimulating meniscus cells to increase production of extracellular 
matrix (ECM).65'73'75'143'168'169 Of these, TGF-|31 has shown the most promise in 
terms of production of glycosaminoglycans (GAGs) and collagen in alginate and 
PGA scaffold studies with meniscus cells.75,143 TGF-(31 is also found in varying 
quantities (2.7 ± 0.37 to 20.9 ± 2.2 ng/ml) in fetal bovine serum (FBS), a vital 
component of cell culture medium involved in aiding cell proliferation and ECM 
formation.170 To examine effects of exogenous TGF-(31 on meniscus cells would, 
therefore, require removal of FBS from the medium. Pilot studies in the 
laboratory, however, have shown that cell proliferation decreases and 
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subsequent cell death ensues in meniscal cells grown in basal culture medium 
devoid of FBS. To overcome this, one may consider the use of FBS, but perhaps 
at a lower concentration (1%), when compared to the current standard (10%). 
Lowering of FBS concentration may also be advantageous as it increases clinical 
translatability by reducing the risk of disease transmission as a result of serum. 
171 
In addition to growth factors, the application of mechanical stimuli, such as 
hydrostatic pressure (HP) or direct compression (DC), has been shown to induce 
positive changes in gene expression and ECM synthesis in meniscal explants 
and cells.84,86,163,172 During every day activity, the knee joint is exposed to 7-10 
MPa HP with a normal observed frequency ranging from 0 to 1.1 Hz.155,173 HP is 
also of particular interest as it results in no macro-scale deformation to the 
construct while the stimulus is applied. Experiments in the literature focusing on 
articular chondrocytes and temporomandibular joint (TMJ) disc fibrochondrocytes 
have shown benefits for both static and intermittent HP regimens.68, 87, 96 For 
example, static HP of 10 MPa applied for 1 wk for 4 hr using a 2 day on, 1 day off 
regimen was shown to upregulate collagen synthesis on PGA scaffolds seeded 
with porcine TMJ disc fibrochondrocytes.96 Intermittent HP of 6.87 MPa (5 s 
pressurized, 15 s unpressurized) has been shown to increase collagen and 
sulfated GAGs on PGA scaffolds seeded with equine articular chondrocytes.174 
Recent growth factor-HP combination studies have shown that TGF-|33 can 
enhance expression of relevant cartilaginous proteins in human mesenchymal 
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stem cells grown in pellet culture and the addition of intermittent HP of 10 MPa, 1 
Hz can further increase gene expression of these proteins.175,176 
The goal of this experiment was two-fold. In Phase I, we investigated the effects 
of FBS concentration and TGF-(31 on the ability of meniscal cells to proliferate 
and produce ECM on poly-l-lactic acid (PLLA). It was hypothesized that TGF-01 
would increase ECM production on the constructs and that lowering FBS 
concentration would not be detrimental to ECM formation. In Phase II, we 
examined whether the combination of HP (static or intermittent) and TGF-(31 
would enhance the biochemical and biomechanical properties of tissue-
engineered constructs. It was hypothesized that an additive or synergistic effect 
would occur between the HP treatment and the growth factor. 
Materials and methods 
Cell harvesting, culture and passage (Phase I and II) 
Lateral and medial meniscus cells from ten skeletally mature New Zealand white 
rabbits were harvested using aseptic technique. All procedures used were in 
strict accordance with the National Institutes of Health Guidelines on the Care 
and Use of Laboratory Animals. Ethics approval was obtained from Rice 
University before commencement of the study. The tissue was minced and 
digested overnight with 0.2% collagenase (Worthington, Lakewood, NJ). The 
isolated cells were then counted using a hemocytometer, pooled and stored at -
80 °C. At the start of the experiment, meniscus cells were thawed, and the cell 
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viability was calculated to be over 90%. The cells were plated on T-225 flasks at 
25% confluence and allowed to expand in culture medium containing 50:50 
Dulbecco's modified Eagle's medium (DMEM)- Ham's F12 (Gibco, Grand Island, 
NY), 10% FBS (Biowhittaker, Walkersville, MD), 1% non-essential amino acids 
(NEAA) (Invitrogen, Grand Island, NY), 25 ug of l-ascorbic acid (Sigma, St Louis, 
MO) and 1% penicillin-streptomycin-fungizone (PSF) (Sigma, St Louis, MO). At 
approximately 90% confluence, the cells were passaged using trypsin/EDTA 
(Sigma, St Louis, MO) and counted with a hemocytometer. All cells used in the 
experiment were passaged once. 
Scaffold, spinner flask preparation and cell seeding (Phase I and II) 
For phase I and II of the experiment, non-woven PLLA (Biomedical Structures, 
Warwick, Rl) scaffold sheets of molecular weight 100 kDa were cut into cylinders 
2 mm in thickness and 3 mm in diameter using a 3 mm dermal punch. The 
scaffolds were sterilized by treatment with ethylene oxide. They were then pre-
wetted with 100% ethyl alcohol, washed twice with phosphate buffered saline 
(PBS) and seeded into a spinner flask filled with medium + 10% FBS using a 
technique described elsewhere.177 Briefly, 30 scaffolds were cultured in each 
spinner flask containing 400 ml of medium. A seeding density of 1 million cells/ml 
was utilized. Stirrer bars at the bottom of the spinner flask were rotated at 60 
RPM post-seeding for 3 days. The scaffolds were left in the spinner flask for an 
additional 4 days to allow cells to adhere to the polymer. After 1 wk, the 
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constructs were transferred to agarose-coated six-well plates. The coatings were 
prepared by adding 1.5 ml of 2% sterile molten agarose to each well. 
Tissue culture and experimental groups (Phase I) 
Each agarose coated well plate contained 5 ml of culture medium. The culture 
medium was supplemented with 1% or 10% FBS in the presence or absence of 
10 ng/ml TGF-S1 (PeproTech Inc., Rocky Hill, NJ) (n = 8 per group). Constructs 
(five per well) were housed in static culture and medium was changed once 
every three days for a period of four wks. At t = 4 wks, constructs were collected 
for histological and biochemical analysis. 
HP preparation, application and experimental groups (Phase II) 
Post-seeding, phase II constructs were placed in agarose coated wells 
containing culture medium supplemented with 1% FBS for an additional wk to 
increase cell-scaffold adhesion and improve cell migration into the scaffold. The 
scaffolds were then randomly assigned into HP or control groups and housed in 
sterile customized histology cartridges capable of holding up to nine constructs (n 
= 8 per group). Four different HP groups were tested. Constructs were 
pressurized at 10 MPa, 0 Hz or 10 MPa, 0.1 Hz in the presence or absence of 10 
ng/ml TGF-B1 once every 3 days for 1 hr. The growth factor dose and stimulation 
regimens were chosen based on previous studies that highlighted their 
benefit.143,178 Four control groups were utilized in the experiment. Constructs in 
the presence or absence of TGF-B1 were housed in the incubator (culture 
95 
controls) for the experiment duration or manipulated for HP stimulation (HP 
controls) without receiving any HP stimulus. 
Prior to HP stimulation, the cartridges with cell-seeded scaffolds were transferred 
to individual heat sealable sterile bags (Ampac, Cincinnati, OH) containing 30 ml 
of culture medium supplemented with 10 mM Hepes (Fisher Scientific, Pittsburg, 
PA). The bag was tapped lightly to remove air bubbles from the medium and 
from the cartridges, and heat-sealed. The HP set-up used in this experiment has 
been described previously.96 Briefly, control specimens were placed in an open 
unpressurized chamber while the pressurized specimens were placed in a water-
filled stainless steel chamber that connected to an Instron 8871. Post-stimulation, 
the bags were transferred back to the culture hood and unsealed. The cartridges 
were then placed back into six-well plates with fresh medium. At t = 4 wks, 
samples were collected for histological, immunohistological, biochemical and 
biomechanical analyses. 
Histology (Phase I and II) 
At t = 4 wks, one sample from each group was frozen using HistoPrep (Fisher 
Scientific, Pittsburg, PA) and then sectioned at 14 urn. Safranin-0 / fast green 
stains were performed to examine the distribution of GAGs in the section.147 
Picrosirius red was used to determine the presence of collagen.148 
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Immunohistochemistry (IHC) (Phase II) 
Collagen I and collagen II presence was determined using IHC, as described 
previously.179 Briefly, the sectioned samples were fixed in chilled acetone at 4 °C 
for 20 min and then rinsed with IHC buffer. They were then quenched of 
peroxidase activity with hydrogen peroxide/methanol for 30 min and blocked with 
horse serum (Vectastain ABC kit). Each slide was then exposed to mouse anti-
COL 1 (1:1000 dilution) (Accurate Chemicals, Westbury, NY) mouse or anti-COL 
2 (1:1000 dilution) (Chondrex, Redmond, WA) antibodies for 1 hr. After 
incubation with the primary antibodies, a secondary mouse IgG antibody 
(Vectastain ABC kit) was added for 30 min at the dilution specified by the kit 
protocol and color was developed using the Vectastain ABC reagent and DAB 
(Vector Labs, Burlingame, CA) for 8 min. 
Biochemistry (Phase I and II) 
Biochemical tests were performed on samples at t = 0 and t = 4 wks for both 
phases. The 4 wk samples were obtained post-biomechanical testing for phase II 
of the experiment. All samples were digested at 65 °C overnight with 125 ug/ml 
papain (Sigma, St Louis, MO) in 50 mM phosphate buffer (pH = 6.5) containing 2 
mM N-acetyl cysteine and 2 mM EDTA. A picogreen cell proliferation assay kit 
(Molecular Probes) was used to determine total DNA content in each sample. 
Total GAG was quantified using the Blyscan GAG Assay kit.150 A modified 
chloramine-T hydroxyproline assay was used to determine total collagen in the 
construct.151 
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Biomechanics (Phase II) 
The viscoelastic compressive properties of samples from each group in Phase II 
were obtained at t = 4 wks post-stimulation using an Instron 5565 set-up 
described previously.134 Incremental stress relaxation curves were obtained at 
10%, 20%, and 30% strain. Data were fitted using MATLAB to an incremental 
stepwise viscoelastic stress relaxation solution for a standard linear solid.135 
Fitted parameters obtained were converted to instantaneous modulus (Ej), 
relaxation modulus (Er) and coefficient of viscosity (u). 
Statistical analyses 
Quantitative biochemical and biomechanical data were compared using analysis 
of variance (ANOVA). If significant differences were observed, a Tukey's post 
hoc test was performed to determine specific differences among groups. For 
phase II, univariate regression analysis was conducted to determine whether 
biochemical data correlated with biomechanical data. The presence of synergy 
between TGF-f31 and HP in our system was examined using the interaction term 
obtained from the 2-way ANOVA between the culture control (with and without 
TGF-p1) and each individual HP group (with and without TGF-P1).180 A 
significance level of 95% with a p value of 0.05 was used in all statistical tests 
performed. All values are reported as mean ± standard deviation. JMP IN 
statistical software was used for all statistical analyses. 
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Results 
Phase I - Effect of serum and TGF-B1 on PLLA scaffolds 
Gross morphology and histology (n = 3) 
Figure 14 shows histology sections of constructs at t = 4 wks. Morphologically, 
white translucent tissue was observed in all groups. Groups treated with TGF-|31 
exhibited a higher density of ECM when compared to the untreated samples, at 
both 1% and 10% FBS concentrations. Collagen and GAG staining was positive 
in all groups, with more intense staining observed in the TGF-f31 treated groups. 
Biochemistry (n = 5) 
At t = 4 wks, the total number of cells per construct increased by 100% in the 
TGF-(31 + 1% FBS group when compared to the 1% FBS control, while no 
significant difference was observed between the TGF-01 + 10% FBS and the 
10% FBS group (p = 0.02) (Figure 14). A 15-fold and 8-fold increase was 
observed in total collagen and total GAG/construct, respectively, in TGF-01 
treated samples when compared to their non-treated controls for the 1 % and 
10% FBS groups (p < 0.001) (Figure 14). No significant difference was observed, 
however, between the 1% FBS + TGF-(31 and 10% FBS + TGF-|31 groups for 
collagen or GAG content. Thus, for phase II of the experiment, a concentration of 
1% FBS was utilized in the culture medium. 
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Phase II - Effect of TGF-B1 + HP on PLLA scaffolds 
Gross morphology, histology and IHC (n = 3) 
On gross examination, all constructs showed presence of ECM. However, 
constructs cultured with TGF-B1 appeared denser than the constructs cultured 
without TGF-B1, HP application notwithstanding. At t = 4 wks, construct thickness 
and diameter ranged from 1.8 ± 0.4 mm to 2.2 ± 0.1 mm and 2.8 ± 0.2 mm to 3.2 
± 0.1 mm, respectively; however, no significant difference was observed between 
any of the scaffolds for culturing condition (p = 0.43, p = 0.63) or for growth factor 
treatment (p = 0.09, p = 0.07) (Table 5). Weak staining for collagen and GAG 
was observed for constructs cultured without TGF-B1 using picrosirius red and 
safranin-0 / fast green stains (Figure 15). The staining was more intense in 
TGF-B1 treated groups, especially around the periphery of the scaffolds. IHC 
staining showed presence of collagen I in all groups, with weak staining for 
collagen II (images not shown). 
Biochemistry (n = 5) 
Wet weight of the constructs ranged from 11.3 ± 2.5 mg to 15.9 ± 1.4 ring (Table 
5). The growth factor treatment was found to be a significant factor (p = 0.004) 
using a 2-way ANOVA while the culturing condition was not (p = 0.35). Dry 
weights of the constructs ranged from 1.8 ± 0.1 mg to 2.1 ±0 .1 mg, with a 
significant difference observed in samples treated with TGF-31 over the 
untreated groups, (p = 0.03) but not when comparing different culturing 
conditions (p = 0.06) (Table 5). 
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Aft - 0, the cell seeding density was found to be approximately 0.61 ±0.1 million 
cells/scaffold (shown by the dotted line in Figure 16A). By t = 4 wks, the cell 
number/scaffold increased to 0.71 ±0.1 million cells/scaffold in the culture control 
group. A drop in cell number (approximately 20%) was observed in all HP treated 
groups when compared to the culture control; however, the cell numbers were 
not significantly different from the seeding density at t = 0. The addition of TGF-
(31 significantly increased cell number in all groups when compared to their 
respective no-GF groups by at least 15%. 
In terms of total collagen/scaffold, at t = 4 wks both the type of stimulus applied 
and growth factor treatment were found to be significant factors (p = 0.01, and p 
= 0.004, respectively) (Figure 16B). Specifically, samples stimulated with 10 
MPa, 0 Hz induced a two-fold increase in collagen content/construct when 
compared to the culture and HP control. If normalized to cell number, this effect 
was even higher with a three-fold increase observed in collagen/cell number. 
TGF-P1 alone was found to significantly increase collagen deposition on the 
scaffold up to 4-fold when compared to respective no-GF groups. TGF-01 was 
found to further enhance collagen deposition on constructs exposed to HP (10 
MPa, 0 Hz) by approximately 1.6 fold. This resulted in constructs with the highest 
overall collagen/construct with 76 ± 22 ug. If normalized to cell number, this 
effect was even higher with a 2-fold increase in collagen deposition over the 
culture control + GF control. Overall, an additive effect was observed in 
constructs exposed to TGF-J31 and HP, 10 MPa, 0 Hz when compared to the 
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culture control group suggesting a beneficial interplay between the applied 
chemical and mechanical stimuli. 
Both treatment type and growth factor application were found to be significant 
factors when analyzing total GAG/scaffold (p = 0.03 and p = 0.01, respectively) 
(Figure 16C). Without TGF-(31 treatment, constructs in the 10 MPa, 0 Hz group 
contained at least 50% more GAG than when compared to other groups. If 
normalized to cell number, a 7-fold increase in GAG content was observed in the 
10 MPa, 0 Hz group when compared to the culture control. In the presence of 
TGF-(31, GAG production increased 4-fold in the culture control group when 
compared to its no-GF group. A significant increase in GAG was not observed, 
however, in the 10 MPa, 0 Hz group when compared to its no GF group. Despite 
this, the highest GAG content was observed in the 10 MPa, 0 Hz + TGF-(31 
group (28 ± 6 ug). These results suggest that although the individual application 
of TGF-(31 and HP enhanced the GAG formation on constructs, their combination 
did not result in an additive or synergistic effect. 
Biomechanics (n = 5) 
At all strain levels (10, 20 and 30%), the type of stimulus and growth factor were 
found to be significant factors for all three tested parameters. TGF-01 was found 
to increase the compressive properties of all unpressurized and pressurized 
constructs. Its effect was most pronounced for the coefficient of viscosity where a 
2.3 fold increase was measured in constructs exposed to the combination of 
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TGF-B1 and 10 MPa of HP when compared to the HP group alone. At 10% 
strain, the 10 MPa, 0 Hz + TGF-B1 group exhibited an instantaneous modulus, 
relaxation modulus , and coefficient of viscosity of 104 ± 16 kPa, 40 ± 5 kPa, and 
1403 ±193 Pa-s, respectively; these values were statistically higher than the 
other tested groups (Figure 17 A, B and C). An additive effect of TGF-pi and HP 
10 MPa, 0 Hz group was observed for the instantaneous modulus. A synergistic 
increase in the relaxation modulus and coefficient of viscosity was observed in 
the 10 MPa, 0 Hz group when compared to the culture control group. 
Correlation between biochemical and biomechanical data 
The three compressive properties obtained from incremental stress relaxation 
curves were correlated with the two measured ECM components, GAG and 
collagen at each strain level strain. At 10% strain, univariate regression analysis 
showed a significant correlation between instantaneous modulus and 
GAG/construct (r2 = 0.42, p < 0.001), and collagen/construct (r2 = 0.56, p < 
0.001) (Figure 18 A, B). Similar results were obtained when correlating the 
relaxation modulus and GAG/construct (r2 = 0.24, p = 0.002), and 
collagen/constructor2 = 0.45, p < 0.001) (Figure 18 C, D). Further, the coefficient 
of viscosity correlated significantly with GAG/construct (r2 = 0.16, p = 0.01), and 
collagen/construct (r2 = 0.52 p < 0.001) (Figure 18 E, F) as well. Similar 
significant correlations were obtained at 20 and 30% strain levels (data not 
shown). 
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Discussion 
This study investigated the effects of TGF-01 and HP at low serum 
concentrations on the ability of meniscus cells to produce relevant ECM and 
enhance construct biomechanical functionality. TGF-(31 was found to significantly 
increase collagen and GAG deposition in PLLA scaffolds in phase I of the study. 
In addition, no significant differences were observed in the biochemical 
composition of PLLA constructs cultured with TGF-01 at 1% or 10% FBS. In 
phase II, an HP regimen of 10 MPa, 0 Hz was found to significantly increase 
collagen and GAG deposition on the scaffold over the controls and the 10 MPa, 
0.1 Hz group. ECM formation and compressive properties were further enhanced 
when TGF-pi was added in conjunction with 10 MPa, 0 Hz HP, with additive 
increases in collagen deposition on the scaffold and the instantaneous modulus. 
Synergistic increases in the relaxation modulus and coefficient of viscosity were 
observed in this group as well over the culture control. 
In traditional cell culture, a high concentration of FBS (-10%) is used in the 
medium to enhance cell attachment and proliferation. Unfortunately, this 
introduces the risk of disease transmission in clinical settings.171 The ability to 
use a defined culture medium in lieu of FBS increases the safety of engineered 
meniscus constructs and may help to reduce construct variability due to changes 
in serum components originating from different animals. Defined culture medium 
like knock-out serum replacement (KOSR) or Nutridoma, have been successfully 
used in articular cartilage engineering while serum-free medium with bFGF has 
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been reported effective in self-assembling meniscus cells and co-cultures of 
meniscus cells and articular chondrocytes.181"183 However, for scaffold culture, 
elimination of serum during meniscus cell culture on scaffolds significantly lowers 
the ability of cells to proliferate and produce ECM (data not reported). In this 
experiment, it was found that lowering FBS concentration from 10% to 1% 
resulted in a significant drop (~60%) in cell number per scaffold, as well as -50% 
less collagen and GAG deposition on the scaffold. However, when both groups 
were supplemented with 10 ng/ml of TGF-pi the effect of FBS concentration was 
overshadowed, resulting in increased cell proliferation and a 15-fold increase in 
collagen and a 8-fold increase in GAG over the no-growth factor controls. This 
suggests that lowering FBS concentration to 1% does not have a detrimental 
effect on the cells' ability to proliferate on PLLA scaffolds and produce ECM, so 
long that the medium is supplemented with 10 ng/ml of exogenous TGF-01. 
Our experiment showed a dramatic effect of TGF-pi on ECM formation by adult 
meniscal cells in vitro that has not been shown before. Several studies have 
investigated the effects of TGF-pi in monolayer culture and on scaffolds using 
fibroblasts, articular chondrocytes and immature meniscus cells.28,143,166,184,185 
In fibroblasts, TGF-pi has been shown to increase fibronectin, thrombospondin 
and collagen mRNA levels.186 In chondrocytes, TGF-pi has been implicated in 
increasing cell proliferation, and collagen II and sulfated GAG synthesis 129,186" 
188
. TGF-pi may directly influence GAG synthesis by accelerating glucose 
transport in human articular chondrocytes via protein kinase C and extracellular 
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signal-regulated kinase-dependent signaling pathways.189 A study with human 
chondrocytes showed that TIMP mRNA was upregulated in the presence of TGF-
|31 suggesting that the growth factor also played a protective role once ECM was 
formed.166 In all biochemical and biomechanical tests conducted in this study, the 
growth factor was found to be significant. In Phase I, for example, a dramatic 
increase was observed in collagen (15-fold) and GAG (8-fold) deposition when 
TGF-pt was added. In addition, TGF-(31 was also responsible in increasing cell 
proliferation on the PLLA scaffolds as determined from picogreen assays. Thus, 
the results support the hypothesis that TGF-|31 is a powerful modulator of ECM 
synthesis. 
This study showed benefits for both static and intermittent hydrostatic pressure, 
although static hydrostatic pressure resulted in a greater enhancement of 
construct biochemical and biomechanical properties. In the absence of TGF-01, 
constructs stimulated with static HP at 10 MPa were found to have the highest 
collagen and GAG content when compared to control and intermittent HP groups. 
This result is in agreement with previous studies applying static HP in 3-D where 
increases in protein production were observed for important cartilaginous 
markers.190, 191 If the total collagen and GAG production per construct were 
normalized to cell number, however, both static and intermittent HP regimens 
were found to significantly enhance collagen and GAG production per cell when 
compared to the controls. This is consistent with prior studies conducted in 
monolayer culture with TMJ disc fibrochondrocytes and articular chondrocytes 
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where enhances in collagen and aggrecan gene expression were observed 
under static and cyclic HP conditions.87,93,94,96 
The hypothesis that the combination of HP and TGF-P1 would result in additive 
or synergistic effects in the biochemical properties was confirmed. In a previous 
study, we highlighted the benefit of static and intermittent HP for meniscus tissue 
engineering purposes.178 In the current study, we examined the effect of adding a 
growth factor, TGF-(31 in concert with the HP stimulus on the biochemical and 
biomechanical properties of the construct. We found that the combination of 10 
ng/ml of TGF-J31 and 10 MPa, 0 Hz of HP was responsible in generating PLLA 
constructs with the highest overall biochemical and biomechanical properties. 
Additive increases were observed in collagen deposition/construct and the 
instantaneous modulus, while synergistic increases were observed in the 
relaxation modulus and coefficient of viscosity for our 10 MPa, 0 Hz constructs 
exposed to TGF-pi 
The combination of HP (static or intermittent) and TGF-(31 may stimulate similar 
down-stream pathways leading to adjunctive, additive or synergistic effects. For 
example, both HP and TGF-P1 have been shown to increase TIMP expression in 
meniscus cells and chondrocytes.86,166 HP is known to alter conformations of cell 
membrane ion transport pathways resulting in altered intracellular ion flux, 
thereby influencing other downstream processes.92 A recent study has shown 
that intracellular Ca2+ mobilization can significantly affect the cells' response to 
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the TGF-p1 by controlling the Smad-TGF-0 pathway.192 Certainly, we may expect 
several different cell-signaling pathways with feedback loops either 
complementing or antagonizing the final down-stream effect. Though the exact 
mechanism is yet to be elucidated, we can conclude that for the pressure and 
dosage combination we chose, i.e., 10 MPa, 0 Hz and 10 ng/ml of TGF-J31, there 
was a positive effect. It is possible that other HP regimens or TGF-01 doses may 
foster alternative responses. For example, a recent study from our laboratory 
using TGF-(31 (30 ng/nl) and 10 MPa static HP showed synergistic increases in 
collagen/wet weight and additive increases in aggregate and Young's modulus in 
self-assembled articular cartilage constructs.193 Interestingly, the same result 
could not be reproduced when static HP of 5 MPa was applied in the presence of 
TGF-(31. This suggests that cells respond differently to varying HP regimens in 3-
D environments, possibly by stimulating different downstream pathways that can 
affect eventual gene expression and protein production levels. This might explain 
why additive and synergistic increases in construct biochemical and 
biomechanical properties under static culturing conditions could not be achieved 
under the particular intermittent conditions that we examined (10 MPa, 0.1 Hz). 
Our compressive biomechanical data (instantaneous modulus, instantaneous 
modulus and coefficient of viscosity) showed significant correlations with 
GAG/construct (p •<• 0.05) and collagen/construct (p < 0.05) data. Traditionally, 
compressive properties are linked with GAG production since GAGs sequester 
water molecules which provide the bulk of the resistance to compressive 
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forces.13 These results suggest, however, that interplay between GAG molecules 
and collagen fibers might be responsible for the overall compressive 
biomechanical properties of the constructs, possibly via smaller proteoglycans 
such as decorin and biglycan which are known to affect collagen diameter and 
alignment.194 A detailed analysis on the composition of the proteoglycans, as well 
as collagen, needs to be performed in the future. 
After 4 wks in culture, the instantaneous moduli in the 10 MPa, 0 Hz group was 
approximately 105 kPa. This result is exciting since as it approaches native 
values; for example, the aggregate modulus of the tibial posterior portion of the 
medial leporine meniscus is 130 ± 30 kPa.18 One needs to be cautious, however, 
in directly comparing results from the biphasic model to derive the aggregate 
modulus to a viscoelastic model to derive the instantaneous modulus. A 
comparison between the two techniques shows that values for instantaneous 
moduli are generally slightly lower than the aggregate moduli.195 In a prior study, 
an HP regimen of 10 MPa, 0 Hz significantly increased construct compressive 
properties.178 The inclusion of TGF-01 in this study in conjunction with the HP 
stimulus resulted in additive and synergistic increases to the instantaneous 
modulus, relaxation modulus and the coefficient of viscosity. This effect was 
observed at all tested strain levels (10, 20 and 30% - data not shown for 20 and 
30% strain). In addition, to ensure that the mechanical properties obtained were 
not those of the PLLA scaffold, separate biomechanical tests were performed on 
109 
unseeded constructs at t = 0 and t = 4 wks in regular culture medium with an 
obtained instantaneous modulus ranging from 10-15 kPa. 
Conclusions 
It was found that 90% of the FBS content in the standard tissue culture medium 
could be successfully replaced with addition of 10 ng/ml TGF-(31 in knee 
meniscus tissue engineering, yielding significant increases in ECM production 
and cell proliferation. Furthermore, a combination of HP and TGF-(31 led to 
additive and synergistic increases in the biochemical and compressive properties 
of tissue engineered meniscal constructs. To produce constructs mimicking 
native tissue, additional combinatorial stimulation regimens will need to be tested 
in future experiments to maximize the effect of the applied biochemical and 
biomechanical stimuli. 
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Figure 14. Phase I data 
(A) Histological sections of scaffolds. Collagen and GAG presence is observed, 
especially on the periphery of the scaffolds. Scale bar: 200 urn. (B) Cell 
number/construct. Both 10% FBS and 10 ng/ml of TGF-(31 were responsible in 
increasing cell number on the scaffold. (C) GAG and collagen/construct. The 
inclusion of TGF-01 significantly increased collagen and GAG deposition on the 
construct in both the 1% FBS and 10% FBS groups. 1-way ANOVAs were 
performed followed by a Tukey's post hoc analysis to determine significant 
differences between groups for collagen/construct and GAG/construct. Groups 
with the same letter (capital or small) are not significantly different from each 
other. All values are reported as mean ± SD. An n = 5 was used for all 
biochemical tests. 
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Figure 15. Phase II - histological sections of scaffolds 
(A) Picrosirius Red. (B) Safranin-0 / fast green. TGF-J31 was found to increase 
intensity in collagen staining in all groups. In the 10 MPa, 0 Hz + TGF-pi group, 
strong staining for collagen and GAG was observed throughout the construct. 
Scale bar: 200 um 
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Figure 16. Phase II - Biochemical analysis 
A) Cell number/scaffold. The static culture control was found to contain more 
cell/construct than all other groups at t = 4 wks. Dotted line signifies original 
seeding density of 0.61 million cells/scaffold. B) Collagen/scaffold. A significant 
increase in collagen deposition is observed in constructs exposed to 10 MPa and 
0 Hz hydrostatic pressure. In addition, a significant increase is also observed in 
all groups treated with growth factor over the untreated groups C) GAG/scaffold. 
A significant increase in GAG deposition is observed in constructs exposed to 10 
MPa and 0 Hz hydrostatic pressure. In addition, a significant increase is also 
observed in all groups treated with growth factor over the untreated groups. 
Statistics were conducted using a 2-way ANOVA. Groups with the same letter 
(capital or small) are not significantly different from each other. All values are 
reported in mean ± SD. An n=5 was used for all biochemical tests. 
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Figure 17. Phase II - compressive properties of the constructs (10% strain) 
(A) Instantaneous modulus (B) Relaxation modulus (C) Coefficient of viscosity. 
Statistics were conducted using a 2-way ANOVA. The instantaneous modulus, 
relaxation modulus and coefficient of viscosity of constructs stimulated at 10 
MPa, 0 Hz was significantly high than constructs in other groups. Growth factor 
treatment was significant for all measurements Groups with the same letter 
(capital or small) are not significantly different from each other. All values are 
reported in mean ± SD. An n=5 was used for all biomechanical tests. 
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Figure 18. Correlation analysis between compressive properties (10% 
strain) and biochemical properties 
(A) Correlation to GAG content/construct (B) Correlation to collagen 
content/construct. Significant correlations were observed for all parameters 
between the compressive properties and the two ECM components. 40 data 
points from TGF-01 and no-TGF-(31 treated groups were used in each 
comparison. 
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Table 5. Phase II - Wet weight, dry weight, thickness and diameter of 
constructs 
Growth factor application was found to significantly increase the wet and dry 
weight of the constructs. No significant differences were observed among groups 
for the wet weight, dry weight, thickness and diameter of the constructs 
Groups 
Culture 
control 
HP 
control 
HP 
10MPa, 0 Hz 
HP 
10 MPa, 0.1 Hz 
p value -
growth factor 
culture 
condition 
Wet weight 
No TGF-P1 
(mg) 
11.3 ±2.5 
11.2±2.9 
13.2 ±2.5 
12.7 ±1.6 
TGF-P1 
(mg) 
13.1 ±1.0 
13.0 ±2.1 
15.3 ±3.3 
15.9 ±1.4 
0.004 
0.35 
Dry weight 
No TGF-P1 
(mg) 
1.8±0.1 
1.9 ± 0.2 
1.8 ±0.3 
1.8 ±0.2 
0.03 
0.06 
TGF-P1 
(mg) 
2.0 ±0.1 
2.0 ± 0.2 
2.1 ±0.1 
2.0 ±0.1 
Thickness 
No TGF-P1 
(mm) 
1.9 ±0.2 
2.0 ± 0.1 
1.8 ±0.4 
2.0 ±0.1 
0.07 
0.43 
TGF-P1 
(mm) 
2.2 ±0.1 
2.0 ±0.3 
2.2 ±0.1 
2.1 ±0.2 
Diameter 
No TGF-pi 
(mm) 
2.8 ±0.2 
2.9 ± 0.2 
2.8 ±0.4 
3.0 ±0.1 
0.09 
0.63 
TGF-P1 
(mm) 
3.0 ±0.2 
3.1 ±0.3 
3.2 ±0.1 
2.9 ±0.5 
' 
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hypoxia on leporine meniscus cell-seeded PLLA 
scaffolds 
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Abstract 
Injuries to avascular regions of menisci do not heal and result in significant 
discomfort to patients. Current treatments, such as partial meniscectomy, 
alleviate these symptoms in the short-term, but lead to premature osteoarthritis 
as a result of compromised stability and changes in knee biomechanics. Thus, 
functional tissue engineering of the meniscus may provide an alternate treatment 
modality to overcome this problem. In this experiment, a scaffold-based tissue 
engineering approach was utilized to regenerate the meniscus. Meniscus cells 
were cultured on poly-l-lactic acid scaffolds in normoxic (~21% oxygen) or 
physiologically relevant hypoxic (~2% oxygen) conditions in the presence or 
absence of the growth factor, basic fibroblast growth factor (bFGF) for 4 wks. 
Qualitative and quantitative tests were performed to examine the morphological, 
biochemical and biomechanical properties of the cell-seeded constructs in each 
group. At t = 4 wks, histological sections of constructs showed presence of 
collagen and glycosaminoglycan (GAG) in all groups. Immunohistochemical 
staining showed presence of collagen I in all groups, and collagen II in groups 
cultured in hypoxic conditions. The presence of bFGF in the culture medium 
significantly increased cell number/construct by 25%, regardless of culturing 
condition. No significant differences were observed among groups for 
collagen/construct. For GAG/construct, synergistic increases were observed in 
constructs cultured in hypoxic conditions and bFGF (2-fold) when compared to 
constructs cultured in normoxic conditions. Viscoelastic compressive tests 
showed synergistic increases in the relaxation modulus and coefficient of 
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viscosity, and additive increases in the instantaneous modulus for constructs 
cultured in hypoxic conditions and bFGF when compared to constructs cultured 
in normoxic conditions. This was observed at all tested strain levels (10, 20 and 
30% strain). Overall, these results demonstrate that bFGF and hypoxia can 
significantly enhance the ability of meniscus cells to produce GAGs and improve 
the compressive properties of tissue engineered meniscus constructs in vitro. 
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Introduction 
Injuries to avascular portions of the knee meniscus do not heal and can result in 
significant pain, swelling and loss of range of motion to patients. Current 
arthroscopic treatments to remove all or part of the meniscus alleviate these 
symptoms but lead to premature osteoarthritis as a result of compromised 
stability and changes in knee biomechanics.167 Functional tissue engineering of 
the meniscus may provide an alternative treatment modality to overcome this 
problem. To obtain high cell numbers necessary in cartilage tissue engineering 
experiments, cells are usually passaged multiple times in standard Dulbecco's 
modified Eagle's medium (DMEM) medium supplemented with 10% fetal bovine 
serum (FBS). The expansion of these cells, however, results in phenotypic loss 
with rapid drop in cellular collagen II and COMP expression.60, 106, 159 
Researchers have employed several vehicles to recover losses in gene 
expression by culturing cells in three dimensional alginate gels, plating cells on 
two dimensional surface coatings and adding growth factors to the expansion 
medium.60, 61, 159, 196, 197 These techniques have been generally successful in 
reversing the effects of markers such as COMP and collagen I; however, 
collagen II expression reversal has been particularly challenging. 
Recent work has suggested that low oxygen tension (hypoxia) may aid in 
meniscus cell (MC) and articular chondrocyte (AC) phenotype maintenance and 
enhancement,65"68 with increases in expression of hypoxia inducible factor-
1 alpha (HIF-1a) and SOX-9. These transcription factors play important roles in 
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collagen II synthesi.69, 70 Furthermore, in vivo, cartilaginous tissues reside in 
hypoxic conditions where the lack of the blood supply creates a low oxygen 
environment (1 to 8%) for cartilage cells.71,72 The tissue engineering strategy 
used in this experiment aims to mimic in vivo conditions by culturing meniscus 
cells on poly-l-lactic acid (PLLA) scaffolds under hypoxic conditions. Other 
physiologically-relevant loading environments such as direct compression and 
hydrostatic pressure have also been studied in the literature with beneficial 
results obtained at 3-D level.86'198'1" 
In addition to hypoxia, we also examined whether basic fibroblast growth factor 
(bFGF), an ubiquitous growth factor with several different functions,200,201 would 
affect extracellular matrix (ECM) production on a PLLA scaffold and influence the 
final biomechanical properties of the cell-seeded construct. bFGF has been 
shown to promote glycosaminoglycan (GAG) synthesis in costal chondrocytes 
and MCs and aid in maintaining their phenotype.85,202 bFGF is also a.regular-
component of serum-free medium used for cartilaginous tissue engineering as 
well as for chondro-differentiation of mesenchymal stem cells.203,204 
Thus, the goal of this experiment was to investigate whether bFGF and hypoxia 
would influence the matrix and functional properties of MC seeded-PLLA 
scaffolds. It was hypothesized that the individual application of bFGF and 
hypoxia would enhance the biochemical and compressive biomechanical 
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properties of the constructs and that their combination would result in an additive 
or synergistic effect. 
Materials and methods 
Cell harvesting, culture and passage 
Cells were obtained from avascular portions of lateral and medial menisci of eight 
skeletally mature New Zealand white rabbits less than 12 hr after slaughter using 
a protocol described previously.205 Briefly, meniscus tissue was aseptically 
harvested from the knee joint and transferred to a sterile cell culture hood. The 
tissue was minced to less than 1 mm3 sections and digested with collagenase II 
overnight. Cells were then pooled the following day from the rabbits to reduce 
animal variability and counted using a hemocytometer. Cell viability (over 95%) 
was assessed using a trypan blue exclusion test. Cells were then frozen at -80°C 
in DMEM supplemented with 20% FBS and 10% dimethyl sufloxide for one 
month. At the start of the experiment, cells were thawed and cell viability was 
determined to be 90%. The cells were plated on T-225 flasks at approximately 
25% confluence in chemically defined culture medium. The medium consisted of 
DMEM, 4.5 g/L-glucose and L-glutamine, 40 ug/mL L-proline, 100nM 
dexamethasone, 1% penicillin/streptomycin/fungizone, 50 ug/ml_, ascorbate-2-
phosphate, 100 ug/mL sodium pyruvate, 1% ITS+ and 1% FBS. FBS was used 
to promote cell attachment and proliferation during monolayer expansion. Cells 
used in the experiment were passaged at 90% confluence using trypsin/EDTA 
and counted with a hemocytometer. 
122 
Cell seeding 
Cylindrical 2 mm thick and 3 mm wide non-woven PLLA scaffolds (Biomedical 
Structures Warwick, Rl) of molecular weight 100 kDa were obtained from a PLLA 
sheet using a 3 mm dermal punch. The scaffolds were sterilized using ethylene 
oxide. They were then pre-wetted with 70% ethyl alcohol, and subsequently 
washed twice with phosphate buffered saline (PBS). The scaffolds were housed 
in individual wells of 12-well plates that were previously coated with 0.5 ml of 2% 
sterile molten agarose and incubated overnight in culture medium. Prior to 
seeding, the culture medium was changed and passaged cells were injected into 
the scaffolds at a density of 1 million cells/scaffold. The 12-well plates were 
placed on an orbital shaker (80 rpm) in the incubator for 3 days. The plates were 
then removed from the orbital shaker and placed in static culture for an additional 
2 days to allow for the cells to adhere to and infiltrate the PLLA scaffold. 
Tissue culture 
Post-seeding, constructs were randomly divided into four experimental groups. 
Constructs in the first group were housed in an incubator set at 37°C, 5% CO2 
and approximately 21% CMnormoxic, no bFGF group). Constructs in the second 
group were housed in the same incubator; however, the culture medium was 
supplemented with 5 ng/ml of bFGF (normoxic, bFGF group). The dose was 
chosen based on prior literature that showed its benefit for meniscus cell culture 
65
. Constructs in the third group were housed in a Billups-Rothenberg modular 
incubator chamber (Billups-Rothenberg, Del Mar, CA) that contained a custom 
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gas mixture of 5% C02, 93% N2 and 2% 02 (hypoxic, no bFGF group). Sterile 
deiohized water was used to humidify the chamber and the entire chamber was 
placed in the regular incubator housing the normoxic constructs. Constructs in 
the fourth group were housed in the same incubator; however, the culture 
medium was supplemented with 5 ng/ml of bFGF (hypoxic, bFGF group). The 
culture medium in all groups was devoid of FBS and was changed once every 3 
days. In addition, a fresh dose of bFGF was added during every medium change 
to groups that were cultured with the growth factor. The custom gas mixture used 
in the Billups-Rothenberg incubator was flushed once every 3 days during each 
medium change. Constructs were kept in culture for a period of 4 wks post-
seeding. 
Histology and immunohistochemistry 
At t = 4 wks, two samples from each group were frozen using HistoPrep and then 
sectioned at 14 urn. Safranin-0 / fast green stains were used to determine GAG 
distribution.147 Picrosirius red staining was used to qualitatively determine the 
presence of collagen.148 Collagen I and collagen II distributions were determined 
using a Biogenex i6000 autostainer. Sectioned samples were fixed in chilled 
acetone and rinsed with IHC buffer. They were then quenched of peroxidase 
activity with hydrogen peroxide/methanol and blocked with horse serum 
(Vectastain ABC kit). Slides were then incubated with mouse anti-COL 1 
(Accurate Chemicals) or mouse anti-COL 2 (Chondrex) antibodies. After 
incubation with the primary antibodies, a secondary mouse IgG antibody 
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(Vectastain ABC kit) was added and color was developed using the Vectastain 
ABC reagent and DAB (Vector Labs). 
Quantitative biochemistry 
At t = 0 (5 days post-seeding) and t = 4 wks, samples were digested at 65 °C 
overnight with 125 ug/ml papain in 50 mM phosphate buffer (pH = 6.5) containing 
2 mM N-acetyl cysteine and 2 mM EDTA. A picogreen cell proliferation assay kit 
(Invitrogen, Carlsbad, CA) was used to determine total DNA content in each 
sample. Total GAG was quantified using the Blyscan Glycosaminoglycan Assay 
kit.150 A modified chloramine-T hydroxyproline assay was used to determine total 
collagen in the construct.151 For the 4 wk samples, compressive properties of the 
constructs were first determined prior to biochemical testing. 
Biomechanics 
The viscoelastic compressive properties of samples from each group were tested 
at t = 4 wks using a set up described previously.134 Briefly, an incremental stress 
relaxation test at 10%, 20% and 30% strain was designed and implemented after 
determining the height of the construct. Each sample was held at the chosen 
strain level for 20 min with a 10% strain step. The strain rate was kept constant 
throughout at 0.5 mm/s. Data obtained from each test were fitted using MATLAB 
to an incremental stepwise viscoelastic stress relaxation solution for a standard 
linear solid.135 The parameters obtained were converted to instantaneous 
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modulus (Ej), relaxation modulus (Er) and coefficient of viscosity (u) for each 
strain level. 
Statistical analyses 
The quantitative biochemical and biomechanical data were compared using a 
two way analysis of variance (ANOVA). If significant differences were observed, 
a Tukey's post hoc test was performed to determine specific differences among 
groups. The 2-way ANOVA was also used to determine if synergistic effects were 
observed among groups.180 Specifically, the presence of synergy between the 
culturing condition and the growth factor was examined using the interaction term 
obtained from the 2-way ANOVA. A significance level of 95% with a p value of 
0.05 was used in all statistical tests performed. All values are reported as mean ± 
standard deviation. 
Results 
Gross morphology, histology, and IHC (n = 2) 
Morphological analysis at t = 4 wks showed presence of translucent cartilage-like 
matrix in all groups (Figure 19). Constructs retained their structural integrity over 
the culture period with no observable signs of scaffold degradation. No significant 
differences were observed for the construct diameter and thickness for the 
culturing condition (p = 0.52, p = 0.43) and for the growth factor treatment (p = 
0.20, p = 0.41) (Table 6). Histological analysis showed presence of collagen and 
GAG in all constructs (Figure 19). Collagen staining was uniform throughout the 
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construct in groups exposed to bFGF while staining was limited to the periphery 
of the constructs in other groups. GAG staining was concentrated to the 
periphery of the construct with interspersed pockets of GAG observed in 
constructs cultured simultaneously under hypoxic conditions and bFGF. All 
constructs stained positively for collagen I (data not shown). Collagen II staining 
was diffuse in constructs exposed to hypoxia and absent for constructs cultured 
in normoxic conditions (Figure 19). 
Biochemistry (n = 5) 
At t = 4 wks, wet weight of constructs were significantly higher in groups cultured 
with bFGF (p = 0.03), regardless of culturing condition (p = 0.63) (Table 6). No 
significant differences were observed in the dry weight at the same time point for 
the growth factor treatment (p = 0.55) and culturing condition (p = 0.74) (Table 6). 
At t = 0, the cell number was found to be 0.60 ± 0.2 million cells/construct via 
picogreen analysis. At t = 4 wks, cell numbers/constructs significantly increased 
in constructs exposed to bFGF (p = 0.002), to approximately 0.74 ±0.1 million 
cells/construct (Figure 20); however, the culturing condition was not found to be 
significant (p = 0.82). Thus, hypoxic conditions did not affect meniscus cell 
proliferation rates on PLLA constructs. 
Collagen and GAG contents were undetectable at t - 0 in all groups. At t = 4 wks, 
the neither the culturing condition (p = 0.81) nor growth factor treatment (p = 
0.31) were found to be significantly different for total collagen/construct. Values 
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ranged between 15 ± 7 |jg for the normoxic, no bFGF group to 21 ± 3 ug for the 
hypoxic, no bFGF group (Figure 21). For GAG/construct, however, both the 
culturing condition (p = 0.01) and the growth factor (p = 0.004) were found to be 
significant factors. Specifically, GAG/construct was at least 2 times higher in the 
hypoxia + bFGF group (17 ± 5 ug) when compared to both non-bFGF treated 
groups (~ 8 ± 2 ug) (Figure 22). Further, it was determined that a synergistic 
increase was observed in the total GAG content for constructs stimulated in 
hypoxic conditions with bFGF when compared to constructs cultured in the 
normoxic condition with no bFGF. 
Biomechanics (n = 5) 
Compressive viscoelastic tests were performed at three different strain levels 
(10%, 20%, and 30%) and the instantaneous modulus, relaxation modulus, and 
coefficient of viscosity were determined at each strain level (Figure 23). At each 
strain level, the constructs exposed to hypoxia and bFGF were found to have 
significantly higher instantaneous modulus, relaxation modulus, and coefficient of 
viscosity when compared to the no growth factor control groups. At 30% strain, 
for example, the relaxation modulus and the instantaneous modulus for the 
hypoxia + bFGF group were 31 ± 7 kPa, and 80 ± 10 kPa respectively, 
approximately 35% and 50% higher than their corresponding normoxia - bFGF 
control group values. The coefficient of viscosity at the same strain for the 
hypoxia + bFGF group was 205 ± 58 kPa, approximately 38% higher than the 
normoxia - bFGF group. Further, it was determined that an additive increase was 
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observed for the instantaneous modulus, and synergistic increases were 
observed for the relaxation modulus, and the coefficient of viscosity at all strain 
levels. 
Correlation between biochemical and biomechanical data 
The compressive properties obtained from incremental stress relaxation curves 
were correlated with the GAG and collagen content at each strain level. At 30% 
strain, univariate regression analysis showed a significant correlation between 
instantaneous modulus and GAG/construct (p < 0.0001, r2 = 0.56), and 
collagen/construct (p = 0.002, r2 = 0,24). Similar results were obtained when 
correlating the relaxation modulus and GAG/construct (p < 0.0001, r2 = 0.61), 
and collagen/construct (p.< 0.001, R2 = 0.31). Further, the coefficient of viscosity 
correlated significantly with GAG/construct (p = 0.001, r2 = 0.45), and 
collagen/construct (p = 0.01, r2 = 0.32) as well. Similar significant correlations 
were obtained at 20 and 30% strain levels. 
Discussion 
This study demonstrates the potential benefit of hypoxia and bFGF for knee 
meniscus tissue engineering. The biochemical content was enhanced with 
synergistic increases in total GAG content for constructs exposed to hypoxia and 
bFGF. The compressive properties of the construct also increased, with additive 
increases in the instantaneous modulus and synergistic increases in the 
relaxation modulus and the coefficient of viscosity observed for constructs 
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exposed to both hypoxia and bFGF. Although, significant differences were not 
observed for total collagen content/construct, scaffolds exposed to hypoxia and a 
combination of hypoxia and bFGF showed diffuse staining for collagen II, which 
was absent in the normoxic groups. Together, these results demonstrate that 
growth factors and oxygen concentrations can significantly enhance the ability of 
meniscus cells to produce relevant ECM in vitro. 
Cells in the inner regions of a skeletally mature meniscus reside in an avascular, 
low oxygen tension environment that may induce their chondrogenic-like 
phenotype.70 Studies have shown that under hypoxic conditions, MCs express 
HIF-1a that controls SOX-9 expression 65, 70 which has been implicated in 
modulating aggrecan and collagen II gene expression.206,207 In this experiment, a 
significant increase in GAG was observed in constructs cultured in hypoxic 
conditions suggesting increases in the production of aggrecan and other 
proteoglycans with sulfated GAG chains such as decorin and biglycan. Further, 
IHC data showed that collagen II production was enhanced relative to collagen I 
production in the hypoxic constructs. In a previous experiment, we showed that 
inner avascular portions of the meniscus that consist of mainly chondrocyte-like 
cells rapidly dedifferentiate during monolayer and express very low levels of 
collagen II.159 Thus, the observed collagen II increase in this study was exciting 
and suggests that post-translational processing of collagen II relative to collagen 
I was increased under hypoxic conditions, even though total collagen processed 
remained the same. 
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Lateral and medial meniscus cells under hypoxic conditions have also been 
shown to upregulate TGF-f31 gene expression after 8 and 24 hrs of hypoxia.208 
TGF-pi has been shown previously to be a potent regulator of GAG synthesis in 
meniscus cells.143' 209 In chondrocytes, TGF-J31 has been shown to directly 
influence the synthesis of GAGs by accelerating glucose transport via 
extracellular signal-regulated kinase-dependent signaling and protein kinase C 
pathways.189 Further, hypoxia and TGF-(3 pathways have also been shown to 
function synergistically,210 and may supplement SOX-9 pathways, to enhance 
GAG production on the meniscus-cell seeded scaffolds. 
The presence of bFGF in the medium significantly increased the GAG production 
in the constructs. Furthermore, in the presence of hypoxia and bFGF, a 
synergistic increase was observed in GAG content over the normoxic control. 
These results build upon a prior study that showed increases in GAG/DNA in 3-D 
MC aggregates in the presence of bFGF alone or bFGF and hypoxia.65 The exact 
mechanism by which bFGF might modulate GAG synthesis in meniscus cells is 
unclear. It is known that bFGF has the ability to maintain meniscus cells in a 
plastic state in monolayer and0020make them more responsive to a 
chondrogenic stimulus,65 In addition, bFGF also plays an important role in 
modulating intracellular Ca2+ levels through protein kinase C activity.211 Changes 
in intracellular Ca2+ levels can affect downstream signaling pathways that 
influence gene expression and protein synthesis of various extracellular matrix 
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molecules.192 In the vascular literature, the combination of hypoxia and bFGF has 
been shown to induce tube formation by human microvascular endothelial cells in 
fibrin clots by activating transcription factor NF-KB (p65) and increasing 
phosphorlyated mitogen-activated protein kinases ERK1/2 over normoxic levels 
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. NF-KB, usually associated with inflammation pathways, has also been shown 
to be activated in differentiated chondrocytes.213 This suggests that the 
combination of hypoxia and bFGF may be responsible in enhancing cartilaginous 
markers, such as GAGs and collagen II, in differentiated MCs used in this 
experiment. 
This study also showed that bFGF in the culture medium resulted in increased 
cell number/construct for both hypoxic and normoxic groups. This increase is 
likely mediated through transmembrane surface receptors with tyrosine kinase 
activity.214 Other groups have also reported increases in cell number in the 
presence of bFGF for MCs,143 fibroblasts,215 chondrocytes,216 and 
dedifferentiated chondrocytes.217 It is yet unclear whether bFGF treatment results 
in selective proliferation of chondrocyte-like cells from the inner meniscus over 
fibroblast-like cells from the outer meniscus or whether it maintains both cell 
types in a plastic state as they proliferate and makes them more responsive to a 
chondrogenic stimulus. Future studies will have to examine inner and outer 
meniscus cells separately to isolate the effects of cell type. It is known that inner 
and outer meniscus cells respond differently to hypoxic treatment with stark 
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changes in gene expression of SOX-9 and collagen I;70 however, whether bFGF 
elicits a similar response has not been shown. 
The compressive properties of meniscus constructs increased when exposed to 
bFGF in the presence of hypoxia with synergistic increases in the relaxation 
modulus and coefficient of viscosity and additive increases to the instantaneous 
modulus. Compressive properties of the meniscus can be correlated with the 
concentration of GAGs in the tissues. In this study, the instantaneous modulus, 
the relaxation modulus, and the coefficient of viscosity were all found to be 
strongly correlated to GAG/construct. GAGs are negatively charged particles that 
attract water molecules into the tissue and increase the overall construct 
stiffness.1 A weaker but statistically significant correlation was observed with 
collagen/construct and the instantaneous modulus, relaxation modulus, and the 
coefficient of viscosity. Collagen provides tensile resistance to the tissue 218 and 
although we did not perform tensile tests in this experiment, we hypothesize that 
a stronger correlation to collagen would exist with tensile properties such as 
Young's modulus and ultimate tensile strength when compared to compressive 
properties. It is of interest to note that a weak but significant correlation between 
the coefficient of viscosity and GAG was also observed. We are not aware of any 
such correlation in the literature. This result may be explained via the enhanced 
electrostatic forces generated by GAGs, which may in turn inhibit fluid flow and 
render the construct more viscous in behavior. 
133 
Conclusions 
Overall, these results demonstrate the effectiveness of combining bFGF and low 
oxygen tension (2% 02) to synergistically enhance matrix and functional 
properties of tissue engineered meniscus constructs in vitro. Specifically, we 
were able to observe significant enhancements in GAG content, collagen II 
content, and cell number/construct in groups exposed to hypoxia and bFGF 
when compared to the controls. In future studies, additional anabolic stimuli, such 
as hydrostatic pressure 178 or direct compression 1 " can be employed in 
conjunction with hypoxia + bFGF to further leverage potential synergies between 
the systems and further enhance the overall functional properties of the 
meniscus constructs towards native values. 
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Figures associated with chapter 6 
Gross Morphology Collagen (1 OX) GAG (1 OX) Collagen II (40 X) 
Figure 19. Gross morphological, histological and immunohistochemical 
sections of constructs 
All constructs showed presence of translucent cartilage-like matrix. Histological 
sections of constructs showed presence of both collagen and GAG in all groups. 
Collagen staining was more uniform in constructs exposed to bFGF. GAG 
staining was concentrated towards the periphery of the constructs in all groups. 
In constructs exposed to bFGF and hypoxia, additional pockets of GAG were 
observed interspersed throughout the constructs. Collagen II was present in 
groups exposed to hypoxic conditions. 
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Figure 20. Cell number per construct 
At t = 0, cell number per construct was found to be 0.60 ± 0.2 million cells, as 
indicated by the dashed line. Cell proliferation on the PLLA constructs was 
observed in constructs exposed to bFGF, regardless of culturing condition. A 2-
way ANOVA was performed followed by a Tukey's post hoc analysis to 
determine significant differences within factors. Groups with different letters are 
significantly different from each other. All values are reported as mean ± SD. An 
n = 5 was used to perform the assay. 
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Figure 21. Total collagen per construct 
At t = 4 wks, no significant differences were observed in the total collagen 
content/construct. Statistics were conducted using a 2-way ANOVA. All values 
are reported in mean ± SD. An n = 5 was used to perform the assay. 
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Figure 22. Total GAG per construct 
At t = 4 wks, a significant increase in GAG deposition was observed in constructs 
exposed to bFGF and this was further enhanced in hypoxic conditions with a 
synergistic increased in GAG deposition in the hypoxic, bFGF group when 
compared to the normoxic, no bFGF group. Statistics were conducted using a 2-
way ANOVA. Groups with different letters (capital or small) are significantly 
different from each other. Star symbol refers to a synergistic increase in GAG 
production. All values are reported as mean ± SD. An n = 5 was used to perform 
the assay. 
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Figure 23. Compressive properties of the constructs (30% strain) 
At t = 4 wks, the culturing condition and the growth factor treatment were found 
to be significant factors when investigating the instantaneous modulus, 
relaxation modulus and coefficient of viscosity. Specifically, additive increases 
were observed for the instantaneous modulus and synergistic increases were 
observed for the relaxation modulus and coefficient of viscosity in constructs 
exposed to both hypoxia and bFGF. Statistics were conducted using a 2-way 
ANOVA. Groups with different letters (capital or small) are significantly different 
from each other. Star symbol refers to a synergistic increase in relaxation 
modulus and coefficient of viscosity. Box symbol refers to an additive increase in 
instantaneous modulus. An n = 5 was used for all compressive tests. 
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Table 6. Wet weight, dry weight, thickness and diameter of constructs 
Wet weight of the constructs increased in the presence of b-FGF. No significant 
differences were observed among groups for the dry weight, thickness and 
diameter. A p value < 0.05 was considered significant. 
Groups 
Normoxic 
Hypoxic 
p value -
culture 
condition 
growth factor 
Wet wei 
No bFGF 
(mg) 
11.4 ± 
1.1 
11.5± 
1.3 
0.63 
0.03 
ight 
bFGF 
(mg) 
12.8 ± 
1.2 
13.8 ± 
1.4 
Dry wei 
No bFGF 
(mg) 
0.59 ± 
0.2 
0.61 ± 
0.2 
0.74 
0.55 
ght 
bFGF 
(mg) 
0.60 ± 
0.1 
0.62 ± 
0.3 
Thickness 
No bFGF bFGF 
(mm) (mm) 
1.9 ± 2.2 ± 
0.2 0.1 
2.0 ± 2.0 ± 
0.1 0.3 
0.43 
0.41 
Diameter 
No bFGF 
(mm) 
2.8 ± 
0.2 
2.9 ± 
0.2 
0.52 
0.20 
bFGF 
(mm) 
3.0 ± 
0.2 
3.1 ± 
0.3 
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Chapter 7: Effects of co-cultures of meniscus cells and 
articular chondrocytes on PLLA scaffolds 
Najmuddin J. Gunja and Kyriacos A. Athanasiou 
Chapter submitted as: Gunja NJ and Athanasiou KA. Effects of co-cultures of 
meniscus cells and articular chondrocytes on PLLA scaffolds. Biotechnology and 
Bioengineering. 
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Abstract 
The knee meniscus, a fibrocartilaginous tissue located in the knee joint, is 
characterized by heterogeneity in extracellular matrix and biomechanical 
properties. To recreate these properties using a tissue engineering approach, 
co-cultures of meniscus cells (MCs) and articular chondrocytes (ACs) were 
seeded in varying ratios (100:0, 75:25, 50:50, 25:75 and 0:100) on poly-l-lactic 
acid (PLLA) scaffolds and cultured in serum free medium for 4 wks. Histological, 
biochemical and biomechanical tests were used to assess constructs at the end 
time point. Strong staining for collagen and glycosaminoglycan (GAG) was 
observed in all groups. Constructs with 100% MCs were positive for collagen I 
and constructs cultured with 100% AGs were positive for collagen II, while a mix 
of collagen I and II was observed in other co-culture groups. Total collagen and 
GAG per construct increased as the percentage of ACs increased (27 ± 8 ug, 
0% AC to 45 ± 8 ug, 100% ACs for collagen and 12 ± 4 ug, 0% ACs to 40 ± 5 ug, 
100% ACs for GAG). Compressive modulus (instantaneous and relaxation 
modulus) of the constructs were significantly higher in the 100% ACs group (63 ± 
12 kPa and 22 ± 9 kPa, respectively) when compared to groups with higher 
percentage of MCs. No differences in tensile properties were noted among 
groups. Specific co-culture ratios were identified mimicking the GAG/DW of the 
inner (0:100, 25:75 and 50:50) and outer regions (100:0) of the meniscus. 
Overall, it was demonstrated that co-culturing MCs and ACs on PLLA scaffolds 
results in functional tissue engineered meniscus constructs with a spectrum of 
biochemical and biomechanical properties. 
142 
Introduction 
Knee menisci are semi-lunar shaped fibrocartilaginous discs located in between 
the tibia and the femur in the knee joint. They contain a heterogeneous cell 
population with the outer third containing predominantly elongated fibroblast-like 
cells and the inner two thirds containing predominantly rounded chondrocyte-like 
cells.11 The outer meniscus is mainly fibrous with collagen type I, while the inner 
meniscus contains both collagen I and collagen II in a 2:3 ratio.1 In addition, the 
meniscus also contains several glycoproteins including aggrecan, biglycan, 
decorin and COMP that aid in the constructs compressive and tensile 
properties.219 The mechanical properties of menisci vary significantly between 
regions with the inner meniscus possessing higher compressive strength when 
compared to the outer meniscus.164 In addition, tensile properties of the 
meniscus are greater in the circumferential direction when compared to the 
radial direction.19 Menisci play an important role in knee mechanics and stability, 
but unfortunately are prone to damage, and do not heal due to low tissue 
vascularity. Several attempts are underway to tissue engineer the meniscus; 
however, much work remains before a functional construct mimicking the 
heterogeneities of the native meniscus is achieved.220 
The limited supply of allogenic or autologous meniscus cells (MCs) for tissue 
engineering experiments necessitates the need for monolayer cell expansion to 
attain high cell numbers. This approach can lead to significant changes in the 
cells' phenotype and matrix production capability. Cartilaginous cells, such as 
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articular chondrocytes (ACs), MCs and tempormandibular joint (TMJ) disc 
fibrochondrocytes, are especially susceptible to monolayer dedifferentiation and 
have shown rapid changes in gene expression over passage for important 
cartilaginous markers.61, 106, 159, 221 For instance, in bovine meniscal 
fibrochondrocytes, collagen II expression has been shown to drop 70 fold over 
four passages with a dramatic 5800 fold increase in collagen I expression.159 
Several different redifferentiation vehicles have been instituted to reverse losses 
in gene expression for cartilaginous cells with mixed results; these include 
exogenous growth factor addition into the medium, cell plating on surface protein 
coating and cell encapsulation in agarose or alginate gels.60, 63, 65, 159, 197 
Recovery of collagen II expression back to native values has posed a significant 
challenge, with only two studies reporting a retention of matrix phenotype in 
passaged MCs using a combination of hypoxia and a growth factor, bFGF.65,70 
Both studies, however, utilized gene expression and cell aggregates to 
determine the matrix forming capabilities of passaged cells. Recent work has 
investigated the potential of using primary ACs to treat defects in the inner 
meniscus with the goal of increasing collagen II and glycosaminoglycans (GAGs) 
content.222,223 Primary chondrocytes express high levels of collagen II and GAGs 
and if co-cultured with MCs on a scaffold may result in constructs resembling 
various regions of the knee meniscus.27, 60 Additionally, primary chondrocytes 
have been used as a re-differentiation tool for passaged chondrocytes in 
monolayer.224 Such an approach, however, has not been attempted with MCs. 
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Thus, this experiment investigated the effects of co-culturing various ratios of 
passaged MCs and primary ACs on poly-l-lactic acid (PLLA) scaffolds. It was 
hypothesized that constructs with a spectrum of histological, biochemical and 
biomechanical properties would be achieved depending on the MC:AC co-
culture ratio. 
Materials and methods 
Cell harvesting, culture and passage 
ACs and MCs were aseptically harvested from the knee joint of ten skeletally 
mature New Zealand white rabbits less than 12 hrs after slaughter. The tissues 
were minced and then digested overnight using 0.2% collagenase II 
(Worthington, Lakewood, NJ) dissolved in Dulbecco's modified culture medium 
(DMEM) (Gibco, Grand Island, NY). The medium was supplemented with 10% 
fetal bovine serum (FBS) (Biowhittaker, Walkersville, MD), 4.5 g/L-glucose and 
L-glutamine (Gibco, Grand Island, NY), 1% penicillin/streptomycin/fungizone 
(Sigma, St Louis, MO), 1% non-essential amino acids (Invitrogen, Grand Island, 
NY), and 50 ng/ml L-ascorbic acid (Sigma, St Louis, MO). Post-digestion, ACs 
and MCs were pooled separately and counted using a hemocytometer. Cell 
viability was assessed using a trypan blue exclusion test and found to be over 
95% for both cell types. 
ACs were then placed in culture medium supplemented with 20% FBS and 10% 
dimethyl sulfoxide and stored in liquid nitrogen. The MCs were plated on T-225 
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flasks at approximately 25% confluence in chemically defined serum free DMEM 
medium containing 4.5 g/L-glucose and L-glutamine, 40 ug/mL L-proline, 100nM 
dexamethasone, 1% penicillin / streptomycin / fungizone, 50 ug/mL, ascorbate-2-
phosphate, 100 ug/mL sodium pyruvate and 1% insulin-transferrin-selenium 
(ITS+) (BD Biosciences, San Jose, CA). MCs were expanded to the second 
passage and then counted using a hemocytometer. ACs were thawed post MC 
expansion and counted using a hemocytometer. AC viability was calculated to 
be over 95%. 
Scaffold preparation and cell seeding 
Non-woven PLLA scaffolds (molecular weight = 100 kDa) (Biomedical 
Structures, Warwick, Rl), 2 mm thick and 3 mm wide, were obtained from a 
PLLA sheet using a 3 mm dermal punch. Scaffolds were sterilized using 
ethylene oxide, pre-wetted using ethyl alcohol (70%) and then washed twice with 
phosphate buffered saline (PBS). Prior to cell-seeding, scaffolds were housed in 
serum free medium in 12 well plates that were previously coated with 0.5 ml of 
2% sterile agarose. ACs and MCs were pooled into five different co-culture ratio 
groups (n = 17 for each group): 1) 100% MCs; 2) 75% MCs + 25% ACs; 3) 50% 
MCs + 50% ACs; 4) 25% MCs + 75% ACs; and 5) 100% ACs. Cells were 
injected into scaffolds at a density of 1 million cells/scaffold. The 12-well plates, 
containing cell-seeded scaffolds were placed on an orbital shaker (80 rpm) in the 
incubator for 3 days followed by static culture in the incubator for an additional 2 
days. 
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Tissue culture 
Post-seeding, five constructs from each of the five co-culture groups were 
removed and processed for several biochemical assays to determine cell 
seeding numbers and total collagen and GAG levels at t = 0. The remaining 
constructs were transferred to 6-well plates, each well housing one scaffold. 6 ml 
of serum-free medium was added to each well and changed every once every 
two days. Constructs were kept in culture for a period of 4 wks. 
Histology and immunohistochemistry 
At t = 4 wks, two samples from each group were frozen using HistoPrep (Fisher 
Scientific, Pittsburg, PA) and sectioned at 14 urn. GAG distribution was 
determined using a Safranin-0 / fast green stain.147 Collagen distribution was 
determined using a Picrosirius red stain.148 Collagen I and collagen II 
distributions were determined using a Biogenex i6000 autostainer. Briefly, 
samples were fixed in chilled acetone and rinsed with IHC buffer. They were 
then treated with hydrogen peroxide/methanol and blocked with horse serum 
(Vectastain ABC kit). Slides was incubated with mouse anti-COL 1 (Accurate 
Chemicals, Westbury, NY) or mouse anti-COL 2 (Chondrex, Redmond, WA) 
antibodies. Post-incubation, a secondary mouse IgG antibody (Vectastain ABC 
kit) was added and color was developed using the Vectastain ABC reagent and 
DAB (Vector Labs, Burlingame, CA)). 
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Quantitative biochemistry 
Five samples collected at t = 0 (5 days post seeding) and t = 4 wks (33 days post 
seeding), were processed for biochemical analysis post compressive testing. 
The samples from each group at t = 4 wks were digested overnight at 65 °C with 
125 ug/ml papain in 50 mM phosphate buffer (pH = 6.5) containing 2 mM N-
acetyl cysteine and 2 mM EDTA. Total DNA content/sample was determined 
using a picogreen cell proliferation assay kit (Molecular Probes). Total 
GAG/sample was quantified using the Blyscan Glycosaminoglycan Assay kit.150 
Total collagen/sample was determined using a modified chloramine-T 
hydroxyproline assay.151 
Compressive tests 
Prior to biochemical testing of 4 wk samples, five samples from each group were 
subjected to biomechanical analysis. Viscoelastic compressive properties of 
samples from each group were examined by performing incremental stress 
relaxation tests at 10%, 20% and 30% strain levels using an Instron 5565.134 
Each sample was held at the chosen strain level for 20 min with a 10% strain 
step. The strain rate was kept constant throughout the test at 0.5 mm/s. Data 
obtained from each test were fitted using MATLAB to an incremental stepwise 
viscoelastic stress relaxation solution for a standard linear solid as described 
elsewhere.135 The parameters obtained from the model were converted to 
instantaneous modulus (Ej), relaxation modulus (Er) and coefficient of viscosity 
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(|j) for each strain level. Compressive properties of unseeded PLLA constructs at 
t = 4 wks after culture were also determined and served as a control. 
Tensile tests 
Five samples were used for tensile tests at t = 4 wks. Tests were performed 
using an Instron 5565 with a 50 N load cell. To ensure testability, samples were 
carefully carved into a dog-bone shape with a 2 mm gauge length. The ends of 
the samples were glued to paper tabs using cyanoacrylate. After a 0.05 N tare 
load was applied, the constructs were pulled to failure at a constant strain rate of 
0.02 s"1. Stress-strain curves generated from the test yielded the tensile stiffness 
and the ultimate tensile strength (UTS) of each construct. Tensile properties of 
unseeded PLLA constructs at t = 4 wks were also determined and served as a 
control. 
Statistical analyses 
The quantitative biochemical and biomechanical data were compared using an 
analysis of variance (ANOVA) test. If significant differences were observed, a 
Tukey's post hoc test was performed to determine specific differences among 
groups. A significance level of 95% with a p value of 0.05 was used in all 
statistical tests performed. All values are reported as mean ± standard deviation. 
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Results 
Gross morphology, histology and IHC 
At t = 4 wks, all constructs showed presence of ECM inside the scaffold. As the 
percentage of AGs increased, pockets of ECM were observed on the periphery 
of the scaffold (Figure 24). Construct diameter increased significantly as the 
percentage of ACs increased from 3.0 ± 0.4 mm for the 100% MC group to 3.2 ± 
0.3 mm for the 100% AC group (Table 7) (p = 0.02). Similar significant increases 
were observed for the thickness of constructs from 2.0 ± 0.1 mm for the 100% 
MC group to 2.3 ±0.1 mm for the 100% AC group (Table 7) (p = 0.003). 
Collagen and GAG staining was positive in all groups, with stronger staining for 
both ECM components observed in 100% AC group (Figure 24). Positive 
staining for collagen I was observed in constructs cultured with 100% MCs while 
positive staining for collagen II was observed in constructs cultured with 100% 
ACs. A mix of collagen I and II was observed in other co-culture groups (Figure 
24). 
Biochemistry 
The dry weight of samples cultured with 100% ACs (1.6 ± 0.1 mg) was 
significantly higher than all other groups (p = 0.002) (Table 7); however, no 
significant differences were observed in the wet weight of constructs (p = 0.31) 
(Table 7). At t = 0, a cell seeding density of 0.67 ± 0.23 million cells/scaffold was 
obtained. Over the 4 wk culture period, no significant increases were observed 
among groups for cell number/construct with cell numbers ranging from 0.85 ± 
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0.14 to 0.68 ±0.19 million (p = 0.35) (Figure 25). Total collagen (Figure 26) and 
GAG (Figure 27) per construct increased significantly as the percentage of ACs 
increased (27 ± 8 ug, 0% AC to 45 ± 8 ug, 100% ACs for collagen (p = 0.03) and 
12 ± 4 ug, 0% ACs to 40 ± 5 ug, 100% ACs for GAG (p = 0.006). When collagen 
content was normalized to dry weight, groups with 25, 50, 75% ACs were not 
significantly different from each other, but were significantly higher than the 
100% MC and 100% AC groups (p = 0.03) (Figure 26). Similar trends were 
observed for collagen per wet weight with 100% MC constructs (~2 ug collagen / 
mg DW) containing significantly less collagen than the 100% AC group (~3.5 ug 
collagen / mg DW) (p = 0.03). For GAG/dry weight, constructs exposed to 50, 75 
or 100% ACs were significantly different from the other groups (p = 0.002) 
(Figure 27). GAG per WW mirrored total GAG values with significant increases 
observed in constructs with higher percentage of ACs (p = 0.02). 
Compressive properties 
Compressive moduli (instantaneous and relaxation modulus) and coefficient of 
viscosity were measured at 10, 20 and 30% strain levels. At 10% strain, the 
instantaneous and relaxation modulus of constructs with 100% ACs (63 ± 12 kPa 
and 22 ± 9 kPa, respectively) was significantly higher than the other groups (p = 
0.03) (Figure 28). No significant differences were observed among groups for the 
coefficient of viscosity. Similar results were observed at 20 and 30% strain 
levels. Compressive properties of unseeded PLLA constructs in medium at t = 4 
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wks were found to be 12 ± 4 kPa for the instantaneous modulus, 6 ± 3 kPa for 
the relaxation modulus, and 3 ± 1 MPa-s for the coefficient of viscosity. 
Tensile properties 
NO significant differences were observed among groups for tensile properties (p 
= 0.31) (Figure 29). Tensile stiffness ranged from 690 ± 220 kPa for the 100% 
MC group to 595 ± 200 kPa for the 100% AC group. UTS ranged from 500 ± 250 
kPa for the 100% MC group to 300 ± 250 kPa. Tensile properties of unseeded 
PLLA constructs at t = 4 wks in medium were found to be 300 ± 60 kPa for the 
tensile stiffness and180 ± 80 kPa for the UTS. 
Correlation between biochemical and biomechanical data 
The compressive and tensile properties obtained were correlated with the GAG 
and collagen content, respectively. For compressive properties at 10% strain, 
univariate regression analysis showed a significant correlation between 
instantaneous modulus and GAG/construct (p = 0.0001, r2 = 0.71), and 
collagen/construct (p = 0.0002, r2 = 0.39). Similar results were obtained when 
correlating the relaxation modulus and GAG/construct (p < 0.0001, r2 = 0.74), 
and collagen/construct (p = 0.007, r2 = 0.33). Further, the coefficient of viscosity 
correlated significantly with GAG/construct (p = 0.0001, r2 = 0.50), and 
collagen/construct (p = 0.0001, r2 - 0.42) as well. Similar significant correlations 
were obtained at 20 and 30% strain levels. For tensile properties, a significant 
correlation was observed between the tensile stiffness and collagen/construct (p 
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= 0.008, r2 = 0.53), and GAG/construct (p = 0.002, r2 = 0.21). In addition, the 
UTS was also found to correlate significantly with collagen/construct (p < 0.0001, 
r2 = 0.45), and GAG/construct (p < 0.001, r2 = 0.19) 
Discussion 
This study employed five different co-culture ratios of passaged MCs and primary 
ACs on PLLA scaffolds to identify co-culture ratios most closely resembling the 
biochemical and biomechanical properties of the inner and outer regions of the 
knee meniscus. Qualitative and quantitative tests showed clear differences 
between the ECM and biomechanical properties of the constructs in each group. 
Specifically, constructs cultured with a higher percentage of ACs had enhanced 
compressive properties and contained significantly higher levels of collagen, 
collagen II, and GAG. Constructs cultured with higher percentage of MCs 
contained higher levels of collagen I. Overall, it was demonstrated that co-
culturing MCs and ACs on PLLA scaffolds resulted in functional tissue 
engineered meniscus constructs with a spectrum of biochemical and 
biomechanical properties. 
The approach used in this tissue engineering study was unconventional in that it 
utilized a co-culture of second passaged MCs and primary ACs. Second passage 
MCs were used in this experiment to address the limitation of the number of 
primary rabbit MCs available and with the knowledge that MCs retain their ability 
to produce extracellular matrix up to the second passage.225 Primary ACs were 
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judiciously chosen based on their ability to enhance collagen II and GAG content, 
both of which are found in abundance in the inner regions of the meniscus 1 and 
are down-regulated in passaged meniscus cells.159 The IHC data showed that, as 
the percentage of ACs increased in the constructs, a concomitant increase in 
collagen II and GAG production was observed. In addition, for the first time, we 
were able to mimic certain compositions of the meniscus. The GAG/DW for the 
100, 75 and 50% AC groups were found to be in the range of the inner region of 
the rabbit meniscus (-20 to 25 ug GAG/mg dry tissue) while the GAG/DW for the 
100% MC group was in the range of the outer region of the rabbit meniscus (~5 
to 10 ug GAG/mg dry tissue).226 The collagen content/DW in all groups (~25 to 
35 ug collagen/mg dry tissue) was found to be lower than native values (600-700 
ug collagen/mg dry tissue).226 It should be noted, however, that the dry weight 
data presented are likely underestimated, as approximately 65-75% of the 
constructs' dry weights are that of the PLLA scaffold. If the weight of the scaffold 
is excluded, and the data re-normalized, the new collagen per dry weights 
approach those of native tissue with values ranging from 70 to 100 ug 
collagen/mg dry tissue. 
Primary ACs were also used in the experiment to aid in enhancing the 
capabilities of passaged MCs to produce relevant ECM. It has been shown that a 
low percentage of primary ACs (up to 20%), cultured with passaged ACs can aid 
in the reversal of gene expression of the passaged ACs.224 Specifically, the 
authors observed increases in expression of chondrogenic markers, collagen II, 
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SOX-9 and aggrecan, and decreases in expression of the fibroblastic marker 
collagen I in the passaged cells. Akin to that experiment, we examined whether 
low percentages of ACs would significantly increase the ability of MCs to produce 
relevant meniscus markers, especially those pertaining to the inner meniscus, 
such as collagen II. IHC images of collagen II distribution, however, did not allude 
to possible redifferentiation of MCs towards a chondrogenic phenotype. Gene 
expression analyses may provide a better understanding of the cells' phenotype 
post co-culture. In future experiments, ACs and MCs can be separated by flow-
associated cell sorting and examined for gene expression levels of relevant ECM 
markers.227 
The compressive biomechanical properties were evaluated at 4 wks with 
increases observed in the instantaneous and relaxation modulus for constructs 
cultured with higher percentage of ACs. The instantaneous modulus, relaxation 
modulus and the coefficient of viscosity correlated strongly with the amount of 
GAG in the construct. GAGs are negatively charged particles that attract water 
molecules into the constructs and increase the overall compressive stiffness. 
Weaker but statistically significant correlations were observed for 
collagen/construct and the three tested variables for the compressive tests. The 
compressive properties obtained were in the range of 30 to 75 kPa, approaching 
those of the rabbit inner meniscus (~120 kPa).19 
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The tensile properties, UTS and tensile stiffness, at 4 wks were found to correlate 
strongly with the collagen content in the scaffolds. Collagen provides tensile 
resistance to the tissue,218 and thus, this result was not unexpected. Weaker but 
statistically significant correlations were observed for the tensile properties with 
GAG per construct. Much work remains, however, to enhance the tensile 
properties of the cell-seeded constructs towards native tissue (approximately 150 
MPa for the tensile stiffness and 20 MPa for the UTS).19 Chemical agents such 
as chondroitinase-ABC can be utilized during culture to temporarily deplete 
GAGs from the constructs while enhancing collagen alignment.228 In addition, 
strategies to enhance collagen content need to be employed, perhaps by the 
addition of growth factors such as TGF-(31 into the culture medium or by the 
application of mechanical stimuli, such as hydrostatic pressure.198,229 
In this experiment, the absence of serum did not appear to hinder ECM 
production or decrease cell attachment to the PLLA constructs. Previous 
experiments in the laboratory have shown that 1% fetal bovine serum in the 
culture medium is necessary for meniscus cell attachment and proliferation in 
monolayer culture.229 However, to enhance the clinical translatability of our 
approach, we employed a serum free medium containing ITS+ and 
dexamethasone in this experiment. The serum free formulation obviates 
concerns of possible immune rejection and batch-to-batch variations in animal 
serum.171, 230 This cocktail has been used previously for both meniscus and 
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articular cartilage tissue engineering to maintain cell phenotype and increase 
proteoglycan synthesis.182'203'231,232 
An interesting observation in this study was the presence of small nodules of 
tissue growing atop the PLLA constructs with higher percentage of ACs. Several 
studies have shown that chondrocytes prefer to bind to other chondrocytes when 
placed in a 3-D environment, possibly to minimize their surface free energy.233 
This process is likely mediated by cadherin-cadherin interactions that are 
described by the differential adhesion hypothesis.56 In addition, the surface of 
PLLA is hydrophobic and does not possess physiologic activity which may further 
hinder chondrocyte cell adhesion.234 Although, nodules Were observed in 
constructs with a high percentage of ACs, they were conspicuously absent in 
groups with a higher percentage of MCs. In previous experiments, primary and 
passaged MCs have been shown to attach, proliferate and migrate inwards on 
PLLA scaffolds as evidenced by histological examination.229 The phenotype of 
the cell may dictate its attachment preferences to a substrate. The elongated or 
spindle-shaped MCs may reduce their free surface energy by attaching to the 
PLLA scaffold and spreading, while the spherical chondrocytes stay rounded and 
form nodules.235'236 
Constructs in all groups stained positively for GAG and collagen. Interestingly, 
the intensity of staining increased as the percentage of ACs increased with 
stronger staining observed at the periphery of the construct and weaker staining 
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towards the center. The disparity in staining intensity may be an indication of cell 
location within the tissue. Primary ACs are known to produce GAGs and collagen 
II in large amounts while passaged MCs produce mainly collagen I.159 Based on 
this and our histological findings, we can speculate that over the 4 wk culture 
period, ACs migrate towards the periphery of the construct while MCs populate 
the center. The differential expression of cadherins on the cell surface has been 
shown to drive cell sorting 237 and it is likely that passaged MCs and primary ACs 
express different levels of cadherins prior to and during co-culture. Further, MCs 
are known to exert contractile forces in scaffoldless meniscus constructs and 
may migrate toward the center of the scaffold.53 In future experiments, tracking 
agents such as Cell Tracker Orange can be utilized to confirm whether cell 
migration and sorting is indeed taking place. A gradual cell separation from a 
fibroblastic phenotype to a chondrocytic phenotype would be ideal for a meniscus 
tissue engineering strategy, as it would mimic the native meniscus cell 
distribution. 
Conclusions 
In conclusion, this study used co-cultures of passaged MCs and primary ACs to 
form robust constructs with a spectrum of biochemical and biomechanical 
properties. Collagen, GAG and compressive properties increased significantly as 
the percentage of ACs increased. Excitingly, we were able to achieve GAG levels 
close to native values for the inner and outer meniscus using a variety of co-
culture ratios. Collagen levels approached native meniscus as well if the dry 
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weight normalizations excluded the weight of PLLA. It is envisioned that this 
study will provide a baseline for future meniscus tissue engineering studies 
attempting to regenerate different regions of the meniscus. 
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Figures associated with chapter 7 
Gross Morphology Collagen GAG Collagen II Collagen I 
Figure 24. Gross morphological, histological and immunohistochemical 
sections of constructs 
Strong staining for collagen and GAG was observed in all groups. Constructs 
with 100% MCs were positive for collagen I and constructs cultured with 100% 
ACs were positive for collagen II, while a mix of collagen I and II was observed in 
other co-culture groups. Scale bar is 200 urn. 
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Figure 25. Cell number per construct 
All values are reported as mean ± SD. An n = 5 was used to perform the assay. 
No significant differences were observed among groups using a one-way 
ANOVA. Dotted line represents initial cell seeding density. 
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Figure 26. Total collagen per construct and collagen/DW 
Total collagen per construct increased as the percentage of ACs increased. 
Groups with different letters are significantly different from each other. All values 
are reported as mean ± SD. An n = 5 was used to perform the assay. 
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Figure 27. Total GAG per construct and GAG/DW 
Total GAG per construct increased as the percentage of ACs increased. Groups 
with different letters are significantly different from each other. All values are 
reported as mean ± SD. An n = 5 was used to perform the assay. 
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Figure 28. Compressive properties of the constructs at 10% strain 
Compressive moduli of the constructs were significantly higher in the 100% ACs 
group when compared to groups with higher percentage of MCs. No significant 
differences were observed among groups for the coefficient of viscosity. Dotted 
line represents compressive properties of unseeded PLLA scaffolds. Groups with 
different letters are significantly different from each other. All values are reported 
as mean ± SD. An n = 5 was used to perform the assay. 
164 
1000 i 
• . 
1 L. 
J 
,-J !_, pj -—_—1- , 1 ' ' " 
• • 
1
—r^  
• • 
1 !_, 
T 
-J L^  
1 
[_1 L_, 
•• 
' ' I 
100:0 75:25 50:50 25:75 0:100 100:0 75:25 50:50 25:75 0:100 
Tensile Stiffness (MC:AC) Ultimate Tensile Strength 
Figure 29. Tensile properties of the constructs 
No differences in tensile properties were noted among groups. Dotted line 
represents tensile properties of unseeded PLLA scaffolds. All values are reported 
as mean ± SD. An n = 5 was used to perform the assay. 
Table 7. Wet weight, dry weight, thickness and diameter of constructs 
MC:AC 
100:0 
75:25 
50:50 
25:75 
0:100 
p value 
Wet weight 
(mg) 
12.3 ±2.4 
12.4 ±2.4 
12.5 ±2.2 
12.9 ±1.7 
13.1 ±1.5 
0.31 
Dry weight 
(mg) 
1.3 ± 0.3 D 
1.3 ±0.4° 
1.3 ± 0.5 b 
1.4 ±0.4D 
1.5 ± 0.1 a 
0.002 
Thickness 
(mm) 
2.0 ±0.1 D 
2.0 ± 0.2 b 
2.1 ±0 .2 b 
2.1 ±0.1 b 
2 . 3 ± 0 . 1 a 
0.003 
Diameter 
(mm) 
3.0 ± 0.1D 
3.0 ± 0.2 b 
3.0 ± 0.1 b 
3.1 ± 0 . 1 b 
3.2 ± 0.3 a 
0.02 
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Chapter 8: Co-cultures of bovine meniscus cells and 
articular chondrocytes for leporine meniscus tissue 
engineering 
Najmuddin J. Gunja and Kyriacos A. Athanasiou 
Chapter submitted as: Gunja NJ and Athanasiou KA. Co-cultures of bovine 
meniscus cells and articular chondrocytes for leporine meniscus tissue 
engineering. Arthritis Research and Therapy. 
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Abstract 
To regenerate the meniscus in vitro, a scaffoldless tissue engineering approach 
was utilized using co-cultures of primary bovine articular chondrocytes (ACs) and 
meniscus cells (MCs). Bovine cells were investigated to produce extracellular 
matrix (ECM) that mimics leporine menisci and to serve as a potential xenogenic 
cell source for future in vivo work. Five different MC:AC co-culture ratios (100:0, 
75:25, 50:50, 25:75, 0:100) were investigated to identify the ratio most closely 
resembling the inner and outer regions of the leporine meniscus. Primary MCs 
and ACs were cultured in serum-free medium for 4 wks in non-adherent, 
cylindrical 3 mm agarose molds using a self-assembly, scaffoldless approach. 
Constructs with higher MC% contracted over the culture period. Histological 
examination showed presence of uniform collagen distribution in all groups. 
Glycosaminoglycan (GAG) staining was uniform in all groups, except the 100% 
MC group, which contained interspersed pockets of GAG. Biochemical tests 
showed that the 0% MC group contained the highest collagen per wet weight 
(WW) (-8%) and GAG per WW (~8.7%). The 50% MC group was found to mimic 
the inner meniscus in collagen II to collagen I content. Aggregate moduli for the 
lower MC% groups (~120 kPa) were found to be in the range of the aggregate 
moduli of the outer meniscus (~160 kPa). Tensile moduli and ultimate tensile 
strengths increased as the MC% increased; however, these values were 
significantly lower than native tissue. Overall, bovine MC and AC scaffoldless 
constructs recapitulated certain biochemical and biomechanical properties of the 
inner and outer regions of the leporine meniscus. Further examination of these 
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cells as a potential xenogenic cell source for leporine meniscus tissue 
engineering is warranted. 
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Introduction 
The menisci are fibrocartilaginous discs located on the tibial plateau in the knee 
joint. They serve primarily a mechanical function, aiding in shock absorption, 
stabilization and joint lubrication.1 Meniscal injuries may not heal, especially 
those in the inner avascular regions of the meniscus, and can lead to significant 
changes in joint function, degradation of articular cartilage, and osteoarthritis.238 
To overcome these problems, several attempts are underway to regenerate the 
meniscus in vitro and subsequently replace the damaged tissue in vivo. 
By composition, the meniscus consists of a fluid and solid phase. The fluid phase 
is mainly water (75% by wet weight (WW)), while the solid phase comprises of 
collagen (23% by WW) and glycoproteins (2% by WW). Collagen I is the 
predominant fibrillar collagen in the meniscus and is present in the outer regions 
of the meniscus, while the inner regions contain both collagen I and collagen II in 
a 2:3 ratio,1 Several glycoproteins are also present in the meniscus, including 
aggrecan, biglycan, decorin, and cartilage oligomeric matrix protein (COMP) that 
aid in the constructs' compressive and tensile properties.219 Recent work has 
investigated the utilization of articular chondrocytes (ACs) for meniscus repair 
and tissue engineering.27, 222, 223 ACs express high levels of collagen II and 
glycosaminoglycan (GAG), both of which are found in the inner regions of the 
meniscus. Recapitulating the heterogeneity of the inner and outer regions is a 
major goal of meniscus tissue engineering and may be achieved using a co-
culture of meniscus cells (MCs) and ACs. 
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Polymeric scaffolds such as poly-L-lactic acid, poly-glycolic acid, and poly-
caprolactone have been used successfully to enhance biochemical and 
biomechanical properties of MC-seeded constructs.229, 239, 240 In addition to the 
scaffold-based approach, our laboratory is investigating a self-assembly, 
scaffoldless approach for meniscus regeneration using a high density of MCs 
and ACs.27,53 In this technique, cells are seeded in high density on non-adherent 
agarose molds and allowed to coalesce without a scaffold.54 This approach 
addresses several inherent limitations of scaffolds. For instance, the random 
arrangement of non-woven scaffold meshes introduces a formidable challenge in 
producing anisotropic constructs mimicking the native meniscus. In addition, 
degradation times of scaffolds can vary significantly in vivo, a phenomenon which 
may interfere with extracellular matrix (ECM) production and maturation, and 
long term mechanical properties. A scaffoldless tissue engineering approach 
circumvents these issues and may be ideal for meniscus regeneration. 
The animal model of choice in our tissue engineering studies is the rabbit. The 
leporine model has been well characterized in the literature for its biomechanical 
characteristics.19 In addition, the leporine model has been commonly employed in 
in vivo meniscal repair and replacement studies.39, 160 A disadvantage of this 
model, however, is the small number of cells obtainable from rabbit menisci for 
tissue engineering studies (-1 to 2 million per meniscus). 
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Leporine MCs are generally expanded in monolayer until sufficient cell numbers 
are obtained prior to embarking on a tissue engineering study.229 An unintended 
consequence of this is the dedifferentiation of MCs towards a fibroblast-like 
phenotype. It has been shown that MCs increase collagen I expression and 
decrease collagen II expression over passage.159 Gene expression reversal 
attempts are underway using serum-free media; however, alternative approaches 
need to be examined as well. One solution may be to use primary cells from a 
readily available cell source, such as immature cows cells.52 Using this approach, 
meniscus tissue engineering technologies can be developed and bovine cells 
can be examined as a potential xenogenic cell source for leporine tissue 
engineering. 
Thus, this experiment investigated the effects of co-culturing various ratios of 
primary bovine MCs and ACs using a scaffoldless approach. Bovine cells were 
investigated for their capacity to produce ECM on par with leporine menisci and 
as a potential xenogenic cell source in future in vivo rabbit studies. Medial 
leporine menisci were used as internal controls. It was hypothesized that: 1) 
different co-culture ratios of passaged MCs and ACs would result in constructs 
with significantly different biochemical and biomechanical properties; 2) a higher 
MC:AC bovine co-culture ratio would result in a construct more closely 
resembling the outer leporine meniscus while a lower MC:AC ratio would result in 
a construct more closely resembling the inner leporine meniscus. 
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Materials and methods 
Cell and tissue harvest 
ACs and MCs were aseptically harvested from the distal femur and the medial 
menisci of six 1 wk old male calves (Research 87, Boston, MA) less than 24 hrs 
after slaughter. The tissues were digested overnight using 0.2% collagenase II 
(Worthington, Lakewood, NJ) dissolved in Dulbecco's modified culture medium 
(DMEM) (Gibco, Grand Island, NY). The culture medium was supplemented with 
10% fetal bovine serum (Biowhittaker, Walkersville, MD), 1% 
penicillin/streptomycin/fungizone (Sigma, St Louis, MO), 1% non-essential amino 
acids (Invitrogen, Grand Island, NY), 50 jig/ml L-ascorbic acid (Sigma, St Louis, 
MO), and 4.5 g/L-glucose and L-glutamine (Gibco, Grand Island, NY). Post-
isolation, ACs and MCs were pooled separately and counted using a 
hemocytometer. Cell viability was found to be over 95% for ACs and MCs. In 
addition to bovine MCs and ACs, medial menisci were also isolated from six 
skeletally mature New Zealand white rabbits using sterile technique and 
examined for their biochemical content and biomechanical properties. 
Agarose well preparation, cell seeding and tissue culture 
Agarose wells were prepared on 24-well plates by using a negative polysulfone 
mold consisting of cylindrical prongs 3 mm in diameter and 10 mm in length. 
Wells were created by pressing the negative mold into 1 ml of sterile molten 2% 
agarose (2 g in 100 ml of phosphate buffered saline, PBS). The agarose was 
allowed to gel at room temperature for 1 hr with the negative mold. The negative 
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mold was then removed after 1 hr leaving behind a smooth agarose mold 3 mm 
in diameter. Serum-free medium was added once every day for 3 days to 
saturate the well and remove remnants of PBS. The medium consisted of 
DMEM, 4.5 g/L-glucose and L-glutafnine, 40 ug/mL L-proline, lOOnM 
dexamethasone, 1% penicillin/streptomycin/fungizone, 50 ug/mL, ascorbate-2-
phosphate, 100 ug/mL sodium pyruvate and 1% insulin-transferrin-selenium 
(ITS+) (BD Biosciences, San Jose, CA). ACs and MCs were pooled into five 
different co-culture ratio groups (n = 12 for each group): 1) 100% MCs and 0% 
ACs; 2) 75% MCs and 25% ACs; 3) 50% MCs and 50% ACs; 4) 25% MCs and 
75% ACs; and 5) 0% MCs and 100% ACs. Cells were seeded by adding 100 pi 
of the cell-suspension (2 million cells/100 ul of medium) into the mold. An 
additional 5 ml of culture medium was added to the wells to submerge the 
agarose molds. The serum-free medium was changed once every 2 days for a 
period of 4 wks. Constructs were left confined in the wells for the entire culture 
period. 
Histology 
At t = 4 wks, two samples from each group were frozen using cryoembedding 
medium and sectioned at a thickness of 14 urn. Safranin-0 / fast green stain was 
used to determine GAG distribution. Picrosirius red stain was used to determine 
collagen distribution. Polarized light images were also taken to examine collagen 
alignment within the constructs. Two rabbit medial menisci were defrosted, 
placed in cryoembedding medium, frozen and then sectioned at 14 urn. Safranin-
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O / fast green and picrdsirius and staining was used to examine GAG and 
collagen distribution in the inner and outer regions of the meniscus. 
Compressive tests 
Five test samples from each group and six medial inner and outer leporine 
menisci were subjected to creep indentation testing. Briefly, 2 mm constructs and 
tissue samples, obtained using a 2 mm biopsy punch, were attached to a sample 
holder using cyanoacrylate glue and submerged in PBS. The samples were 
positioned under the load shaft such that they rested perpendicular to 0.5 mm flat 
ended, porous intender tip. A tare load of 0,2 g (0.002 N) was applied and 
samples were allowed to reach tare creep equilibrium. A step load of 0.7 g (0.007 
N) was then applied and displacement of the sample was measured until 
equilibrium was reached. Three intrinsic mechanical properties were determined, 
the aggregate modulus, the Poisson's ratio, and the permeability using the linear 
biphasic theory.241 
Tensile tests 
Five test samples and six inner and outer medial leporine menisci were used for 
tensile tests at t = 4 wks using a previously described protocol.26 Tests were 
performed using an Instron 5565 with a 50 N load cell. To ensure testability, 
samples were carefully carved into a dog-bone shape. The ends were fixed to 
paper tabs using cyanoacrylate glue. A 0.05 N tare load was applied and the 
constructs were pulled to failure at a strain rate of 1% of the gauge length. 
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Tensile stiffness and the ultimate tensile strength (UTS) of each construct were 
determined using stress-strain curves. Portions of the constructs not use for 
tensile tests were processed for biochemical analyses. 
Quantitative biochemistry 
At t = 4 wks, five samples from each group, and six samples from inner and outer 
leporine menisci were processed for biochemical analysis. Samples were 
lyophilized and digested with pepsin (10 mg/ml) followed by elastin (1 mg/ml) at 
4°C. Total DNA content/sample was determined using a picogreen cell 
proliferation assay kit (Molecular Probes, Eugene, OR). Total sulfated GAG per 
sample was quantified using the Blyscan GAG Assay kit (Biocolor, 
Newtownabbey, Northern Ireland). Total collagen per sample was determined 
using a modified chloramine-T hydroxyproline assay.151 Collagen I and collagen 
II levels were quantified using an enzyme-linked immunosorbent assay (ELISA) 
developed by Chondrex Inc. (Chondrex, Redmond, WA). Detailed protocols for 
these assays have been described previously.26 
Statistical analysis 
Biochemical and biomechanical data were compared using a one-way analysis of 
variance test. If significant differences were observed, a Tukey's post hoc test 
was performed to determine specific differences among groups. A significance 
level of 95% with a p value of 0.05 was used in all statistical tests performed. All 
values are reported as mean ± standard deviation. Univariate regression analysis 
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was conducted to probe for correlations between the biochemical and 
biomechanical data. 
Results 
Gross morphology and histology 
Constructs were examined at t = 4 wks for their physical characteristics. 
Presence of glistening cartilage-like matrix was present in all groups. As AC% 
increased, constructs were found to expand radially towards the well edges while 
constructs in higher MC% groups appeared to contract inwards (Figure 30A). 
The diameter of the constructs (p < 0.0001) ranged from 2.2 ± 0.1 mm (100% 
MC) to 3.1 ± 0.1 mm (100% AC) (Table 8). Differences were also observed 
among groups for thickness (p = 0.005); constructs in the 100% MC group (0.8 ± 
0.1 mm) were significantly thicker than those in other groups (0.6 ± 0 1 mm) 
(Table 8). 
Uniform collagen staining was observed throughout the construct in all groups 
(Figure 30B). Polarized light images showed stronger collagen alignment in the 
higher MC% groups (Figure 30C). GAG staining was uniform in all groups 
containing AGs while in the 100% MC group, pockets of GAG were observed 
toward the construct periphery and were absent in the inner portions of the 
construct (Figure 30D). Native leporine tissue stained strongly for collagen with 
collagen alignment visible in the circumferential direction without polarized light 
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(Figure 31). GAG staining was limited to the inner regions of the rabbit meniscus 
(Figure 31). 
Biochemistry 
Values of cells per construct, WW per construct, collagen per dry weight (DW), 
and GAG per DW are found in Table 8. Briefly, cell number per construct was 
found to increase significantly with increasing MC% (p = 0.0006). Wet weights 
ranged from 4.4 ± 0.3 mg in the 100% MC group to 6,3 ± 0.2 mg in the 50 and 
25% MC group (p < 0.0001). GAG per DW significantly increased from 11.9 ± 2.2 
ug/mg in the 100% MC group to 830.5 ± 99.7 ug/mg in the 0% MC group (p < 
0.0001). GAG per DW was found to be 38.8 ± 5.7 ug/mg and 9.6 ± 1.7 ug/mg for 
the inner and outer leporine meniscus, respectively. Collagen per DW varied 
significantly between the 100% MC group (559.8 ± 165.8) and the 0% MC group 
(793.6 ±84.3) (p = 0.007); however, no differences were observed among the 
co-culture groups. Collagen per DW was found to be 698.4 ± 100.9 ug/mg and 
794.3 ± 68.1 mg for the inner and outer meniscus, respectively. 
Total GAG content varied significantly among groups (p < 0.0001) with the 
highest value obtained in the 0% MC group (440.5 ± 34.4 ug) and the lowest 
value obtained in the 100% MC group (4.8 ± 0 . 7 ug) (Figure 32A). When 
normalized to WW, the same trends were observed (p < 0.0001) (Figure 32B). 
The GAG per WW levels were 8.7 ± 1.7%, 3.2 ± 0.2%, 1.6 ± 0.3%, 0,7 ± 0.2%, 
and 0.1 ± 0.0% for the 0, 25, 50, 75, and 100% MC groups, respectively. GAG 
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per WW was found to be 0.9 ± 0.2% and 0.3 ± 0.0% in the inner and outer 
meniscus, respectively. 
Total collagen content varied significantly among groups (p < 0.0001) with the 
highest value obtained in the 0% MC group (421.0 ± 24.9 ug) and the lowest 
value obtained in the 100% MC group (224.7 ± 49.5 ug) (Figure 32C). When 
normalized to WW, the collagen content in 0% AC group was significantly higher 
when compared to the other groups (p < 0.0001) (Figure 32D); however, no 
significant differences were observed among groups containing 25, 50, 75, or 
100% MCs. Specifically, the collagen per WW levels were 8.3 ± 1.4%, 5.1 ± 
0.2%, 4.6 ± 1.2%, 4.4 ± 1.2%, and 5.1 + 1.1% for the 0, 25, 50, 75, and 100% 
MCs, respectively. Collagen per WW was found to be 15.2 ± 1.2% and 20.9 ± 
1.3% for the inner and outer meniscus, respectively. 
Total collagen I (p < 0.0001) and collagen II (p < 0.0001) content were found to 
be significantly different among groups. Collagen I content was highest in the 
100% MC group and dropped with decreasing MC percentage. The collagen I 
levels were 101.4 ± 15.9 ug, 53.4 ±15 ug, 39.4 ± 5.3 ug, 36.2 ± 7.8 ug, and 7.4 ± 
2.0 ug, for the 100, 75, 50, 25, and 0% MC groups, respectively. Trends were 
reversed for collagen II content, with the highest levels observed in the 0% MC 
group. The collagen II levels were 18.5 ± 4.3 ug, 26.1 ± 4.9 ug, 91.6 ± 28 ug, 
237.4 ± 18.4 ug, and 417.9 ± 34.0 for the 100, 75, 50, 25, and 0% MC groups, 
respectively. Collagen II to collagen I (or collagen I to collagen II) normalizations 
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showed that the 100 and 75% MC groups, and the outer meniscus contained 
approximately 5.9, 2.1, and 27.3 times more collagen I than collagen II, 
respectively. The 50, 25, and 0% MC groups, and the inner meniscus contained 
approximately 2.4, 6.9, 59.3, and 1.7 times more collagen II than collagen I, 
respectively (Figure 33). 
Compressive properties 
The aggregate modulus (p < 0.0001) (Figure 34) and Poisson's ratio (p = 0.01) 
were found to be significantly different among test groups. The 0% MC group had 
the highest aggregate modulus (112 ± 18 kPa), approximately three times that of 
the 100% MC group (34 ± 12 kPa). The aggregate modulus of the leporine inner 
meniscus was found to be 360 ± 90 kPa while that of the outer meniscus was 
found to be 160 ± 45 kPa. Poisson's ratio of the constructs were 0.1 ± 0.1, 0.1 ± 
0.1, 0.1 ± 0.1, 0.1 ± 0.1, and 0.3 ± 0.1 for the 100, 75, 50, 25 and 0% MC groups, 
respectively. These values were significantly higher than the Poisson's ratio for 
the inner and outer meniscus, both of which were found to be 0.0 ± 0.0. No 
significant differences were observed among groups for the permeability of the 
constructs (p = 0.2). The permeability values were 2.9 ± 1.2 (x10"15) m4/N-s, 3.6 ± 
2.6 (x10'15) m4/N-s, 3.5 ± 2.5 (x10"15) m4/N-s, 4.8 ± 3.0 (x10"15) m4/N-s, and 6.2 ± 
2.0 (x10'15) m4/N-s for the 100, 75, 50, 25 and 0% MC groups, respectively. 
These values were all significantly higher (p = 0.002), however, when compared 
to those of the leporine inner meniscus (1.1± 0.2 (x10~15) m4/N-s) and outer 
meniscus (0.9 ± 0.2 (x10-15) m4/N-s). 
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Tensile properties 
The tensile modulus (p < 0.0001) (Figure 35A) and UTS (p < 0.0001) (Figure 
35B) were found to be significantly different among test groups. The highest 
tensile modulus was observed in the 100% MC group (1.5 ± 0.1 MPa) while the 
lowest tensile modulus was observed in the 25% MC group (0.8 ± 0.0 MPa). 
Tensile values for the inner meniscus and outer meniscus were found to be 60 ± 
40 MPa and 130 ±70 MPa, respectively. The highest UTS was observed in the 
100% MC group (0.4 ± 0.1 MPa) while the lowest tensile modulus was observed 
in the 25% MC group (0.2 ± 0.0 MPa). UTS values for the inner and outer 
meniscus were found to be 12 ± 4 MPa and 23 ± 6 MPa, respectively. 
Correlation between biochemical and biomechanical data 
Aggregate and tensile moduli obtained from the mechanical tests were correlated 
with GAG and collagen values per construct and WW. Strong significant 
correlations were obtained between the aggregate modulus and GAG per 
construct (p = 0.0002, r2 = 0.7), and GAG per WW (p < 0.0001, r2 = 0.6). Weaker 
significant correlations were observed between the aggregate modulus and 
collagen per construct (p = 0.01, r2 = 0.3) and collagen per WW (p = 0.02, r2 = 
0.2). Strong significant correlations were obtained between the tensile modulus 
and collagen per construct (p < 0.0001, r2 = 0.5), and collagen per WW (p < 
0.0001, r2= 0.5). Weaker non-significant correlations were observed between the 
tensile modulus and GAG per constructs (p = 0.7, i f = 0.002) and GAG per WW 
(p = 0.5, i^= 0.008). 
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Correlations were also examined between the mechanical and biochemical 
properties for the inner and outer meniscus. Strong significant correlations were 
observed between the aggregate modulus and the GAG per WW of the inner (p < 
0.0001,1^= 0.8) and outer meniscus (p < 0.0001, r2 = 0.8). Weaker but significant 
correlations were observed for aggregate modulus and the collagen per WW of 
the inner (p = 0.002, r2 = 0.4) and outer meniscus (p = 0.01, r2 = 0.3). Strong 
significant correlations were observed for the tensile modulus and collagen per 
WW of inner (p < 0.0001, r2 = 0.9) and outer (p < 0.0001, r2 = 0.9) meniscus. 
Weaker but significant correlations were observed for the tensile modulus and 
the GAG per WW of the inner (p = 0.005, r2 = 0.4) and outer (p = 0.002, r2 = 0.4) 
meniscus. 
Discussion 
The meniscus contains a heterogeneous ECM population which leads to 
differences in its biomechanical properties. Thus, recapitulating tissue 
heterogeneity will aid in the successful regeneration of the meniscus. This study 
identified co-cultures of bovine MCs and ACs that resulted in a spectrum of 
fibrocartilages mimicking several biochemical and biomechanical properties of 
inner and outer leporine menisci. The result supports the future use of a 
xenogenic cell source (bovine cells) for leporine tissue engineering. The results 
also showed clear differences among groups with higher MC% groups 
contracting over the culture period while lower MC% groups expanded. In 
addition, higher MC% groups resulted in constructs more closely resembling the 
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outer regions of leporine menisci, while lower MC% groups resulted in constructs 
more closely resembling the inner regions of leporine menisci, confirming the 
original hypotheses. 
The use of five different MC:AC co-culture ratios (100:0, 75:25, 50:50, 25:75, and 
0:100) resulted in a spectrum of biochemical properties, ranging from fibrous to 
cartilaginous. As the MC% decreased, collagen II levels increased and collagen I 
levels decreased. Excitingly, we were able to show that a 50:50 co-culture of 
MCs and ACs resulted in a collagen II to collagen I ratio (2.4 ±0.8) mimicking the 
inner leporine meniscus (1.7 ±0.2). Collagen I to collagen II ratio for the outer 
meniscus (27.3 ± 5.6), however, could not be matched by any of the co-culture 
groups, with the closest group comprising of 100% MCs (5.9 ±2.4). Growth 
factors such as transforming growth factor-beta 1 242 or mechanical stimuli, such 
as tension,243 may be used to enhance the fibroblastic phenotype of cells. 
Statistically significant changes in construct compressive properties were 
accompanied by concomitant changes in GAG production. As MC% decreased, 
significant increases in GAG per WW and aggregate modulus were observed. 
Moreover, univariate regression analysis showed a strong significant correlation 
between GAG content and aggregate modulus of the constructs. In terms of 
GAG per WW, the higher MC% groups (100% and 75%) were found to be 
equivalent to the outer meniscus. GAG levels in the inner meniscus were 
matched by the 75% and 50% MC groups. Despite the similarities in GAG 
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content between higher MC% groups and native tissue, the overall compressive 
properties of these constructs lagged behind native values. Interestingly, the 
lower MC% groups (25% and 0%) were found to exhibit the highest aggregate 
modulus values (-100 to 115 kPa) and these were approaching outer meniscus 
values-(~160 kPa). One possible reason for this discrepancy may be the lack of 
collagen production per WW in the higher MC% groups. It is known that collagen 
plays an important in the final compressive properties of the construct, possibly 
by interacting with small leucine rich proteoglycans that can affect collagen 
diameter and alignment.194 Thus, future studies will need to investigate 
techniques to enhance collagen deposition to further increase the aggregate 
modulus. This may be achieved through the use of chemical agents, such as 
chondroitinase-ABC, which has been shown to temporarily deplete GAGs from 
constructs while enhancing the collagen network.228 
Strong correlations were observed between the tensile properties and the total 
collagen, as well as collagen per WW, of the constructs. The highest collagen 
content and highest collagen per WW were observed in the 0% MC group, while 
the highest tensile properties were observed in the 100% MC group. It is possible 
that tensile stiffening in 100% MC constructs occurred due to construct 
contraction which may have resulted in increased collagen alignment and cross-
linking in the ECM. Polarized light images confirmed that a greater degree of 
alignment was observed in the 100% MC constructs with little to no alignment 
observed in the lower MC% groups. Regardless of these variations, the overall 
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tensile properties were found to be almost two orders of magnitude below native 
values. Collagen content per WW lagged as well in the tissue engineered groups 
(~5 to 8%) when compared to the inner and outer rabbit meniscus (~15 to 20%). 
It appears that increasing collagen content and tensile properties towards native 
values remains a challenging problem, even for articular cartilage tissue 
engineering.54, 228 Future work will need to investigate novel methods to create 
constructs with preferred collagen orientations that will enhance the tensile 
properties. One technique may be to use ring-shaped agarose molds which have 
been shown to enhance collagen alignment in the circumferential direction, 
similar to that observed in the native tissue.53 
The growth characteristics of the tissue engineered constructs were found to be 
dependent on cell type. Constructs containing a higher percentage of MCs 
tended to contract while constructs containing a higher percentage of ACs 
tended to expand. This result has been observed in a prior study investigating 
50:50 co-cultures of MCs and ACs, and MCs alone cultured on cylindrical 
agarose molds in serum-free or serum-containing medium 26. MCs contain a 
mixed population of fibroblast-like and chondrocyte-like cells. Fibroblasts have 
been shown in the past to generate contractile forces in scaffolds containing 
collagen and GAGs.244 These contractile forces are likely caused by the 
reorganization of the cytoskeleton, possibly through cross-bridges between actin 
and myosin filaments 245 or through upregulation of alpha-smooth muscle actin 
(SMA).246 These contractile forces in fibroblasts have been shown to range from 
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1 to 25 nN and depend on the mode of measurement and cell substrate.244,247,248 
Similarly, we hypothesize that MCs exhibit this contractile behavior that is 
characteristic of fibroblasts. 
Bovine cells were used in this experiment for leporine tissue engineering to 
circumvent issues of cell scarcity and for possible examination as a future 
xenogehic cell source. A bovine medial meniscus yields 20 to 30 million MCs in 
comparison to a rabbit medial meniscus which yields 1 to 2 million cells. The low 
cell numbers obtained from the rabbit necessitate cell expansion in monolayer. 
This technique leads to rapid changes in the phenotype of MCs and losses in 
gene expression of important ECM markers, such as collagen II and COMP 159. 
To preserve MC phenotype, an alternative approach may be to use primary cells 
from an easily available cell source, such as bovine MCs and ACs. Using these 
cells, meniscus tissue engineering technologies can be developed and the ability 
of bovine cells to produce matrix similar to that of the leporine meniscus can be 
assessed. If successful, a xenogenic approach may be employed in future in vivo 
studies in the rabbit. This approach may be feasible since the knee joint is 
considered as an immunoprivileged site due to low vascularity. A recent study 
has shown that pig ACs implanted into osteochondral defects of adult rabbits do 
not illicit a noticeable immune response.249 In addition, immune response was 
limited when rabbit ACs, embedded in fibrin glue, were implanted in a goat full 
thickness articular cartilage defect.250 Success with these studies provides 
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excitement for the use of xenogenic cells and may diminish fears of a major 
immune rejection in the joint. 
Although the inner and outer leporine menisci were characterized primarily to 
serve as internal controls for our tissue engineering groups, it is also interesting 
to examine the biochemical and biomechanical characterization results to other 
animal models in the literature. GAG per DW levels were found to be slightly 
higher in the inner meniscus of the rabbit when compared to human menisci.251 A 
possible explanation for this may be due to high loads placed on the inner 
portions of the meniscus due to the flexed knee-resting stance of the rabbit and 
its propensity to jump. Collagen content in human and porcine menisci have 
been measured in terms of hydroxyproline levels.219,251_253 if our collagen data is 
converted to hydroxyproline using a conversion factor of 10 254, the obtained 
hydroxyproline values are slightly lower (~70 to 80 ug/mg DW) than those 
observed in human and porcine tissue (~100 to 140 ug/mg DW). This was 
unexpected and the animal model is most likely the source of this discrepancy. 
Both, the aggregate and tensile moduli were found to be in the same range of 
values obtained with larger animal models.251,255"260 Overall, the similarities in the 
biochemical and biomechanical properties between the results obtained in this 
study and those of larger animal models justified the investigation of the leporine 
model as a first step towards tissue engineering the knee meniscus. 
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Conclusions 
This work examined five different co-culture ratios of bovine ACs and MCs for 
leporine meniscus tissue engineering. Lower MC% groups approached the 
compressive moduli of the outer regions of native tissue and collagen per WW of 
the inner regions of native tissue. Higher MC% groups more closely mimicked 
the GAG per WW of both the inner and outer regions of the meniscus. The 50% 
MC group was found to mimic the inner meniscus in collagen II to collagen I 
content. Tensile properties of native tissue could not be matched by any of the 
test groups. Based on these data, a 50% MC group may be suitable to 
recapitulate biochemical characteristics of the inner regions of the tissue. For the 
outer regions, a lower MC% group with higher compressive strength may be 
suitable from a functional tissue engineering viewpoint. Finally, further 
examination of bovine cells as a potential xenogenic cell source is warranted 
based on their ability to produce constructs approaching those of the leporine 
meniscus. 
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Figure associated with chapter 8 
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Polarized light (20X) 
GAG staining (10X) 
Figure 30. Gross morphological and histological sections of constructs 
Constructs contracted with increasing MC%. Uniform collagen staining (20X) was 
observed in all groups. Polarized light images (20X) showed greater degree of 
collagen alignment in higher MC% groups. Uniform GAG staining (10X) was 
observed in all groups, except the 100% MC group. 
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Figure 31. Gross morphology and histology of the leporine meniscus 
Inner and outer regions of the native tissue (designated by the dashed line) were 
examined separately for their biochemical and biomechanical characteristics. 
Strong GAG staining was observed in the inner regions of the meniscus. Strong 
collagen alignment was visible in all regions of the meniscus in the 
circumferential direction. 
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Figure 32. Biochemical properties of constructs and native tissue 
(A) Total GAG per construct. (B) GAG per wet weight (constructs and native 
tissue). (C) Total collagen per construct. (D) Collagen per wet weight (constructs 
and native tissue). Groups with different letters are significantly different from 
each other. All values are reported as mean ± SD. An n = 5 (constructs) and n = 
6 (for native tissue) was used to perform the assays. 
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Figure 33. Spectrum of fibrous to cartilaginous nature of constructs and 
native tissue 
Groups with higher collagen I to collagen II ratio (fibrous) are shown on the upper 
panel, while groups with higher collagen II to collagen I (cartilaginous) ratio are 
shown in the lower panel. 
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Figure 34. Aggregate modulus of constructs and native tissue 
Groups with different letters are significantly different from each other. All values 
are reported as mean ± SD. An n = 5 (constructs) and n = 6 (for native tissue) 
was used to perform the assays. 
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Figure 35. Tensile properties of constructs and native tissue 
(A) Tensile moduli. (B) Ultimate tensile strength. All values are reported as mean 
± SD. An n = 5 (constructs) and n = 6 (for native tissue) was used to perform the 
assays. 
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Table 8. Biochemical and gross morphological properties of constructs and 
native tissue 
The star symbol denotes that inner and outer meniscus groups were only 
compared to tissue engineered construct groups for the GAG and collagen per 
DW. 
Groups 
100:0 (MC:AC) 
75:25 (MC:AC) 
50:50 (MC:AC) 
25:75 (MC:AC) 
0:100 (MC:AC) 
Inner meniscus* 
Outer meniscus* 
p value 
GAG/DW 
(ug/mg) 
11.9 ±2.2' 
80.8±16.1d 
191.3 ±32.7C 
374.7 ±17.4b 
830.5 ± 99.7a 
38.8 ± 5.7e 
9.6 ±1.7' 
< 0.0001 
Collagen / DW 
(ug/mg) 
559.8 ±165.8" 
521.8 ±180.4" 
534.1 ± 108.9" 
599.7 ± 55.6a" 
793.6 ± 84.3" 
698.4 ±100.9a" 
794.3 ± 68.1a 
0.007 
Cell number 
(millions) 
2.2 ± 0.2a 
2.1 ± 0.3a" 
1.8±0.3abc 
1.7 ±0.2"° 
1.6±0.2C 
0.0006 
WW 
(mg) 
4.4 ± 0.3" 
5.7 ± O ^ * 
6.3 ± 0.2ab 
6.3 ± 0.2a 
5.1 ±0.6° 
< 0.0001 
Diameter 
(mm) 
2.2 ±0 .1" 
2.7±0.1 c 
2.7±0.1 c 
2.9 ±0 .1 " 
3.1 ±0.1° 
< 0.0001 
Thickness 
(mm) 
0.8 ±0.1" 
0.6 ±0.1" 
0.6 ±0 .1" 
0.6 ±0 .1" 
0.6 ±0 .1" 
0.005 
195 
Chapter 9: Effects of mold compliance and surface 
roughness on scaffoldless meniscus-shaped constructs 
Najmuddin J. Gunja, Dan J. Huey, Regis A. James and Kyriacos A. 
Athanasiou 
Chapter submitted as: Gunja NJ, Huey DJ, James RA and Athanasiou KA. 
Effects of mold compliance and surface roughness on scaffoldless meniscus-
shaped constructs. Journal of Tissue Engineering and Regenerative Medicine. 
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Abstract 
The meniscus is a fibrocartilaginous tissue that is critically important to the 
loading patterns within the knee joint. If the meniscus structure is compromised, 
there is little chance of healing due to limited vascularity in the inner portions of 
the tissue. Several tissue engineering techniques to mimic the complex geometry 
of the meniscus have been employed. Of these, a self-assembly, scaffoldless 
approach employing agarose molds avoids drawbacks associated with scaffold 
use while still allowing formation of robust tissue. In this experiment two factors 
were examined, agarose percentage and mold surface roughness, in an effort to 
consistently obtain constructs with adequate geometric properties. Co-cultures of 
ACs and MCs (50:50 ratio) were cultured in smooth or rough molds composed of 
1% or 2% agarose for 4 wks. Morphological results showed that constructs 
formed in 1% agarose molds, particularly smooth molds, were able to maintain 
their shape over the 4 wk culture period. Significant increases were observed for 
the collagen II to collagen I ratio, total collagen, GAG, and tensile and 
compressive properties in smooth wells. Cell number per construct was higher in 
the rough wells. Overall, it was observed that the topology of an agarose surface 
may be able to affect the phenotypic properties of cells that are on that surface, 
with smooth surfaces supporting a more chondrocytic phenotype. In addition, 
wells made from 1% agarose were able to prevent construct buckling potentially 
due to their higher compliance. 
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Introduction 
The meniscus is a fibrocartilaginous tissue that is situated between the femur 
and tibia within the knee joint. Due to its location, geometry, and composition, the 
meniscus protects the underlying articular cartilage from excessive stresses via 
force distribution and shock absorption.3,261 However, if the meniscus structure is 
compromised, its ability to perform these critical functions is lost.20, 262 
Furthermore, injuries to the inner regions of the meniscus do not heal due to 
limited vascularity in that region. Partial meniscectomy is the most common 
treatment for meniscal tears and can alleviate short term symptoms of pain and 
temporarily restore joint function.263 In the long term, the loss of meniscal 
cartilage leads to degeneration of the underlying articular cartilage and quickens 
the onset of osteoarthritis.238 Thus, tissue engineering may be a viable option to 
repair or replace injured tissue. 
The meniscus contains a heterogeneous cell and ECM population.235 The inner 
region contains chondrocyte-like cells and the ECM is composed of a network of 
collagen II and collagen I fibers in a 3:2 ratio, and the proteoglycan aggrecan. In 
vivo, the inner meniscus is loaded with an axial compressive force. The outer 
region contains fibroblast-like cells with circumferentially oriented collagen I 
fibers. Due to the wedge-shaped profile and attachments of the meniscus, the 
compressive load experienced by the inner meniscus is partially converted into 
circumferential tensile forces in the outer regions. Furthermore, the wedge-
shaped profile of the meniscus corrects the incongruity between the curved 
198 
femoral condyles and flat tibial plateau allowing distribution of the compressive 
forces over a larger area of the articular surfaces.264, 265. Finite element models 
have shown that geometrical aspects of the meniscus, particularly the radius of 
curvature to match the femoral condyle, are critically important to the ability of the 
meniscus to absorb and distribute loading.17 Thus, for an engineered meniscal 
substitute, recapitulation of geometry and composition will be critical to achieve 
successful tissue replacement. 
Most attempts at creating meniscus-shaped constructs have involved producing 
scaffolds by pouring a liquid polymer solution into a mold and allowing it to set or 
by adding a cross-linking agent.30,266,267 Other attempts have used solid freeform 
fabrication 268 or physical shaping.160 These attempts at shape-mimicking have 
highlighted a number of issues that must be addressed before a meniscus-
specific construct can be realized, including shape retention and obtaining 
adequate biochemical and biomechanical properties. 
Although widely used in tissue engineering studies, scaffold materials can 
present several drawbacks. These include toxicity associated with scaffold 
degradation byproducts, lack of cellular mechanotransduction due to stress 
shielding, and irregular tissue ingrowth to scaffold degradation rates.52 A self-
assembly, scaffoldless approach developed in our laboratory circumvents these 
issues, and allows for the creation of shape-specific geometries. Previous work 
with this approach has shown that meniscus cells (MCs) and articular 
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chondrocytes (ACs) can be co-cultured in ring-shaped molds.53 However, with 
increasing AC percentage, the constructs expand radially, contact the well edge 
and slide up the smooth wells or buckle in response to the force placed on the 
construct by the agarose well. With increasing MC percentage the constructs 
contract into a torus. Thus, by using various ratios of the two cell types, the 
expansive contribution of ACs and contractile contribution of MCs can be 
modulated to form different shaped constructs. 
Utilizing data from a previous study,53 and from pilot studies in the laboratory, it 
has been determined that a 50:50 co-culture ratio of ACs and MCs, grown in a 
ring-shaped mold, in the presence of serum most closely resembles the native 
meniscus. However, when switching to a serum-free approach, enhanced 
expansive growth is noted as the constructs expand radially.26 To address this 
issue, the compliance of the agarose well was studied to determine if a well that 
provided less resistance to construct impingement would allow for proper 
construct geometry. To this end, two different agarose percentages (1% and 2%) 
were examined. In addition, topology of the well walls was also altered (rough 
and smooth wells) to examine whether roughness would prevent buckling of the 
constructs by increasing the frictional contact between the radially expanding 
constructs and the well wall. It was hypothesized that 1) buckling would be 
reduced by increased compliance of lower agarose-content (1%) wells; and 2) 
buckling would be reduced by increased frictional contact in wells with rough 
edges. 
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Materials and methods 
Well-maker fabrication 
Pictures of rabbit medial menisci were taken to obtain meniscus geometric 
properties. Using AutoCAD 2007 (Autodesk, San Rafael, CA), information from 
these pictures was used to create an idealized elliptical shape with a curved, 
wedge profile which closely matched the meniscus geometry (Figure 36A). In 
order to obtain two molds with similar geometrical properties but differing in 
surface roughness, two different solid-freeform fabrication machines were 
employed. To create the smooth well-maker (i.e., the negative of the idealized 
meniscus geometry), a ZPrinter 310 (Z Corporation, Burlington, MA) was used. 
This machine employs 3D printing technology to place a drop of binding solution 
into a basin of powder to create a part with a layer thickness of 76 urn. Although 
the layer thickness alone was sufficient to obtain a smooth surface, the well-
maker was dipped in latex solution to ensure smoothness and to prevent agarose 
from infiltrating the porous material (Figure 36B). The rough well-maker was 
created using a Dimension 768 SST (Stratasys, Eden Prarie, MN) which utilized 
fused deposition modeling technology to build the part layer by layer using a thin 
acrylonitrile butadiene styrene (ABS) plastic cord (Figure 36C). This method of 
rapid prototyping imparted an inherent anisotropic roughness to the well-maker 
due to the large layer thickness dictated by the use of a 245 urn diameter ABS 
cord. The average roughness value (Ra) was estimated based on the B46.1-
2002 ASME standard by assuming the surface was a waveform composed of 
semi-circles with no gaps in between. Images of the surface of the well-maker 
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were analyzed using Image J (NIH, Bethesda, MD) to determine the diameter of 
the semi-circular protrusions. The surface roughness, Ra, was measured using 
the following formula. 
Ra = -^Y(x)\dx 
Y(x) is the function describing the surface of the well-maker with the horizontal 
axis set midway between the highest and lowest amplitude of the waveform and 
L is the length over which roughness is measured. Roughness was not present in 
the direction corresponding to the long axis of the ABS cord but was present in 
both the horizontal and vertical directions emanating from the center of an 
individual elliptical well-maker post. 
Well fabrication 
Agarose wells (1% and 2%) were created by pouring molten agarose into the 
wells of a 24-well plate (BD, Franklin Lakes, NJ). The well-makers were placed 
into the agarose and left until the agarose hardened. The well-makers were then 
removed and the agarose molds were transferred to 12-well plates (BD, Franklin 
Lakes, NJ). Chemically-defined serum-free medium was allowed to infiltrate the 
agarose hydrogel for 4 days in an incubator before seeding. The medium 
consisted of Dulbecco's Modified Eagle Medium (DMEM) with 4.5 g/L-glucose 
and GlutaMAX (Invitrogen, Carlsbad, CA), 100 nM dexamethasone, 1% 
fungizone (Sigma, St Louis, MO), 1% penicillin/streptomycin (BD Biosciences, 
Bedford, MA), 1% ITS+ premix, 50 mg/mL ascorbate-2-phosphate, 40 mg/mL L-
proline, and 100 mg/mL sodium pyruvate (Fisher Scientific, Pittsburgh, PA). 
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Cell isolation and seeding 
The knee joints of skeletally immature calves (Research 87, Boston, MA) were 
dissected to obtain the medial menisci, and the tibial and femoral articular 
cartilage. In a cell culture hood, the vascular outer third of the meniscus was 
removed and the remainder was diced into small ~1mm pieces. The articular 
cartilage was shaved from the femoral and tibial surfaces. Meniscus and articular 
cartilage fragments were digested separately in a solution of 0.2% collagenase II 
(Worthington, Lakewood, NJ) in serum-free medium. After a 14-18 hr digestion, 
MCs and ACs were isolated through sequential dilution of the tissue/collagenase 
solution with phosphate buffered saline (PBS), centrifugation of the mixture, and 
removal of the supernatant. When the cells were sufficiently separated from the 
digested tissue, they were passed through a 70 Mm cell strainer/counted using a 
hemocytometer, and frozen at -80°C. The freezing medium consisted of the 
same medium described above in addition to 20% fetal bovine serum and 10% 
dimethyl sulfoxide (Sigma, St. Louis, MO). Two wks after harvest, primary bovine 
ACs and MCs were thawed and re-suspended in serum-free medium. The cells 
were then combined in a 50:50 ratio and 20 million cells were seeded into the 
meniscus-shaped mold. Culture medium was changed every other day for the 4 
wk duration of the study. At 4 wks, constructs were removed from the agarose 
wells and assessed via histological, biochemical, and biomechanical tests. 
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Histology 
Constructs were cut in half along the major elliptical axis and a cylindrical 2 mm 
section of neo-tissue was taken from each half-ellipse using a 2 mm biopsy 
punch. Care was taken to note the orientation of the sample relative to the overall 
construct. The samples were frozen using HistoPrep (Histo Prep, Fisher 
Scientific, Pittsburgh, PA) and sectioned at 14 ^im. Safranin-0 / fast green was 
used to examine GAG distribution and picrosirius red was used for qualitative 
examination of collagen content. Slides stained with picrosirius red were also 
viewed under polarized light to examine collagen orientation. 
Biochemistry 
Samples were weighed to determine total wet weights and then processed for 
tensile, compressive, and histological tests. The remainder of the construct was 
then reweighed, lyophilized for 48 hrs, and then dry weights were measured. 
Samples were digested in pepsin (10 mg/ml) for 1 day at 4°C followed by 
elastase (1 mg/ml) for 5 days at 4°C. Biochemical assays performed were 
dimethylmethylene blue (DMMB) (sulfated-GAGs), hydroxyproline (collagen), 
PicoGreen (cell number), and ELISA (collagen I and collagen II). The DMMB 
assay for sulfated GAGs was completed using a commercially available Blyscan 
GAG Assay Kit (Biocolor, Newtownabbey, Northern Ireland). A modified 
hydroxyproline assay was used to determine total collagen in each construct.151 
Each sample was hydrolyzed in 4 M NaOH at 121 °C for 1 hr. The samples were 
then neutralized and placed in buffer. The collagen content was then determined 
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by combining the samples with dimethyl aminobenzaldehyde and chloramine T 
allowing for a colorimetric comparison. The PicoGreen assay (Molecular Probes, 
Eugene, OR) was used to determine the DNA content of scaffoldless constructs. 
Collagen II and collagen I amounts were quantified using ELISA protocols 
described previously.26 Briefly, for collagen II, Chondrex reagents and protocols 
were employed (Chondrex, Redmond, WA). For collagen I, a similar protocol was 
employed with antibodies from US Biological. 
Uniaxial tension 
Tensile tests were performed using an Instron 5565 with a 50 N load cell. To 
ensure testability, samples were taken from the longer axis of the ellipse and 
carved into a dog-bone shape. The ends were fixed to paper tabs using 
cyanoacrylate glue. A 0.05 N tare load was applied and the constructs were 
pulled to failure at a strain rate that was equivalent to 1% of the gauge length. 
Stress-strain curves were created from the load-displacement curves and the 
cross-sectional area of the samples; tensile stiffness and ultimate tensile strength 
were calculated from the linear region of each stress-strain curve. Construct 
thickness was measured using digital calipers. 
Creep indentation 
Disc-shaped constructs, obtained using a 2 mm biopsy punch, were evaluated 
with an indentation apparatus. The specimens were loaded with a tare mass of 
0.4 g (0.004 N), using a 0.5 mm-diameter rigid, flat-ended, porous indenter tip. 
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When tare equilibrium was reached, a step mass of 2.3 g (0.02 N) was applied. 
Displacement of the sample surface was measured until equilibrium was 
reached. At that time, the step load was removed, and the displacement 
recorded until equilibrium was again reached. The aggregate modulus, Poisson's 
ratio and permeability of the samples was then determined using the linear 
biphasic theory. 
Statistical analyses 
Biochemical and biomechanical assessments were performed on all constructs 
(n = 6). A single factor ANOVA was used to analyze the samples, and a Tukey's 
post hoc test was used when warranted. Significance was defined as p < 0.05. 
Univariate regression analysis was also conducted to determine whether the 
biochemical properties correlated with the biomechanical properties. 
Results 
Well-maker roughness 
The average roughness value (Ra) was estimated by assuming the surface was 
entirely composed of semi-circles. Image J (NIH, Bethesda, MD) was used to 
estimate the diameter of these semi-circles (~281 urn). Using the roughness 
formula, the average roughness (Ra) of the rough well-maker was calculated to 
be 44.7 ± 4.0 urn. 
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Gross morphology 
Within 48 hrs of seeding, the cells coalesced into an elliptical shaped construct 
that grew in size over the 4 wk culture period (Figure 37). At t = 4 wks, the 
constructs cultured in the smooth agarose wells were extracted with a spatula by 
maneuvering the construct up the central post. Constructs cultured in the rough 
agarose wells were more difficult to extract and had pieces of agarose adhered 
to the construct. The adhered agarose was carefully removed using a spatula 
prior to histological and biochemical examination. Although translucent cartilage-
like tissue was present in all groups, stark differences were observed in the 
morphology of the constructs in each group. Constructs cultured in the smooth 
wells exhibited a smooth surface topology while those cultured in rough wells 
exhibited an uneven topology. In addition, buckling was observed in constructs 
cultured in 2% agarose wells but was absent in constructs cultured in 1% 
agarose wells. Each elliptical construct was divided down the major axis to yield 
two meniscus-shaped-constructs. No significant differences were observed 
among groups in height (p = 0.70) and thickness (p = 0.38) of the meniscus-
shaped constructs (Table 9). 
Histology 
Uniform collagen and GAG staining was observed in all constructs (Figure 37). 
Polarized light micrographs showed presence of collagen alignment in the 
circumferential direction and the alignment was most prominent in constructs 
cultured in smooth wells with 1% agarose (Figure 37). 
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Biochemistry 
At t = 4 wks, wet weights of the meniscus-shaped constructs were significantly 
different among groups (p = 0.0004) and ranged from 38.8 ± 3.3 mg ( 1 % agarose 
rough) to 32.7 ± 1.8 mg ( 1 % agarose smooth) (Table 9). Cell number/construct 
increased significantly (p = 0.02) from 21.8 ± 2.1 million cells/construct in the 1% 
smooth agarose group to 25.2 ± 1.9 million cells/construct in the rough 1% 
agarose group (Figure 38A). Values for the total collagen, GAG, collagen I, and 
collagen II per construct are shown in Table 1. Significant differences were 
observed among groups for total collagen per WW (p = 0.0008) (Figure 38B), 
GAG per WW (p = 0.0003) (Figure 38C) and collagen II to collagen I levels in the 
constructs (p < 0.0001) (Figure 38D). Specifically, collagen content per WW 
ranged from 8.9 ± 1.9% in the rough 1% agarose group to 12.9 ± 1.7% in the 
smooth 1% agarose group, while GAG content per WW ranged from 3.4 ± 0.9% 
in the rough 1% agarose group to 6.4 ± 0.7% in the smooth 2% agarose group. 
Collagen II to collagen I ratios in the constructs were highest in cells cultured in 
smooth wells with values ranging from 9.8 ± 2.3 in the rough 1% agarose group 
to 27.4 ± 5.3 in the smooth 1% agarose group. 
Biomechanics 
Samples were tested under tension with significant differences observed among 
groups for the tensile modulus (p = 0.008) and the UTS (p = 0.03) (Figure 39A). 
Specifically, samples cultured in the smooth 1% agarose wells exhibited the 
highest tensile modulus (1018 ± 259 kPa) and the highest UTS (252 ± 53 kPa). 
208 
These values were approximately one and half times (tensile modulus: 534 ±201 
kPa, UTS: 151 ±66 kPa) those of constructs cultured in the rough 1% agarose 
wells. 
Meniscus-shaped constructs were evaluated under conditions of creep 
indentation with significant differences observed among groups for the aggregate 
modulus (p = 0.002) (Figure 39B). The highest aggregate modulus was found in 
constructs cultured in the smooth 2% agarose wells (116 ± 38 kPa), 
approximately two and a half times the aggregate modulus of constructs cultured 
in rough 2% agarose wells (45 ± 1 2 kPa). No significant differences were 
observed among groups for the permeability (p = 0.46) and the Poisson's ratio (p 
= 0.91). The values for permeability for the 1% agarose (smooth and rough), and 
the 2% agarose (smooth and rough) were 4.5 ± 3.2 (x 10"15) m47 N-s, 7.1 ± 5.1 (x 
10"15) m4 / N-s, 4.5 ± 1.6 (x 10"15) m4 / N-s, and 6.7 ± 3.0 (x 10"15) m4 /N-s, 
respectively. The values for the Poisson's ratio for the 1% agarose (smooth and 
rough), and the 2% agarose (smooth and rough) were 0.2 ± 0.1, 0.2 ± 0.1, 0.2 ± 
0.1 and 0.2 ± 0.2, respectively. 
Correlation between biochemical and biomechanical data 
Compressive and tensile moduli obtained from the biomechanical data were 
correlated to the total GAG and collagen content in the constructs. Univariate 
regression analysis showed a significant correlation between tensile modulus 
and collagen/construct (r2 = 0.44, p = 0.0007) but not for GAG/construct (r2 = 
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0.0001, p = 0.95). Significant correlations were also observed between aggregate 
modulus and GAG/construct (r2 = 0.45, p = 0.0004) but not for collagen/construct 
(r2 = 0.005, p = 0.74). 
Discussion 
The results presented here demonstrate that agarose percentage and 
topography of the mold can significantly influence the final shape of meniscus 
constructs cultured using a 50:50 ratio of primary bovine MCs and ACs. 
Specifically, it was found that constructs cultured in 1% agarose wells retained 
the shape of the original meniscus mold and did not buckle as a result of growth 
in the radial direction, unlike what was observed with constructs cultured in 2% 
agarose wells. Interestingly, the biochemical and biomechanical properties of the 
resulting constructs were also significantly altered. The highest tensile properties 
and total collagen were observed in the smooth 1% agarose wells, while the 
highest compressive modulus and total GAG were observed in the smooth 2% 
agarose wells. Further, collagen II production relative to collagen I production 
was significantly enhanced in groups cultured in smooth wells. 
In this experiment, an elliptical shaped mold was designed that would closely 
mimic the curved wedge-shaped cross section of the meniscus. The curved 
shaped profile facilitates the translation of axial compressive forces in the inner 
regions to circumferential hoop stresses in the outer regions of the meniscus. 
This provides the meniscus with its shock absorption and load transfer 
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capabilities. In addition, the wedge-shaped profile of the meniscus maintains 
knee stability by preventing the rounded surface of femur from sliding off the flat 
surface of the tibia. In a previous experiment examining various co-culture ratios 
of ACs and MCs seeded in circular ring-shaped molds, we observed that the 
50:50 co-culture ratio resulted in a construct approaching the geometry of the 
native meniscus.53 To more accurately depict the overall geometry of the 
meniscus, the mold design was optimized from a ring to an ellipse and the 
bottom of the mold was fashioned with a changing concave slope to mimic the 
variation in cross-sectional area of the meniscus. These modifications resulted in 
constructs more closely mimicking native tissue, especially those cultured in 
smooth 1% agarose wells. 
Two different agarose percentages (1% and 2%) were examined in this 
experiment to determine their effect on construct geometry during the culturing 
phase. In previous work, meniscus constructs grown in a ring-shaped mold 
expanded radially and buckled as they reached the confining walls of 2% 
agarose wells. Compared to 1% agarose wells, the 2% agarose wells exhibit 
lower compliance and exert greater inward forces onto the constructs as they 
expand. Mechanical properties of agarose gels have been shown to be 
concentration dependent with an equilibrium aggregate modulus of 5 kPa for 1% 
w/v agarose gels and approximately 20 kPa for 2% w/v agarose gels.269 We 
hypothesized that buckling may be reduced by utilizing a lower percentage 
agarose well with increased compliance. This was confirmed by our results 
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where constructs cultured in 1% agarose wells formed meniscus-shaped 
constructs with no buckling, while constructs cultured in 2% agarose wells 
buckled. 
In addition to agarose percentage, the effect of well topography was also 
examined on the final geometrical shape of the meniscus construct. Studies have 
shown that cells are sensitive to the surface texture of the material and can alter 
their attachment, phenotype and matrix deposition patterns on different 
topographies.270"272 For instance, microgrooves on a surface have been shown to 
alter morphology of osteoblasts and influence matrix deposition.273 In this 
experiment, constructs in smooth agarose wells were easily removed using a 
spatula at 4 wks. Interestingly, constructs cultured on rough surfaces exhibited 
resistance upon removal and appeared attached to the bottom of the agarose 
wells. Surface roughness may have provided the means for interdigitation of the 
construct into the biomaterial. We hypothesize that portions of the developing 
matrix were anchored into the microgrooves of the molds. As the construct 
expanded to the well edge, buckling was prevented due to construct anchorage 
to the well bottom. However, reactionary tensile forces on the constructs, as a 
result of non-homogeneous interdigitation with agarose, led to overall uneven 
construct topology and impeded construct extraction from the well. Thus, 
although the original hypothesis that rough surfaces would eliminate buckling due 
to increased frictional contact was proven, the geometry of the final construct did 
not mimic the meniscus due to its high degree of unevenness. 
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An interesting result of this study was that cell number was significantly higher in 
constructs cultured on rough surfaces. One potential reason for this may be 
dedifferentiation and subsequent proliferation of primary ACs and MCs as a 
result of tensile forces exerted due to interdigitation of the construct with the 
agarose mold. The ECM is capable of transducing external mechanical stimuli 
into changes in cell function through mechanotransduction. At the cellular level, 
mechanical forces can stretch protein-cell surface integrin binding sites, deform 
gap junctions containing calcium sensitive stretch receptors, alter ion channel 
permeability, and lead to activation of anabolic or catabolic factors.274, 275 These 
cellular changes can trigger intracellular pathways that can influence cell division 
as well as the regulation of genes that synthesize ECM molecules.274 In this 
experiment, tensile forces appeared to dedifferentiate MCs and ACs cultured in 
rough wells towards a fibroblastic lineage, a phenomenon that has been 
observed previously with mesenchymal stem cells.243 Increases were observed 
in collagen I relative to collagen II production and decreases were observed in 
GAG production in rough wells when compared to ECM produced in smooth 
wells. It has been previously shown with TMJ disc fibrochondrocytes that 
dedifferentiation of cells can also lead to enhanced cell division and proliferation 
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. Thus, cell dedifferentiation due to the external mechanical stimulus likely 
contributed to increased cell number and decreased cartilaginous matrix 
production in constructs cultured on rough surfaces. 
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This experiment utilized a co-culture of primary bovine MCs and ACs. Through 
this approach, large quantities of collagen II and GAG were obtained, both of 
which are important ECM molecules present in the inner regions of the rabbit 
meniscus. Primary cells were chosen since passaged MCs and ACs 
dedifferentiate in monolayer and express high levels of collagen I, and low levels 
of collagen II and aggrecan.159, 276 Bovine cells were judiciously chosen to 
recreate the rabbit meniscus since they are an easily available cell source that 
can be harnessed to develop meniscus tissue engineering technologies. In 
addition, bovine cells may also be considered as a potential xenogenic cell 
source for leporine meniscus tissue engineering. For this approach to be 
successful in vivo, a battery of tests will need to be conducted in vitro and in vivo 
to ensure the cells do not elicit a humoral immune response. This approach may 
be feasible so long as the cells are shielded by a scaffold or ECM.250 
To enhance the clinical translatability of our approach, as well as to modulate the 
phenotype of cells during culture, this experiment utilized a serum-free medium 
to grow meniscus-shaped constructs. Previous studies have shown that serum-
free medium containing additives such as ITS+ and dexamethasone can 
significantly enhance GAG production in ACs.231, 277 We have also obtained 
similar results in a previous study comparing serum-containing and serum-free 
medium.26 Co-cultures of MCs and ACs (50:50), grown in cylindrical molds using 
a similar scaffoldless approach, were found to contain higher levels of GAG in 
constructs in serum-free medium when compared to those cultured in serum-
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containing medium. In addition, total collagen was increased and the collagen I to 
collagen II ratio was decreased when comparing serum-free culture to serum-
containing culture. This showed that the matrix was more cartilaginous in nature 
when cultured in serum-free conditions. Our results utilizing the elliptical mold 
design were even more dramatic, with greater amounts of total collagen II 
produced than collagen I. Specifically, collagen II levels surpassed collagen I 
levels by at least ten times in constructs cultured in rough wells and up to 27 
times in constructs cultured in smooth wells. This was an exciting result, 
especially since the inner region rabbit meniscus contains a high amount of 
collagen II. In future work, AC to MC ratios can be modified to attain the correct 
levels Of each type of collagen in the construct. 
While recapitulating the geometric shape of the meniscus is an important 
component of a meniscus tissue engineering strategy, the functional properties of 
the engineered construct are also an effective assessment tool. Examination of 
the structure-function relationships of the constructs showed that increased GAG 
levels resulted in increased compressive stiffness of the constructs, while 
increased collagen content resulted in increased tensile stiffness of the construct. 
Excitingly, we were able to achieve GAG levels per wet weight (~5 to 6%) similar 
to those of native rabbit meniscus values (~3-4%). Collagen levels per wet weight 
ranged from 8 to 13%, lower than native values (~23%).1 Compressive stiffness 
of constructs cultured in 2% agarose smooth wells (~120 kPa) mimicked those of 
the outer regions of the rabbit meniscus (-120 kPa), although the compressive 
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properties of the inner meniscus are four times higher (~510 kPa). The highest 
tensile stiffness (~1 MPa) and UTS (~0.25 MPa) were observed in the 1% 
agarose smooth wells. These results were corroborated by polarized light 
micrographs showing most prominent collagen alignment in this group. In spite of 
this, the tensile values obtained were two orders of magnitude below those of 
native tissue.19 Thus, future work will need to investigate strategies to enhance 
the tensile properties of the constructs without comprising their compressive 
properties. This could be achieved by using exogenous factors, such as 
chondroitinase ABC, which temporarily remove GAGs from the matrix and allow 
enhancement of the collagen network.228 
Conclusions 
A smooth mold made of 1% agarose was able to create geometrically-mimetic 
meniscus constructs for meniscus tissue engineering using a scaffold less 
approach. Rough wells inhibited construct buckling but resulted in uneven 
shaped constructs. Stark changes were observed in ECM components among 
groups, with smooth wells enhancing cartilaginous markers such as GAG and 
collagen II and rough wells enhancing the fibroblastic marker collagen I. Overall, 
this work presents an effective strategy for knee meniscus tissue engineering 
using a self-assembly, scaffoldless process to create constructs approaching the 
geometrical, biochemical, and biomechanical properties of the native meniscus. 
216 
Figures associated with chapter 9 
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Figure 36. Meniscus well-maker 
(A) AutoCAD drawing of the elliptical well-maker (B) Well-maker fabricated with 
smooth topology (scale bar = 2 mm). (C) Well-maker fabricated with rough 
topology (scale bar = 2 mm). 
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Figure 37. Gross morphology and histology of constructs 
Picrosirius red (collagen), polarized light and safranin-0 / fast-green staining 
(GAG) of constructs at 10X magnification. 
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Figure 38. Biochemical characterization of constructs 
(A) Cell number per construct. Dashed line indicates original cell seeding density 
of ~20 million cells per construct. (B) Collagen content normalized to construct 
wet weight. (C) GAG content normalized to construct wet weight. (D) Collagen II 
per construct normalized to collagen I per construct. Data presented as mean ± 
SD with significance among groups labeled with different letters (p < 0.05). 
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Figure 39. Biomechanical characterization of constructs 
(A) Tensile modulus and ultimate strength of constructs. (B) Aggregate modulus 
determined from creep indentation testing. Data presented as mean ± SD with 
significance between groups labeled with different letters (p < 0.05). 
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Table 9. Gross morphological and biochemical results 
Data presented as mean ± SD with significance between groups labeled with 
different letters (p<0.05). 
Group 
1% agarose 
smooth 
2% agarose 
smooth 
1% agarose 
rough 
2% agarose 
rough 
p value 
Average 
thickness 
(mm) 
3.5 
±0.1 
3.7 
±0.1 
3.6 
±0.2 
3.7 
±0.2 
0.38 
Average 
height 
(mm) 
1.0 
±0.1 
1.0 
±0.1 
1.0 
±0.0 
1.0 
±0.1 
0.70 
Wet 
weight 
(mg) 
32.7 
±1.8 b 
32.0 
±2.7" 
38.8 
±3 .3 a 
36.0 
±1.9 * 
0.0004 
Total 
GAG 
(mg) 
1.5 
±0 .3 a 
2.0 
±0.2a b 
1.3 
±0.3" 
1.3 
±0.4b 
0.002 
Total 
collagen 
(mg) 
4.2 
±0.6 
3.8 
±0.7 
3.4 
±0.5 
3.4 
±0.3 
0.05 
Collagen 
I 
(U9) 
22.5 
±1.7b 
22.1 
±4.6b 
45.5 
±8.9a 
45.8 
±7.4a 
< 0.0001 
Collagen 
II 
(mg) 
0.6 
± 0 . 1 a 
0.6 
±.0.1 ' 
0.4 
± 0 . 1 b 
0.4 
± 0 . 1 b 
0.003 
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Conclusions 
The overall objective of this thesis was to identify exogenous stimuli that could 
enhance the biochemical and biomechanical properties of tissue engineered 
meniscus constructs. To achieve this objective, the thesis was divided into three 
aims. In aim 1, meniscus cells (MCs) were characterized in vitro, and the effects 
of monolayer on the gene expression of important ECM markers were quantified. 
In aim 2, a scaffold-based approach using non-woven PLLA meshes was used to 
tissue engineer the meniscus. Several anabolic stimuli were utilized including 
growth factors and mechanical forces. In aim 3, a self-assembly, scaffoldless 
approach was utilized for meniscus tissue engineering. In this approach, a high 
density of MCs and articular chondrocytes (ACs) were seeded on non-adherent 
agarose molds and allowed to coalesce into constructs with varying biochemical 
and biomechanical properties, and geometries. 
The global hypotheses of this investigation were that 1) MCs would experience 
rapid phenotypic changes during culture, but these changes could be modulated 
by controlling the culturing conditions (aim 1); 2) exogenous factors, individually 
or in combination, would allow for the formation of meniscus constructs 
resembling native tissue (aim 2); and 3) a scaffoldless approach could be used to 
recreate the heterogeneities of the knee meniscus (aim 3). The results obtained 
through various tissue engineering experiments confirmed our original 
hypotheses and are presented in chapters 2 to 9 of this thesis. 
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Aim 1 of this thesis was to investigate the phenotypic changes in MCs with 
passage and examine gene expression reversal techniques (chapter 2). It was 
found that MCs undergo significant changes during monolayer expansion and 
passage. They experienced losses in major chondrocytic markers (collagen II 
and COMP) while simultaneously experiencing gains in fibroblastic markers 
(collagen I). The rapid changes in gene expression of MCs over passage was 
concerning as this had important implications for future tissue engineering 
studies involving passaged meniscus cells. Several techniques have been used 
in the past to promote gene expression reversal of passaged chondrocytes and 
TMJ disc fibrochondrocytes back to primary cell values. These techniques have 
included utilizing growth factors, 3-D hydrogels and protein coatings.60,62,64,67 In 
this experiment, collagen I and aggrecan protein coatings were used successfully 
to regain lost phenotype in passaged MCs for collagen I and COMP genes; 
however, collagen II gene expression reversal proved to be unsuccessful. A lack 
of collagen II could result in structural breakdown of the tissue as well as preempt 
osteoarthritis.14, 125, 126 To overcome this, several exogenous stimuli were 
investigated in aim 2 (serum-free medium, bFGF, hypoxia and ACs) to modulate 
MC phenotype in culture and enhance collagen II formation on meniscus cell-
seeded PLLA constructs. 
Aim 2 of this thesis was to investigate exogenous stimuli to enhance the 
biochemical and biomechanical properties of meniscus constructs. This aim 
consisted of five studies (chapters 3 to 7). In chapter 3, the effects of long term 
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culture of PLLA scaffolds in PBS, serum-containing medium, or serum-free 
medium were examined. The objective was to determine whether the scaffold 
used in our meniscus tissue engineering studies did not degrade prematurely, 
potentially impeding ECM production. It was shown that the PLLA scaffolds 
retained their mechanical properties and MW, and did not degrade up to at least 
12 wks in PBS, serum-free or serum-containing media. Future studies will have 
to examine whether the presence of cells accelerates potential degradation and 
subsequent drop in biomechanical properties. 
In chapters 4 and 5, the effects of hydrostatic pressure and the combination of 
hydrostatic pressure and TGF-pi were examined. The objective of the first study 
(chapter 4) was to identify a HP regimen that enhanced the properties of MC-
seeded PLLA constructs. Physiologic pressures in the knee joint range from 3-18 
MPa.152, 153 In addition, a frequency ranging from 0.6 to 1.09 Hz is observed 
during normal walking rhythm of an adult human.155 Thus, a physiologically 
relevant HP pressure of 10 MPa was applied on MC-seeded PLLA constructs at 
several frequencies (0, 0.1 and 1 Hz). The experimental data provided significant 
evidence for the benefit of static HP (10 MPa, 0 Hz) with increases in the total 
collagen and compressive moduli of the constructs. Since HP does not result in 
macroscopic construct deformation, it was postulated that it may directly affect 
cell transmembrane ion transporters that can activate signal transduction 
cascades that lead to enhances in gene expression of relevant ECM markers. 
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To further improve the structural integrity of our constructs, a growth factor, TGF-
|31, was used alone and in combination with the static hydrostatic pressure 
regimen identified from the previous chapter (chapter 5). TGF-(31 alone was 
found to significantly increase collagen and GAG deposition in PLLA scaffolds. 
TGF-01 may directly influence GAG synthesis fay accelerating glucose transport 
in human articular chondrocytes via protein kinase C and extracellular signal-
regulated kinase-dependent signaling pathways.189 The combination of static HP 
and TGF-(31 led to additive increases in the collagen deposition and 
instantaneous modulus, and synergistic increases in the relaxation modulus and 
coefficient of viscosity of the PLLA constructs. As mentioned in the previous 
paragraph, HP is known to alter conformations of cell membrane ion transport 
pathways. This results in altered intracellular ion flux, thereby influencing other 
downstream processes.92 A recent study has shown that intracellular Ca2+ 
mobilization can significantly affect the cells' response to TGF-J31 by controlling 
the Smad-TGF-p pathway.192 Certainly, several different cell-signaling pathways 
with feedback loops either complementing or antagonizing the final down-stream 
effect may affect our system. Future work will need to identify and examine these 
pathways more closely to better understand the mechanisms involved in this 
process. 
In chapter 6, the effects of hypoxia and bFGF were examined on MC-seeded 
PLLA constructs. The objective was to investigate whether a hypoxic 
environment and bFGF would significantly enhance constructs' ECM and 
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functional properties. The results demonstrated the effectiveness of combining 
bFGF and low oxygen tension (2% 02) to synergistically enhance matrix and 
functional properties of tissue engineered meniscus constructs in vitro. 
Specifically, we observed significant enhancements in GAG content (synergistic 
increase), collagen II content, and cell number/construct in groups exposed to 
hypoxia and bFGF when compared to the controls. In addition, the compressive 
properties of the construct also increased, with additive increases in the 
instantaneous modulus, and synergistic increases in the relaxation modulus and 
the coefficient of viscosity. bFGF has been shown to play an important role in 
modulating intracellular Ca2+ levels through protein kinase C activity.211 Changes 
in intracellular Ca2+ levels can affect downstream signaling pathways that 
influence gene expression and protein synthesis of various extracellular matrix 
molecules.192 MCs under hypoxic conditions have been shown to upregulate 
TGF-P1 expression which has been implicated as a potent ECM modulator. 
Further, hypoxia and TGF-P pathways have also been shown to function 
synergistically,210 and may supplement SOX-9 pathways, to enhance GAG 
production on the meniscus-cell seeded scaffolds. In future work, combinations 
of identified stimuli from chapters 4, 5 and 6 may be synergized or applied in a 
temporally coordinated fashion to maximize the functional and organizational 
properties of MC-seeded PLLA constructs. 
In chapter 7, five different co-culture ratios of primary ACs and passaged MCs 
were seeded on PLLA scaffolds and cultured in serum-free medium. The 
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objective of this study was to identify co-culture ratios most closely resembling 
the biochemical and biomechanical properties of the inner and outer regions of 
the knee meniscus. Qualitative and quantitative tests showed clear differences 
between the ECM and biomechanical properties of the constructs in each group. 
Specifically, constructs cultured with a higher percentage of ACs had enhanced 
compressive properties and contained significantly higher levels of collagen, 
collagen II, and GAG. Constructs cultured with higher percentage of MCs 
contained higher levels of collagen I. Excitingly, GAG levels close to native 
values for the inner and outer meniscus were achieved using this approach. 
Collagen levels approached native meniscus as well if the dry weight 
normalizations excluded the weight of PLLA. Overall, we were able to 
demonstrate that co-culturing MCs and ACs on PLLA scaffolds resulted in 
functional tissue engineered meniscus constructs with a spectrum of biochemical 
and biomechanical properties. It is envisioned that this study will provide a 
baseline for future meniscus tissue engineering studies attempting to regenerate 
different regions of the meniscus. 
Aim 3 of this thesis was to optimize cell and tissue culture conditions for 
scaffoldless meniscus constructs. This aim consisted of two studies (chapters 8 
and 9). In chapter 8, five different co-culture ratios of primary bovine MCs and 
ACs were investigated for leporine meniscus tissue engineering. The objective 
was to determine co-culture ratios that mimic the inner and outer regions of the 
leporine meniscus. Medial leporine menisci were used as internal controls. 
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Bovine cells were utilized since they are an easily available cell source, unlike 
leporine cells, and are ideal to develop meniscus tissue engineering 
technologies. In addition, bovine cells were also investigated for their capacity to 
produce matrix that mimics leporine menisci and for consideration as a potential 
xenogenic cell source in future in vivo studies in the rabbit. The results of this 
study demonstrated the ability of this co-culture system to create a spectrum of 
fibrocartilages that mimic several biochemical and biomechanical properties of 
leporine menisci. Higher MC% groups more closely mimicked the GAG per wet 
weight of both, the inner and outer regions of the meniscus. The 50% MC group 
was found to mimic the inner meniscus in collagen II to collagen I content. 
Tensile properties of native tissue could not be matched by any of the test 
groups. Based on these data, a 50% MC group may be ideal to recapitulate 
biochemical characteristics of the inner regions of the tissue. For the outer 
regions, a lower MC% group with higher compressive strength may be ideal from 
a functional tissue engineering standpoint. 
In chapter 9, two different agarose mold surfaces and concentrations were 
examined for their ability to produce geometrically-mimetic meniscus shaped 
constructs. The results demonstrated that agarose percentage and topography of 
the mold can significantly influence the final shape of meniscus constructs 
cultured using a 50:50 ratio of primary bovine MCs and ACs. Specifically, it was 
found that constructs cultured in 1% agarose wells retained the shape of the 
original meniscus mold and did not buckle as a result of growth in the radial 
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direction, unlike what was observed with constructs cultured in 2% agarose wells, 
In addition, constructs cultured on rough surfaces resulted in uneven construct 
formation and appeared attached to the agarose at the bottom of the wells. We 
hypothesized that portions of the developing matrix were anchored into the 
microgrooves of the molds. As the construct expanded to the well edge, buckling 
was prevented due to construct anchorage to the well bottom. However, 
reactionary tensile forces on the constructs, as a result of non-homogeneous 
interdigitation with agarose, led to overall uneven construct topology and 
impeded construct extraction from the well. Interestingly, the biochemical and 
biomechanical properties of the resulting constructs were also significantly 
altered. The highest tensile properties and total collagen were observed in the 
smooth 1% agarose wells, while the highest compressive modulus and total GAG 
were observed in the smooth 2% agarose wells. Further, collagen II production 
relative to collagen I production was significantly enhanced in groups cultured in 
smooth wells. This was exciting since the inner regions of the meniscus contain 
higher levels of collagen II when compared to collagen I. Overall, a smooth mold 
made of 1% agarose was able to create geometrically-mimetic meniscus 
constructs for meniscus tissue engineering using a scaffoldless approach. 
The work described in this thesis has made several important advances to the 
field of meniscus tissue engineering. Salient achievements of this thesis include: 
1) the characterization of meniscus cell (MC) dedifferentiation over passage and 
the identification of suitable protein coatings (collagen I and aggrecan protein 
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coatings) to recover losses in gene expression; 2) the identification of specific 
anabolic stimuli (hypoxia, bFGF, TGF-P1, and hydrostatic pressure) that can 
enhance the functional and biochemical properties of meniscus cell-seeded 
PLLA scaffolds; 3) the demonstration of synergistic and additive increases in 
biochemical and biomechanical content via the combination of two types of 
stimuli (hypoxia and bFGF, static hydrostatic pressure and TGF-(31); 4) the 
recreation of heterogeneities of the knee meniscus using a co-culture of articular 
chondrocytes (ACs) and MCs, via a scaffold-based and scaffoldless approach; 
and 5) the optimization of the self-assembly scaffoldless approach to grow 
regionally variant meniscus-shaped constructs. Future work in the meniscus field 
will need to focus on further enhancing the biochemical and biomechanical 
properties of the constructs, especially the tensile properties. This may be 
accomplished by improving scaffold alignment in the circumferential direction by 
techniques such as electrospinning 278 or by using exogenous factors such as 
chondroitinase-ABC to temporarily deplete GAGs while enhancing the collagen 
matrix.228 
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Abstract 
The use of biodegradable materials as implants has revolutionized the way 
medicine is practiced today. This review provides a general description of salient 
biodegradable polymeric materials currently used in arthroscopy. These 
materials include polyglycolic acid, self-reinforced polyglycolic acid, poly-L-lactic 
acid, self-reinforced polylactic-L-acid, poly-D-L-lactic acid, copolymer of poly-D-L-
lactic acid polyglycolic acid, and polyglyconate. The mechanical strength, 
degradation properties, and widespread use of these materials, especially in the 
knee and shoulder, are discussed individually. Also discussed are the relatively 
few complications that are related to these materials' arthroscopic use. Future 
directions in biodegradable materials, including smart polymers, are also 
considered. In the future, novel techniques to identify the ideal polymer for a 
particular application will need to be developed to minimize the risk for implant 
complications. 
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Introduction 
Despite the relative success of metallic implants in surgery, rapid advances in 
science and technology have allowed researchers to explore other avenues that 
can resolve some of the inherent disadvantages that metals present. For 
instance, the permanency of metallic implants makes it difficult for the body to 
recapitulate its native state, a major goal in medicine. In addition, failure of the 
implants due to corrosion, infection, or stress shielding mismatches requires 
removal of the device leading to additional surgeries.279,280 Metallic implants are 
also known to contraindicate imaging applications such as magnetic resonance 
imaging (MRI).281, 282 Additionally, chromium and nickel coatings on stainless 
steel surfaces, applied to prevent corrosion may even be genotoxic and harmful 
to DNA molecules.283'284 
To address these problems in the past three decades there has been a gradual 
focus shift from metallic implants to biodegradable ones. Biodegradable implants 
are natural, synthetic or biosynthetic polymers that are biocompatible with the 
body and do not elicit a foreign body response. Today, more than 40 types of 
polymers are used as implants in both soft and hard tissue applications ranging 
from arthroscopy to tissue engineering.285 
This review serves as an overview of biomaterials primarily used in arthroscopic 
soft tissue applications. These include polyglycolic acid (PGA), polylactic acid 
enantiomers (PLA), polyglyconate, self-reinforced polyglycolic acid (SR-PGA) 
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and polylactic acid (SR-PLLA), and copolymers of lactic and glycolic acid 
(PDLLA-co-PGA). The in vivo and in vitro mechanical strength and degradation 
properties of these polymers are described. Although the polymers have been 
successfully used as degradable implants, there have been few reports of 
complications, the most recent of which are discussed. Special emphasis is 
placed on knee and shoulder, both joints that are most commonly associated 
with arthroscopic surgery. Future directions in biodegradable materials involving 
smart polymers are also addressed. 
Mechanical strength and degradation of polymers 
The ability of biodegradable polymers to withstand high loading early in the 
healing process and then gradually degrade while preserving some of their 
properties is critical for rebuilding healthy tissue. It is therefore essential to 
understand how polymeric mechanical properties change over time when placed 
in a physiological environment. One of the basic parameters used to describe the 
mechanical properties of polymers is mechanical strength. The mechanical 
strength of a polymer implant is largely determined by its molecular weight (MW) 
and degree of crystallinity. Polymeric devices with desired MW and crystallinity 
can now be fashioned by using commercially available fabrication techniques 
such as injection molding, compression molding, extrusion, solution casting, 
solvent casting particulate leaching or gel casting.286,287 The choice of fabrication 
technique is often influenced by the physical and thermal properties of the 
polymer as well as its final desired morphology. For instance, PLLA fibers with 
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high MW ranging from 300-500 kiloDaltons (kDa) can be extruded at 110°C while 
low MW PLLA fibers (below 300kDa) can be extruded at 180°C.287 Three 
dimensional scaffolds and foam can be fabricated by solvent-casting particulate 
leaching,288 Internal fixation devices like screws, rods and plates can be 
fabricated from polymer blocks by injection molding. However, the final desired 
mechanical properties can vary depending on variations in the molding 
process. 
There are several ways to characterize the mechanical strength of a material. 
Stress-strain deformation curves provide valuable information on the tensile 
properties of a polymer, including the tensile strength, elastic modulus and the 
yield strength. Flexural and shear strength are often reported in the literature as 
they provide explanations of the polymer's ability to resist bending and angular 
deformation. The strength of a polymer can also be enhanced by a technique 
called self-reinforcement. In this technique, fibers of the desired polymer made 
from the same material as the polymer matrix are sintered together at high 
temperatures and pressures.290"292 Fatigue behavior of a polymer is also 
important in applications involving cyclic dynamic strain. 
The mechanical properties of an implanted material can change dramatically in 
vivo as it degrades. Results from in vitro and in vivo degradation studies have 
provided us with a basic understanding of how different polymers degrade in 
different environments.293 For example, it is known that most polyesters, 
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including PGA, PLLA, polyglyconate and copolymers of PGA-PLA, degrade via 
non-specific hydrolytic clipping of ester bonds.294, 295 The susceptibility of these 
polymers to hydrolysis is a function of their chemical structure, morphology and 
the harsh in vivo environment of the body.287,296, 297 The mechanical properties 
and degradation times of the above mentioned polymers are described below 
and listed in Table 10 and Table 11 respectively. 
Polyglycolic Acid (PGA) and Self-Reinforced Polyglycolic Acid (SR-PGA) 
PGA has been used extensively as a biodegradable material as its byproduct is a 
natural metabolite, glycolic acid.298 PGA implants of varying MW have been 
fabricated by compression and injection molding.299,300 The melting temperature 
of crystalline PGA ranges from 225-230°C with a glass transition temperature of 
36°C.300 Polymers at temperatures below their glass transition temperature are 
rigid or glassy while those at temperatures greater than their glass transition 
temperature exhibit rubbery characteristics. 
In bulk form, the tensile strength of PGA has been reported to be around 57-70 
MPa.301,302 The shear and flexural strength of injection molded PGA rods have 
been found to vary between 95 MPa and 220 MPa.303 Radiolabeled PGA in 
animal metabolism studies showed that less than 1% of the implant was present 
at the site four months after implantation.304 Self reinforced PGA implants have 
been shown to exhibit vastly improved mechanical properties.290 High initial 
flexural strengths varying between 370-405 MPa and initial shear strengths 
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varying between 250-255 MPa, respectively, have been reported by several 
groups.303,305,306 The high initial strength provided by the reinforcement process 
however is not retained for a long period of time in vivo. Several investigators 
have discovered that, in vivo, the implants rapidly lose their flexural and shear 
strength.306"309 A complete loss of flexural and shear strength of SR-PGA screws 
over six wks was observed by one group.306 Another group observed a 50% drop 
in flexural strength of SR-PGA rods over three wks.307 Histology on implanted 
SR-PGA screws in lambs showed evidence of fragmented screws in four to six 
wks and complete resorption in three months.308 Similar results have been 
observed with SR-PGA pins implanted in a canine femoral canal.309 
Polylactic Acid (PLA) Enantiomers and Self-Reinforced Polylactic-L-Acid 
(SR-PLLA) 
PLA is a semi-crystalline polymer exhibiting thermoplastic properties. Due to its 
asymmetric shape, it can exist in two enantiomeric forms poly-L-lactic acid 
(PLLA) and poly-D-lactic acid (PDLA). PLLA is more commonly used as a 
polymeric implant as its degradation byproduct yields a naturally occurring 
stereoisomer of lactic acid which enters the Krebs cycle and is converted to 
carbon dioxide and water.310 Copolymers of these two enantiomers (PDLLA) can 
exhibit varying physical and chemical properties depending on amount of each 
polymer present in the polymer chain.311, 312 Crystalline PLLA can vary in MW 
from 50 to 300 kDa.313 High MW PLLA (>100 kDa) has a melting temperature 
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ranging from 173-178°C and a glass transition temperature of about 58°C.300 The 
MW of PDLLA implants range from 21 to 550 kDa.313 
The tensile strength of PLLA and PDLLA has been reported between 11 MPa-3.2 
GPa whereas the flexural strength has varied between 45-145 MPa.285,302,313"321 
The shear strength of PLLA rods of high MW (1,800 kDa) was reported to be 
around 45-47MPa.319, 322 PLLA implants have been shown to provide stable 
fixation for at least six months.319,323,324 PLLA rods placed in phosphate buffered 
saline (PBS) for nine wks showed no change in the shear strength or any 
shrinkage in diameter. Further, the MW dropped by less than 20% over 18 
wks.319 PDLLA on the other hand is less stable and degrades faster than 
PLLA.324 A clinical degradation study comparing PLLA and PDLLA interference 
screws for knee ligament reconstruction showed large fragments of PLLA screws 
present in vivo 20 months post operation. However, the PDLLA screws degraded 
completely within 10 to 14 months.324 
The self-reinforcement of PLLA increases its mechanical strength and is thus 
used in applications requiring higher loads such as cortical bone fixation.325 The 
flexural strength of SR-PLLA has varied between 89-210 MPa while the shear 
strength was found to be around 143 MPa.319, 326, 327 An experiment comparing 
SR-PLLA and metallic screws implanted in sheep showed that although both 
provided suitable fixation, SR-PLLA proved more advantageous as its lower 
rigidity prevented stress-shielding and mechanical weakening of bone.328 The 
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degradation rates of SR-PLLA and PLLA in vivo were found to be fairly similar. 
SR-PLLA screws implanted in goat medial menisci were found to be present in 
toto at six months.329 Similar results were observed in SR-PLLA screws 
implanted in bone osteotomies. Complete degradation of the screws was 
observed two yrs post-implantation.308 
Copolymer of Poly-D-L-Lactic Acid arid Polyglycolic Acid (PDLLA-co-PGA) 
Copolymers of PDLLA and PGA have often been used in soft tissue applications 
for bone-tendon-bone grafts and anterior cruciate ligament (ACL) reconstruction. 
Nakafuku and Takehisa330 investigated the mechanical properties of PLLA and 
PDLLA-co-PGA blends at various monomer ratios of PDLLA and PGA. The glass 
transition temperature for pure PDLLA-co-PGA was found to be 38°C. In terms of 
mechanical properties of 75/25 PDLLA-cb-PGA, it was found that the stress-
strain curves varied dramatically at various temperatures around the glass 
transition temperature. At 35°C, a maximum tensile strength of 10 MPa was 
reported while the maximum tensile strength at 40°C dropped to 5 MPa. At 10°C, 
however, the polymer blend became brittle with a maximum tensile strength of 45 
MPa. For clinical applications, however, the mechanical properties of the polymer 
at body temperature (37°C) could be useful. Although the authors did not report 
the stress-strain properties at body temperature, an extrapolation from the graph 
would indicate the maximum tensile strength of a 75/25 PDLLA-co-PGA at 37°C 
would be about 7-8 MPa. In an experiment to compare the pull out force of 
PDLLA-co-PGA interference screws to titanium screws implanted in calf tibia, it 
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was found that the force ranged from 246 N to 737 N and was found to be much 
lower than for titanium screws (605 N to 971 N).331 A pullout force of 565 N has 
been recorded for interference screws used in patellar bone-tendon-bone 
grafts.332 Degradation times for PDLLA-co-PGA constructs have varied between 
one and five yrs depending on application.324,329 
Polyglyconate 
Polyglyconate implants are block copolymers of glycolic acid and trimethylene 
carbonate. They are used extensively in the form of sutures, tacks, screws and 
anchors for internal fixation applications. Literature suggests that polyglyconate 
implants lose their mechanical integrity over six wks in vivo but usually are 
resorbed six to 12 months post-implantation.295'333_335 This absorption profile has 
been shown to mirror the healing response of soft tissue to bone.336 
Mechanical tensile tests on injection molded polyglyconate of varying MW 
showed a maximum initial yield strength of about 62 MPa while the ultimate 
tensile strength was about 57 MPa. When placed in PBS however, the tensile 
strength dropped down to about 4 MPa in one month.295 Another group 
compared the pull-out strength of polyglyconate interference screws to titanium 
screws implanted in calf tibia.331 Pull-out forces for the polyglyconate screws 
ranged from 469 N to 914 N. However, no significant difference was observed 
between the pull-out strength of polyglyconate and titanium screws. For tendon 
to bone suture applications in rotator cuff repairs, monofilament polyglyconate 
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sutures were compared with PGA braided sutures.337 The authors found that 
even though polyglyconate sutures failed at higher loads than PGA, their lower 
stiffness properties resulted in considerable elongation in vitro even at lower 
loads. It was concluded that the combined ultimate tensile strength and stiffness 
of braided PGA sutures were more advantageous than polyglyconate sutures for 
this particular application. 
Clinical applications and complications 
Arthroscopic techniques are used to treat a variety of disorders in the knee, 
shoulder, wrist, elbow and ankle. The relatively large size of the knee and 
shoulder joints renders them amenable to arthroscopic surgery and it is, 
therefore, not surprising that the majority of the articles published in the literature 
focus on knee and shoulder fixation. The following section discusses different 
biodegradable polymers implanted in these two joints as well as reports of some 
complications that have been observed. It should be emphasized, however, that 
complications have been noted only in low percentages of patients. Some of 
these complications involving polymer implants include premature implant 
breakage, delayed implant degradation, superficial wound formation, deep 
infections, effusions, and sinus formations around the implant.282,338 
Biodegradable implants for the knee 
Soft tissues in the knee such as the meniscus and the ACL can be easily injured 
during sports requiring sudden changes of speed or side-to-side motion. Several 
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types of implants including interference screws, arrows, tacks and sutures are 
currently used clinically to repair meniscal tears or to reconstruct the ACL.323,335, 
339-352 
The first biodegradable implants used to repair the meniscus were meniscus 
arrows. Their simple implantation procedure has reduced surgery time and the 
possibility of neurovascular complications, thus becoming an increasingly popular 
clinical treatment modality.346, 347 Early meniscal arrows were made of self-
reinforced 96L/4D PLA, a polymer that was found to be capable of providing 
strength retention for at least six months.349 Ex vivo studies on self-reinforced 
meniscal arrows showed that their biomechanical properties (pullout strength and 
stiffness) were found to be comparable to horizontal suture loops but were 
mechanically inferior to vertical suture loops.340, 347, 348, 353, 354 Despite their 
mechanical inferiority to vertical sutures, meniscal arrows have been shown to 
still provide stable fixation to heal a meniscal tear.355 To improve the pull-out 
strength of the meniscal arrow, a novel arrow made of self-reinforced 80L/20D 
PLA was fabricated and compared to its older counterpart. Mechanical tests 
showed that both arrows exhibited similar stiffness properties, but the new arrow 
showed significantly higher fixation.349 Jones et a/.350, however, have recently 
reported device migration and local soft tissue inflammation in 32% of the 
patients implanted with PDLLA meniscus arrows to treat meniscal tears. 
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Meniscal screws have also been used as a mode to fix meniscal tears. Tsai and 
colleagues341 implanted cannulated PLLA screws in 25 patients with meniscal 
tears. Follow-up interviews were conducted with 18 patients two yrs post-surgery. 
Using modified Tegner and Lysholm scores, rating systems used in knee injury 
evaluations, the authors concluded that the screws were safe and provided 
suitable fixation for meniscal repair applications. A similar study using SR-PLLA 
screws has yielded positive results in patients.344 However, no follow-up 
arthroscopy was performed in both cases to determine if there were any 
morphological changes in the knee joint. A more recent study has shown that 
implanting SR-PLLA meniscal screws in goat menisci resulted in significant 
chondral lesions in all the tested goats.329 In a case report, a patient was treated 
with eight screws to treat a meniscal tear.342 An arthroscopy, 32 months post 
surgery, showed several broken screw fragments near the medial collateral 
ligament but the MW of the screw had dropped only 35.3% in almost three yrs. 
Other groups have also reported delayed degradation of meniscal screws.343, 356 
This delayed degradation of screws is certainly of some concern, and suggests 
that the true degradation time of meniscal screws in vivo is still unknown and 
needs to be further investigated. 
The effectiveness of non-absorbabie sutures in meniscal repair has also been 
compared to that of absorbable sutures.357 Magnetic resonance images of 
menisci from mongrel dogs were obtained and histology was performed one and 
three months post surgery. The authors discovered that the menisci repaired with 
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the absorbable sutures showed significantly greater changes in structure than the 
non-absorbable sutures. This finding suggests perhaps that non-absorbable 
sutures are better suited for meniscal repair than absorbable sutures. 
Metallic interference screws have been commonly used for ACL 
reconstruction.324 However with the advent of biodegradable materials, there has 
been considerable research on a variety of polymeric interference screws. 
Stahelin et al.324 evaluated the biocompatibility and biodegradability of PLLA, 
85/15 PDLLA-co-PGA and PDLLA interference screws for ACL reconstruction in 
six patients. In all cases, there was little to no foreign body reaction to the 
screws. PDLLA screws in patients showed no degradation for the first six wks but 
were completely degraded by 10 months. A second arthroscopy in a patient with 
PLLA screws 20 months post initial surgery showed that the PLLA screw had not 
degraded and there was no sign of any bony ingrowth. Other researchers have 
also reported delayed degradation of PLLA interference screws for ACL and PCL 
reconstruction which caused severe cartilage damage to one patient and 
extreme pain and swelling to another.352, 358, 359 Patients treated with 85/15 
PDLLA-co-PGA showed complete degradation of the screw in one yr and 
presence of bony tissue in the location of the screws.324 On the other hand, 
Lajtai et al.351 reported that 85/15 PDLLA-co-PGA interference screws took five 
yrs to completely degrade in patients. There have also been several reports of 
effusions in patients implanted with PDLLA-co-PGA screws used in ACL 
reconstruction.324, 360 In all cases, however, the effusions disappeared over time 
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after the screws completely degraded. Polyglyconate interference screws have 
also been tested in patients for graft fixation in ACL reconstruction. Complete 
degradation of the screws was observed one yr post surgery without any serious 
complications or osteolysis.335 Benedetto et a/.361, however, reported that about 
19% of the 67 patients implanted with cannulated polyglyconate screws for ACL 
reconstruction developed complications which included effusions (5%), infections 
(2%) and cysts (2%). Thus, current literature suggests that PDLLA interference 
screws may be prime candidates for ACL reconstruction as they completely 
degrade in a yr and have shown low morbidity. 
Although meniscal arrows have traditionally been used to treat vertical, 
longitudinal bucket handle tears of the meniscus, researchers have attempted to 
expand their applicability to other knee related disorders as well. For example, 
self reinforced 96L/4D PLA meniscal arrows were tested in vitro to determine 
their effectiveness in the treatment of osteochondritis dissecans (OD).362 OD is a 
disorder resulting from the separation of a loose piece of bone and cartilage from 
the end of the bone due to a lack of blood supply.363 Pull-out tests of the arrows 
showed a good initial hold in bone and could be potentially used in the treatment 
of OD.362 Tuompo et a/.364 implanted SR-PGA and SR-PLLA rods in 24 patients 
with OD. Patients were analyzed over a 7 yr period and the authors reported 
good clinical and subjective results. In another study by the same group, SR-
PGA rods were implanted in 1879 patients to treat OD. The authors observed a 
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clinical tissue response in 8% of the cases. Complications included effusions 
(5%) and sinus formation (3%) in the knee joint.365 
Biodegradable implants for the shoulder 
The development of biodegradable implants such as suture anchors and tacks 
has provided surgeons with a new arsenal to effectively treat shoulder 
instability.366 Today, these implants are used in rotator cuff repair, shoulder 
reconstruction, biceps anchor lesions and biceps tenodesis.367"369 
Cannulated polyglyconate tacks have been used by several researchers to repair 
Bankart lesions (labral tears in the shoulder) and more recently for rotator cuff 
repair.370"374 Bankart lesions can only be treated by polyglyconate tacks however, 
if the labrum has not completely degenerated, a point that was first noted by 
Resch et a/.371 In their study, 18 patients were treated with the polyglyconate 
tacks. Follow-up at four to 18 months post-surgery showed that almost 80% of 
the patients had regained full motion of their shoulder.371 In another study, 25 
patients with Bankart lesions were treated with polyglyconate tacks. The Rowe 
point score, a clinical rating scale for the shoulder, was utilized as a follow-up test 
to determine whether the surgery was successful. About 95% the patients 
reported good to excellent results and were able to return to normal activity within 
two yrs, confirming that polyglyconate tacks were effective in treating Bankart 
lesions. Burkart et a/.375 reported massive synovitis in shoulders of all patients 
implanted with cannulated polyglyconate tacks. The foreign body reaction was 
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believed to be caused by loose screw fragments that migrated into the joint 
cavity. Other groups have also reported high failure rates•(> 10%) of cannulated 
polyglyconate tacks used to treat anterior shoulder instability.376"378 
Recently a group reported the use of polyglyconate tacks to treat rotator cuff 
injuries.372 Although rotator cuff repairs are usually performed with suture 
anchors, the authors argued that arthroscopic implantation of tacks would 
facilitate the surgery by eliminating the need to ensure proper suture anchor 
placement, suture passing and knot tying. In their experiment, 53 patients were 
implanted with polyglyconate tacks and rated using three different shoulder rating 
systems pre- and post-operatively. All rating systems showed a significant 
improvement in patient pain relief and function after the surgery. Although the 
authors felt confident that tacks could be used successfully for this application, 
the risk of tissue necrosis beneath the head of the implant is high if proper care is 
not taken during the surgical process. 
Several in vivo tests have been conducted comparing the effectiveness of 
biodegradable suture anchors to metallic suture anchors.379, 380 In one study 
comparing biodegradable PDLLA suture anchors with titanium suture anchors in 
goats, no significant difference was observed in the fixation strength over time 
between the two anchors.379 In another study, biodegradable polyglyconate 
suture anchors or non-absorbable implant-grade polyacetyl anchors were 
implanted in humans with Bankart lesions. High Rowe scores were recorded in 
both groups post-surgery indicating that both the degradable and non-degradable 
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suture implants were successful.380 PLLA suture anchors have also been 
successfully implanted in patients undergoing Bankart repair, with high Rowe 
scores reported in follow-up interviews with more than 90% of the patients.381 
These findings suggest that degradable suture anchors are equivalent to metallic 
suture anchors in terms of function and performance. A recent study, however, 
showed that PDLLA suture anchors implanted in shoulder capsules resulted in 
osteolysis in almost 50% of the cases.382 
Future directions 
Recently, a new generation of "smart polymers" is being given considerable 
attention. These polymers have the unique property of changing their shape 
upon application of an external stimulus such as change in temperature or 
lighting. Different materials such as polyurethanes, polynorbornene and 
hydrogels have been shown to exhibit thermal induced shape memory.383 
An application where the smart polymers have been successfully used is in 
wound management. Lendlein and Langer384 described a smart suture system 
that exhibited different mechanical properties with small changes in chemical 
structure. An incision was made into the belly of a euthanized rat. The polymer 
was loosely sutured into the wound site by elongating fibers to 200% strain at a 
controlled stress. When the temperature was raised above the transition for the 
polymer, the fibers shrank forming a tight knot around the wound. Using this 
concept, degradable smart polymers could be placed at the correct position at 
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the implant site through arthroscopy. Increase in temperature would cause the 
material to form the appropriate shape required for that particular application.383 
As biodegradable polymers continue to gain popularity in clinical applications, the 
need to understand the biology and mechanics of the devices in vivo, as well as 
to determine factors that can affect subsequent clinical outcomes, is crucial. With 
an eclectic variety of degradable biomaterials available to clinicians, it can often 
be a challenge to determine the right choice of implant for a particular 
application. For example, suture anchors made from PDLLA, PLLA and 
polyglyconate and tacks made from polyglyconate have all been used 
successfully to treat Bankart lesions in the shoulder.374, 381 Which polymer and 
type of implant should the clinician choose? To address such a problem, 
McFarland et al.367 recently published a review on suture anchors and tacks used 
in shoulder surgery. The group reported a set of 16 questions that clinicians can 
address to account for the multiple variables that could affect the biological and 
biomechanical performance of the biomaterial. Some of the questions posed are 
straightforward, e.g. asking whether the implant is absorbable or not. Others 
address more specific topics, for example a question is asked whether the 
biodegradable implant has been tested in cyclic loading and if so which part of 
the device failed and at what strength. In similar fashion, standardized 
procedures need to be developed for each application to assist clinicians in 
deciding appropriate biomaterials to implant in patients. Only when clinicians can 
confidently address the issue of the ideal polymer for an application in a 
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particular patient will the risk of implant complications decrease dramatically and 
the true effectiveness of biodegradable materials be realized. 
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Table 10. Mechanical properties of polymers 
Polymer 
PGA 
Christel et a/.302 
Tormalaefa/.303 
SR-PGA 
Vainionpaa et a/.305 
Tormala et a/.303 
Vasenius et a/.306 
PLLA 
Engelberg et a/.313 
Haltia era/.319 
Claes322 
PDLLA 
Engelberg et a/.313 
Christel et a/.302 
SR-PLLA 
Casper et a/.326'327 
Haltia et a/.319 
PDLLA-co-PGA 
Nakafuku and 
Takehisa330 
Weiler et a/.323 
Johnson and 
vanDyk332 
Polyglyconate 
Farrarefa/.295 
Weiler et a/.331 
Gerber et a/.337 
Type of 
implant 
Plates 
Rods 
Rods 
Rods 
Screws 
Rods 
Rods 
Plates 
Rods 
Screws 
Screws 
Screws 
Sutures 
Tensile 
strength 
57 MPa 
28-48 MPa 
29-35 MPa 
45.6 MPa 
- 3.2 GPa 
7-8 MPa 
57 MPa 
Flexural 
strength 
90-110 MPa 
370 MPa 
220-405 MPa 
-200 MPa 
89-193 Mpa 
210 MPa 
•) 
Shear 
strength 
205-235 MPa 
250 MPa 
156-255 MPa 
47 MPa 
45 MPa 
143 MPa 
Pull out 
force 
246-737 N 
565 N 
469-914 N 
67 N 
Table 11. Polymer degradation times 
Polymer 
PGA 
Frazzaefa/.304 
SR-PGA 
Peltoniemiefa/.308 
Andrianoefa/.309 
PLLA 
Stahelin ef a/.324 
Willcox et al.342 
PDLLA 
Stahelin ef a/.324 
SR-PLLA 
Peltoniemi et al.308 
PDLLA-co-PGA 
Stahelin et al.324 
Lajtai et a/.351 
Polyglyconate 
Finkefa/.335 
Degradation Time 
4 months 
3 months 
3 months 
> 20 months 
> 32 months 
10-14 months 
2 yrs 
1 yr 
5 yrs 
12 months 
Type of implant 
Sutures 
Screws 
Pins 
Screws 
Screws 
Screws 
Screws 
Screws 
Screws 
Screws 
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Abstract 
The use of degradable polymers for surgery in skeletal repair is becoming 
more frequent. Numerous biocompatible, biodegradable polymers are now 
available for both experimental and clinical use. Despite this, there is a need to 
further develop polymers with a spectrum of mechanical properties especially 
for musculoskeletal applications where loading conditions vary depending on 
location. This chapter reviews some of the prominent biodegradable polymers 
used in medicine today, such as poly-lactic acid, poly-glycolic acid, poly-
caprolactone, polydioxanone, and poly-trimethylene carbonate, and includes 
strategies to improve their mechanical strength through co-polymerization. The 
use of smart polymers, such as energy storing polyesters for skeletal implants, 
is also discussed in addition to state-of-the-art computational modeling 
techniques that might significantly expedite characterization of novel polymers. 
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Introduction 
Historically, metallic implants have been used to treat injuries in load-bearing 
areas of tissues since their high mechanical strength and rigidity allow for the 
healing process to occur in non-collapsed fracture sites. However, concerns 
relating to stress shielding, corrosion, and radiologic imaging have given rise to a 
new generation of biodegradable implants that can resolve the inherent problems 
that metals present.283, 385_388 in addition to being non-toxic and biocompatible, 
the polymer degradation byproducts, in most cases, can be converted to 
naturally occurring compounds and excreted from the body. Further, 
biodegradable polymers can also act as carriers of cells and bioactive agents for 
controlled drug delivery applications. To date, degradable polymers made from 
lactic acid, glycolic acid, and dioxanone, as well as copolymers of these 
materials, are the most commonly studied and are used clinically in fracture 
fixation, bone replacement, articular cartilage and meniscus repair, and ligament 
fixation applications.160-389'397 
Although polymers are successfully used as biodegradable implants, there have 
been a few reports of complications arising as a result of premature implant 
breakage, delayed implant degradation and foreign body reactions to the 
implant.359, 3 9 8 , 3 " To avoid complications resulting from the first two factors, a 
more detailed understanding of the factors influencing the physical and 
mechanical properties of the polymers is required. Two such identified factors are 
the molecular weight (MW) and degree of crystallinity that largely determine the 
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polymer physical properties, such as the glass transition temperature (Tg) and 
melting point (Tm), and polymer mechanical properties, such as stiffness and 
tensile strength. These factors can be controlled during polymer fabrication using 
commercially available techniques like injection molding, extrusion, and 
compression molding.400 
In this chapter, salient biomedical polymers such as poly-lactic acid (PLA), poly-
glycolic acid (PGA), poly-caprolactone (PCL), polydioxanone (PDO), and poly-
trimethylene carbonate (PTMC) are reviewed along with strategies to improve 
their mechanical and degradation properties using self-reinforcement and 
copolymerization. Contributions of smart polymers such as polyhydroxyalkanoate 
(PHA) are also reviewed. In addition, a promising new technology that utilizes 
computer modeling to easily and quickly characterize polymers is discussed. 
Overview of common biodegradable polymers 
Significant advances in materials research have changed the perception of 
degradable polymers and have elevated them to the forefront of surgical fixation 
procedures. The most commonly used biomaterials today are PGA and PLA, first 
approved by the FDA for clinical use as sutures in 1969 and 1971, 
respectively.401, 402 Since then, these polymeric biomaterials and others have 
been fabricated into a variety of fixation devices such as screws, plates and rods 
to be used in a myriad of musculoskeletal applications. A brief overview of the 
most common biopolymers follows. 
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Polyglycolic acid (PGA) 
PGA is the simplest linear aliphatic polyester used as a biodegradable implant 
material. It is a hard, tough, crystalline molecule that is more hydrophobic than its 
counterpart PLA. The crystallinity of PGA may vary from 35 to 75% with a 
molecular weight (MW) ranging from 40 to 210 kDa depending on the fabrication 
technique.299'403 The Tm and Tg for PGA may vary between 185-230 °C and 25-
65 °C, respectively.300,404 PGA exhibits high tensile properties (57-69 MPa), and, 
thus, has been used effectively as a braided suture in rotator cuff repair.294'337 In 
an aqueous environment, PGA has been shown to rapidly degrade in two wks 
and lose about 50% of its mechanical strength.405 
Polylactic acid (PLA) 
PLA is a semi-crystalline asymmetric polymer with two optical isomers. The D-
isomer, PDLA, while readily produced, is not widely used because of its poor 
biological activity. In contrast, the L-isomer, PLLA, is biologically active and, 
thus, used frequently in implant materials. The MW of PLLA can range from 50 to 
300 kDa depending on fabrication technique.313 High MW PLLA (> 100 kDa) has 
a Tm that ranges between 170 to 180 °C and a Tg that ranges between 58-65 
oC 300,404 p L L A e x n i b i t s h i g h t e n s i | e (n.4_82.7 MPa) and flexural (45-145 MPa) 
strength suggesting that it could be suitable for load-bearing applications.294, 313, 
406-408 P L L A implants have been shown to retain their mechanical properties for 
at least six months in vivo, however in some cases complete resorption in the 
joint site can take up to five yrs.324,406,409 
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Polycaprolactone (PCL) 
PCL is a semi-crystalline hydrophobic aliphatic polyester studied for long term 
drug delivery systems and implants. The melting point and glass transition 
temperatures of PCL are unusually low, approximately 58 to 63 °C and -60 to 65 
°C, respectively.404, 410 The tensile strength and elongation of PCL has been 
shown to vary between 21-35 MPa and 300-500%, respectively.404 PCL's slow 
degradation rate (> 2 yrs) makes it an excellent candidate for long-term 
implantable systems, when compared to PGA or PLLA implants.411 
Polydioxanone (PDS) 
PDS is a crystalline polymer (55% crystallinity) with a melting point of 
approximately 115 °C and a glass transition temperature of -10 °C; thus, the 
polymer is usually processed at the lowest possible temperature to prevent 
depolymerization back to monomer.412 In vitro studies have shown that tensile 
strengths of PDS sutures can range from 296-358 MPa, with a percent 
elongation of 43.7-58.1 %.413 An experimental study of PDS implants in rabbits 
showed that the degradation time in vivo ranged from 16 to 25 wks.414,415 
Poly(trimethylene carbonate) (PTMC) 
PTMC is a soft, rubbery polymer that, until recently, had not been considered for 
biomedical applications owing to its tackiness and weak mechanical properties. 
However, recent studies have shown that amorphous PTMC of high MW (~500 
kDa and molecular number > 200,000) exhibits rubber-like properties with a 
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Young's modulus of 6 MPa and a tensile strength of 12-16 MPa.416, 417 The Tm 
and Tg of PTMC can vary from 30 °C to 50 °C and -17 °C to -19 °C, respectively 
depending on the fabrication technique.416 Degradation occurs mostly 
enzymatically and to a lesser extent by hydrolysis since autocatalysis, a 
phenomenon observed in polyesters like PLLA, is absent in PTMC.418 In vivo 
studies in rabbit tibia and femur have shown that high MW PTMC rods (~450 
kDa) degrade rapidly losing about 60% of their mass by the 8th wk.418 
In addition to the above mentioned polymers, numerous other materials have 
been developed and used experimentally in recent yrs, including poly(ortho-
esters),419 poly(3-hydroxybutyrate),420 and poly(3-hydroxybutyrate-co-3-
hydroxyvalerate).421'422 
Challenges in the development of degradable polymers 
For a polymer to function as an efficient skeletal implant, it must exhibit several 
properties, biocompatibility notwithstanding. A polymeric implant should be able 
to withstand the harsh loading environments in vivo early in the healing process. 
At the same time, the implant must provide a suitable anchorage site to cells 
toward integration with the surrounding native tissue. The implant should also be 
expected to gradually degrade over time while transferring the load to healing 
tissues in the surrounding area. These properties are largely influenced by the 
chemical stability of the polymer backbone and the polymer processing technique 
which play a large role in determining the polymers' hydrophilicity, crystallinity, 
312 
melt and glass-transition temperatures, and MW.423"425 In addition, the presence 
of residual monomers or additives can also significantly affect the properties of 
the polymer.424 A polymer scientist working with biodegradable materials must 
evaluate each of these variables and determine the appropriate properties for a 
specific load-bearing skeletal implant. 
The stability of the polymer backbone is an important factor to consider when 
choosing a particular polymeric biomaterial for a load-bearing application. 
Common degradable polymers with ester, anhydride, orthoester and amide 
functional groups have hydrolytically unstable linkages in their backbone, and 
exhibit time-dependent properties resulting in viscoelastic behavior. Polymer 
degradation is accelerated by greater hydrophilicity in the backbone or end 
groups and greater reactivity among hydrolytic groups in the backbone.426' 427 
Thus, the biomaterial of choice must maintain adequate mechanical properties 
over time in an aqueous environment; i.e., not degrade too rapidly or slowly, 
while healing occurs. The mechanical properties of a polymer implant may be 
manipulated by the use of different processing techniques. Some of the current 
techniques to fabricate polymers include extrusion, injection molding, 
compression molding, gel casting, solution casting, solvent casting particulate 
leaching, electrospinning and self-reinforcement.285, 291, 407 The choice of 
technique depends largely on the desired properties and morphology of the final 
product. For instance, the MW of a polymer might be controlled by varying the 
temperature at which the extrusion process takes place.57 Nano-fibrous polymers 
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can be created using electrospinning to enhance cell migration and adhesion on 
a scaffold.428 The strength of a polymer can be increased by self-reinforcement, 
where polymer fibers made from the same material as the desired matrix are 
sintered at high pressures and temperatures.291,429,430 For instance, the flexural 
strength of PGA can be increased from 100 MPa to 400 MPa upon self-
reinforcement.303 Thus, determining a polymer with the appropriate chemical and 
mechanical properties is crucial to the survival and success of an implant in vivo. 
Co-polymers 
In addition to the techniques mentioned above to manipulate the mechanical 
properties of individual polymers, an alternate approach is to chemically 
synthesize two or more different monomers to form a co-polymer. By varying the 
individual amounts of each polymer, the mechanical and degradation properties 
of the copolymer Can be controlled, thereby allowing for greater flexibility in 
choosing an appropriate implant material for a particular application (see Table 
12). A general description of some of the salient copolymers is given below. 
Poly-DL-lactic acid (PDLLA) 
PDLLA is an amorphous copolymer with a random distribution of the two 
enantiomers of PLA (PDLA and PLLA). A combination of PLLA and PDLA serves 
to disrupt the crystallinity of PLLA and accelerate the degradation process. Thus, 
PDLLA has a lower tensile strength (27.6-41.4 MPa), higher elongation (3-10%), 
and quicker degradation time (12-16 months) than PLLA, making it a more 
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attractive option in a load-bearing system requiring shorter fixation times. 404,431, 
432 
Polylactic acid-polyglycolic acid (PLLA-PGA) 
The combination of two distinct polymers, PLLA and PGA offers to extend the 
range of mechanical properties not provided individually by either homopolymer. 
Experiments have shown that a non-linear relationship exists between the 
copolymer composition and the mechanical and degradation properties of the 
individual homopolymers. For instance, a copolymer implant of 50% PGA and 
50% PLLA degrades faster than either homopolymer. Copolymers of PLLA with 
25 to 70% PGA are amorphous due to the disruption of the regularity of the 
polymer chain by the other monomer.311,433 A copolymer of 90% PGA and 10% 
PLLA, developed as an absorbable suture material, degrades within three to four 
months but has a slightly longer strength-retention time.434 
Poly-L-lactic acid-hydroxyapatite (PLLA-HA) 
HA, an inorganic component of bone, has been shown to facilitate and promote 
bone formation.435 HA is highly brittle and exhibits low fracture toughness upon 
mechanical loading. To overcome this issue, researchers have combined HA and 
degradable polymers (e.g., PLLA) using techniques such as electrospinning to 
produce more robust scaffolds that can aid in bone regeneration.435 The 
crystallinity of PLLA-HA can be increased by increasing the HA content in the co-
polymer. Accordingly, the mechanical properties of the PLLA/HA composites vary 
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with HA content with increased levels of HA resulting in increased bending 
modulus from 2 to 7.4 GPa and strength from approximately 3 to 114 MPa.436 
Poly-L-lactide-p-tricalcium phosphate (PLLA-TCP) 
p-TCP is a ceramic with osteoconductive properties that degrades via hydrolysis 
into phosphate and calcium ions.437 Similar to HA, TCP is brittle and exhibits low 
fracture toughness. Thus, the addition of p-TCP to PLLA creates a mechanically 
superior osteoconductive and biocompatible material that facilitates bone healing 
and regeneration. The Young's modulus and yield strength of PLLA-TCP 
scaffolds have been shown to be about 22 MPa and 1.5 MPa, respectively.438 
Future of biodegradable polymer implants 
The market for biodegradable orthopedic implants in the US and Europe 
exceeded over 250 million in revenues in 2006 with growth rates expected to 
increase further.439 2006 As the popularity of biodegradable implants continues to 
grow, researchers are looking to develop novel low cost smart polymers that can 
complement the polymers already in use. An excellent example of this is the 
synthesis of energy-storing aliphatic polyesters, such as polyhydroxyalkanoates 
(PHA), by microorganisms. Two PHA materials, polyhydroxybutyrate (PHB) and 
polyhydroxyvalerate (PHV) have been researched extensively in the field of 
biodegradable plastics.440'442 More recently, PHB has been studied for use in 
drug delivery systems, artificial skin grafts and as bioabsorbable sutures.443 The 
sutures produced by recombinant DNA technology are FDA approved.444 The 
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PHB homopolymer is highly crystalline (~80%) and brittle, and its major 
degradation byproduct, hydroxybutyric acid, is found naturally in human blood. 
The Tm of PHB is around 177 °C, with a recorded tensile and flexural strength of 
40 MPa and 3.5 GPa, respectively.440 The brittleness of the polymer can be 
overcome by copolymerizing it with PHV (80:20 PHB-PHV) to reduce the 
crystallinity to 35% and increase failure strain from 8 to 50%.440,445"447 
The advent of video assisted minimally invasive surgery has resulted in less pain 
for patients, reduced scarring and tissue injury, shortened hospital time and 
increased accuracy of the procedure. The major disadvantage with the 
technique, however, is that the smaller work area for the surgeon may increase 
the challenge in implanting a larger implant or knotting a suture. Groundbreaking 
research in material science has allowed for the development of degradable 
elastic shape memory polymers that can take a certain shape upon thermal or 
light induction.384, 448 These polymers may be introduced into the body in a 
compressed form prior to application of the appropriate stimulus to regain the 
desired shape. Several different biodegradable polymers are currently 
investigated for their potential as shape memory polymers including PLLA-co-
PCL (PCLA), PDLLA/hydroxyapatite composites, 82:18 PLA-PGA, tert-butyl 
acrylate (tBA)/poly ethylene glycol dimethacrylate (PEGDMA), and copolyester-
urethane networks.449"452 
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Advances in computational modeling techniques utilizing high throughput 
screening may now eliminate the need for detailed characterization of individual 
polymers. The traditional mode of materials design begins with the synthesis of a 
new material, followed by its characterization, and eventual identification of a 
suitable application. The goal of the computational approach is to accurately 
predict the behavior of polymers under different conditions and create virtual 
biomaterial libraries containing thousands of individual compositions.453 Using 
these libraries, prediction of material characteristics such as elastic modulus, 
glass transition temperature, hydrophobicity and degradation time will be 
facilitated.453, 454 Several design factors can be controlled to ensure that the 
implants will survive in the host and provide appropriate fixation. These include 
shape, type of implant-abutment mating, presence of threads, thread design, 
surface topography and chemical composition of the material.455, 456 In addition, 
customized implants can now be created directly from computer data by using 
solid freeform fabrication 457"460 and combinatorial polymer scaffold libraries.461 
Solid freeform fabrication is a technique that allows for the three dimensional 
printing of custom designed objects created using a CAD drawing. The 
uniqueness of this technique stems from the ability to add and bond materials in 
layers. This provides the user with precision control and the option to create an 
object with multiple materials. Combinatorial polymer scaffold libraries provide 
the user with a tool to determine the appropriate cell-scaffold variations that are 
most likely to increase tissue formation on the construct for tissue engineering 
applications. With a plethora of biomaterials currently being researched for tissue 
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engineering of load bearing tissues, such as articular cartilage and the knee 
meniscus, a predictive tool such as this could be used to screen cell-polymer 
combinations to streamline the tissue engineering process. 
Conclusion 
We can speculate that advancements in polymer science will continue to fuel the 
development of novel biocompatible polymeric implants, with or without the 
incorporation of bioactive agents, toward fixation as well as healing and repair of 
the injured tissue. Using techniques such as copolymerization and self-
reinforcement, implant tensile, flexural and shear strengths, crystallinity, and in 
vivo degradation profiles can be controlled. In addition, computational modeling 
techniques can now be used to predict polymer properties prior to implantation. 
Finally, novel biodegradable elastic smart polymers, that can change shape by 
triggering changes in the immediate environment, may potentially be used in 
minimally invasive surgeries as fixation devices. 
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Figures associated with appendix B 
Table 12. Some FDA approved polymers and their mechanical 
contributions in a co-polymer system 
Polymer 
PLLA 
PDLA 
PGA 
TMC 
Major properties 
Hydrophobic 
Slow degradation 
Disrupts crystallinity 
Hydrophilic 
Quick degradation 
Subzero glass transition 
temperature 
Rubbery at room 
temperature 
Contribution to 
implants 
Provides strength 
Provides flexibility 
Lowers stiffness 
Improves degradation 
rate 
Enhances malleability 
and toughness 
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Appendix C: A biomechanical survey of salient 
biodegradable ACL interference screws 
Najmuddin J. Gunja and Kyriacos A. Athanasiou 
Chapter accepted as: Gunja NJ and Athanasiou KA. A biomechanical survey of 
salient biodegradable ACL interference screws. In: The Anterior Cruciate 
Ligament: Reconstruction and Basic Science. Prodromos, C: P. M. Gordon 
Associates, 2008 
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Introduction 
Anterior cruciate ligaments are composed of fascicles of dense collagenous 
tissue that function primarily to stabilize the knee joint by preventing the femur 
and tibia from sliding onto each other.462 The ACL is exposed to a variety of axial 
and tensile forces in vivo resulting from its complex ultrastructure and positioning 
in the knee joint. Biomechanical characterization of the ACL, conducted in 
humans, has shown that the ultimate tensile load and linear stiffness of the 
human femur-ACL-tibia complex vary depending on age. In younger cadaveric 
knees (20 - 35 yrs), the ultimate tensile load and stiffness have been shown to be 
2160 N ± 157 N and 242 N ± 28 N/mm, respectively, while in older cadaveric 
knee (60 - 97 yrs) the force and stiffness are lower, 658 N ±129 N and 180 N ± 
25 N, respectively.463 
Today, the ACL is the most commonly studied ligament in the knee joint as a 
result of its high incidence of injury.464 Large mechanical forces caused by 
sudden twisting movements can result in ACL tears. Several different 
approaches are investigated to treat ACL injuries including the use of autograft 
and allograft tissue to replace the torn ACL and more recently tissue engineering 
strategies are also being considered.465 Patellar tendon and hamstring muscle 
tendon autografts and allografts, however, remain the gold standard with over a 
90% success rate in restoring function and stabilizing the knee joint.466, 467 To 
achieve effective fixation of these replacements, several different devices have 
been tested including buttons, washers, cross-pins, sutures, staples, and 
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interference screws.468 The following chapter reviews the material and 
biomechanical properties of the most common class of fixation devices used in 
ACL reconstruction, i.e., ACL interference screws.469 
The past few decades have seen a gradual shift toward the use of biodegradable 
polymeric implants at the expense of metallic implants, especially for soft tissue 
applications. This trend is expected to continue, as novel polymers are 
developed with a wide range of mechanical properties that can be modulated to 
prevent stress shielding mismatches observed with metals. In addition, 
biodegradable devices do not interfere with imaging techniques, do not need to 
be removed for revision surgery, and rarely illicit a foreign body response.57 
Today, over 40 different polymer formulations are used in different applications 
ranging from ligament reconstruction to tissue regeneration.57 For ACL 
reconstruction in particular, the vast majority of the fixation implants are variants 
of poly-lactic acid (PLA) or copolymers of PLA and poly-glycolic acid (PGA). To 
enhance bone regeneration as the screw degrades, several different 
osteoconductive materials are currently being investigated such as tri-methylene 
carbonate (TMC), calcium carbonate (CC), (3-tricalcium phosphate ((3-TCP), 
hydroxyapatite (HA), and biphasic calcium phosphate (BCP) in conjunction with 
the base polymer.437'470"472 
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Mechanical strength, degradation and pH 
The mechanical strength of a polymer is dependent on several different factors 
including molecular weight (MW), degree of crystallinity and choice of fabrication 
technique. The MW of the polymer can be altered by changes in mechanical 
stress, temperature and pressure. Polymeric fixation devices in vivo must be 
designed to account for these changes, since drops in MW can significantly 
decrease the mechanical properties of the implant and jeopardize fixation.296 The 
degree of crystallinity, i.e., percentage of the polymer that is represented by an 
ordered structure, is dependent on the molecular chain structure and molecular 
chemistry of the polymer. Polymers never exhibit 100% crystallinity and, usually, 
the greater the crystallinity of the polymer, the greater are its stiffness and 
density. Polymers can range from amorphous to highly crystalline depending on 
the temperature and cooling rates utilized during the fabrication process.286 A 
variety of fabrication techniques, including solution casting, solvent-casting 
particulate leaching, gas saturation, phase separation, extrusion and injection 
molding, can be utilized to generate polymers with specific properties.287 For 
example, poly-l-lactic acid (PLLA) fibers of high MW (300 - 500 kDa) can be 
extruded at 110°C while PLLA fibers of low MW (< 300 kDa) can be extruded at 
180°C.287 
The mechanical strength of a polymer can be characterized using stress-strain 
curves to obtain tensile properties including the ultimate tensile strength (UTS), 
yield strength, and the elastic modulus or stiffness. Flexural and torsional 
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strengths can also be determined to examine the ability of polymers to resist 
bending. Cyclic loading to determine fatigue behavior of the polymer can also be 
conducted.57 
Degradation of PGA and PLLA molecules via ester hydrolysis results in the 
formation of acidic byproducts, glycolic acid and lactic acid, respectively.296 
These acids enter the Krebs cycle where they are broken down into water and 
carbon dioxide prior to excretion/Materials composed of PGA and PLLA undergo 
bulk degradation which results in loss of MW when placed in an aqueous 
solution. However, the mass of the polymer remains until molecular chains are 
small enough to diffuse out of the polymer matrix. This phenomenon leads to 
accelerated degradation of the polymer that occurs suddenly wks or months 
post-surgery, resulting in an acidic environment with non-physiologic pH levels. 
To overcome this problem, researchers have used calcium compounds, such as 
calcium carbonate, and calcium hydroxyapatite to act as a buffer for the 
degrading acidic byproducts.132 Thus, a variety of factors can influence the fate of 
an implant in vivo. In general, a successful implant must be able to withstand 
high stresses early in the process and degrade gradually while healing occurs. 
Biodegradable materials for ACL interference screws 
A variety of biodegradable interference screws are currently produced by several 
companies with varying mechanical and chemical characteristics. Some of the 
major biodegradable polymers and compounds used to manufacture ACL screws 
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include PLLA, PGA, poly-lactide carbonate (PLC), poly-dl-lactic acid (PDLLA), p-
TCP, TMC, HA, BCP and their combinations (Table 13 and Table 14). The 
following paragraphs describe in vitro or in vivo experiments conducted to 
characterize the mechanical and chemical properties of interference screws. Also 
discussed are clinical studies in patients along with any observed complications: 
Poly-L-lactic acid (PLLA) 
PLLA, an enantiomer of PLA, is the most commonly used biodegradable polymer 
in ACL fixation. Its degradation by-product yields a naturally occurring 
stereoisomer of lactic acid which can be eliminated from the body via the Krebs 
cycle.310 The MW of PLLA can vary depending on manufacturing technique; high 
MW PLLA (>100 kDa) has a melting temperature ranging from 173°C to 178°C 
with a glass transition temperature of 58°C.300 Although PLLA is generally semi-
crystalline, injection molding of PLLA results in non-crystalline products, leading 
to a biomaterial whose modulus drops above the glass transition temperature.473 
To increase the mechanical properties of PLLA, a technique called self-
reinforcement can be used where fibers of the desired polymer, made from the 
same material as the polymer matrix, are sintered together at high pressures and 
temperatures.291 Several studies in the literature have examined the degradation 
profiles and foreign body responses associated with PLLA in vivo. It has been 
shown that PLLA interference screws implanted in patients persisted 20 to 30 
months after surgery with little to no foreign body response observed.324' 474 
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However, in some cases cartilage damage and effusions around the knee joint 
have been observed with delayed PLLA degradation.352,358,359 
The mechanical properties of PLLA interference screws have been extensively 
characterized by performing load to failure experiments and pull-out tests with a 
range of properties obtained depending on the material characteristics of the 
product and the testing protocol used. The fixation strength of PLLA interference 
screws (Arthrex, Inc.) have been compared to titanium (Ti) interference screws 
using bone-patellar tendon bone (BPTB) grafts. No significant differences were 
observed between the ultimate failure loads of the PLLA (680 to 995 N; average 
805.2 N) and Ti screws (544 to 1094 N; average 768.6 N).475 Delta tapered bio-
interference screws® (Arthrex, Inc., non-crystalline PLLA) have been 
mechanically tested for quadruple hamstring tendon graft fixation post-dynamic 
loading. The authors found that the interference screws failed at 647 ± 200 N 
with a displacement at failure of 10.91 ± 4.4 mm. In addition the stiffness of the 
screws was calculated to be 64.54 ± 22.1 N/mm.476 Biomechanical properties of 
the RetroScrew® (Arthrex, Inc., PLLA) for tibialis anterior graft-tibial tunnel 
fixation have also been obtained. During cyclic testing (more information), a 
screw displacement of 1.8 ± 0.5 mm was observed with a stiffness of 114.1 ± 
23.3 N/mm. When load-to-failure tests were conducted, the maximum load at 
failure was found to be 787 ± 177.5 N with a pullout displacement of 5.3 ± 2 mm 
and a pullout stiffness of 204.4 ± 52.9.477 Additional research conducted by 
Arthrex, Inc with the RetroScrew® suggested that screw placement during 
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fixation of whipstitched human anterior tibialis bundles in a porcine model 
significantly affected the pull-out stiffness of the screws.478 
A study using BioScrew® interference screws (Conmed Linvatec, PLLA) in 
cadavers for fixation of BPTB grafts showed that the mean load to failure was 
418 ±118 N.479 Fixation strength of fibrillated Biofix® screws (Bioscience, Ltd., 
SR-PLLA) in a BPTB graft was found to be 1211 ± 362 N with an elastic modulus 
of 189 ± 47.4 in the lower load range (< 500 N) and 304 ± 7.1.8 in the higher load 
range (> 500 N).480 These values were not significantly different from two other 
metallic screws that the authors investigated. BIQRCI® interference screws 
(Smith & Nephew, PLLA) have been mechanically evaluated for femoral fixation 
of soft tissue grafts. The UTS of the screws was found to be 643.5 ± 148.4 N with 
a stiffness of 315.7 ± 38.9 N/mm.481 Universal wedge interference screws® 
(Stryker Endoscopy, PLLA) have been tested for hamstring ACL reconstruction 
at the central and peripheral locations on the tibia. Screws placed in the central 
location were found to be significantly stiffer, with a greater yield load and UTS 
suggesting that central interference screw fixation may allow greater confidence 
in rehabilitation and reduce the risk of failure in wVo.482 Absolute interference 
screws® (DePuy Mitek, Inc., PLLA) have been compared to RigidFix® 
biodegradable pins (Ethicon, Inc.) for BPTB graft fixation strengths in bovine 
knees. The authors found that the interference screw stiffness was 168 ± 42 
N/mm, with yield strength of 402.7 ± 143.9 N and UTS of 515.7 ±168.5 N. In 
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addition, it was found that the use of two pins provided the same mechanical 
stability as one interference screw.483 
Poly-DL-lactic acid (PDLLA) and co-polymers of PDLLA, PLLA and PGA 
Copolymers of the two enantiomers of PLA, PLLA and poly-d-lactic acid (PDLA), 
result in PDLLA which can exhibit a variety of mechanical properties depending 
on the percentage of each enantiomer present.311, 312 PDLLA is typically 
amorphous with a glass transition temperature of 56°C.484 In vivo, PDLLA 
interference screws have been shown to survive at least 6 wks without 
degradation, but are known to resorb completely by 10 months.324 Copolymers of 
PDLLA, PGA and PLLA offer to extend the range of mechanical properties not 
offered by either material individually. For example, the glass transition 
temperature of a 50:50 PDLLA-PGA blend is around 30°C. As the ratio of 
PDLLAPGA increases from 65:35 to 75:25, the glass transition temperature 
increases as well from 33.5°C to 38°C.330 Combining PLLA and PGA in an 82:18 
ratio (Lactosorb®, Biomet Sports Medicine, Inc.) can result in a non-crystalline 
co-polymer with a Tg of 55.3°C. It has been shown that a 2°C rise in temperature 
can dramatically increase the hydrolysis rate of Lactosorb® by 20-25%.485 
Phusiline® interference screws (Phusis, 98/2 PDLLA-PLLA), have been used for 
fixation of patellar tendon autografts in patients. Results at an average follow up 
time of 2 yrs showed that the screws had degraded with observable bony-
ingrowth observed, earlier than what is generally observed with PLLA screws. 
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Clinical tests and MRI examinations showed no adverse effects as a result of 
screw degradation.396 The most common PDLLA polymerization technique 
involves tin octoate as an initiator; however, to reduce any potential immune 
response, Phusiline® screws are polymerized using ring opening polymerization 
in the presence of zinc, a less toxic material.486 Ring opening polymerization is a 
technique where cyclic monomers join to form a large polymer chain through 
ionic interactions. This results in more hydrophilic interference screws with 
quicker degradation rates.396 
Sysorb® screws (Centerpulse Medical AG, 50/50 PDLLA) have been used for 
BPTB graft fixation in 25 patients. In only case, tibial bone enlargement and a 
subcutaneous cyst was observed eight months post-surgery with no bone 
formation in the tibial tunnel.487 Biologically quiet interference screws® 
(Instrument Makar, Inc., 85/15 PDLLA/PGA) have been used for ACL 
reconstruction in patients with complete degradation, bone remodeling and neo-
bone formation observed at the implantation site at an average of 5.2 yrs post 
surgery. In addition, MRI images showed no cystic or osteolytic changes at the 
site with minimal edema.351 
Mechanical testing with Sysorb® screws for BPTB graft fixation in human 
cadavers showed that the load to failure was 544 ± 109 N with stiffness 
162 ±27 N/mm. Cyclic elongation tests showed that at three cycles, 1-5, 5-20 
and 20-1500, the observed elongation was 1.4 ±0.5 mm, 0.14 ± 0.06 mm and 
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4.1 ± 2.7 mm respectively.488 SmartScrew® interference screws (Conmed 
Linvatec, SR 96/4 PDLLA) have been examined for human semitendinosus-
gracilis tendon graft fixation. Single cycle to load failure tests and cyclic loading 
tests were conducted. The yield load for the single cycle test was found to be 665 
± 201 N while the stiffness was 115 ± 34 N/mm. For the cyclic loading test, a 
residual displacement of 3.8 ± 1.5 mm was observed at 1500 cycles.489 
MegaFix® interference screws (Karl Storz - Endoscope, 70/30 PDLLA) of three 
different screw diameters 6 mm, 7 mm and 8 mm were mechanically evaluated in 
porcine knees. The results showed that zero 6 mm screws, three 7 mm screws 
and all 8 mm screws survived the cyclic loading protocol. An elongation of 8.36 
±0.5 mm was observed in the 7 mm screws and 4.26 ± 1.5 mm in the 8 mm 
screws after 1000 loading cycles. Maximum load, yield load and stiffness were 
also determined for the 7 mm (245.4 ±76.5 N, 199.1 ±37.2 N and 98.6 ±20.2 N) 
and 8 mm screws (567.7 ± 177.0 N, 465.9 ± 126.3 N and 151.0 ± 26.4 N).490 
Polymers with trimethylene carbonate (TMC) 
TMC is a mechanically weak material with elastic properties resembling 
rubber.491 In combination with polymers such as PGA, PLLA and PDLLA, 
however, a range of biomechanical properties can be obtained to suit a particular 
application. For example, polyglyconate is an A-B-A block copolymer of PGA and 
TMC in a 2:1 ratio. The letters A and B represent homopolymer sub-units that are 
linked by a covalent bond. The copolymer provides better flexibility than PGA 
alone. In vitro tests have shown that the MW of non-irradiated polyglyconate, 
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cultured in PBS, drops from 124.1 kDa to 18.6 kDa over a period of 31 days. 
Additionally, UTS of the samples dropped from 51.7 MPa to 5.7 MPa over 3 
wks.295 In vivo, polyglyconate implants have been shown to lose their mechanical 
integrity over 6 wks but usually take about 6-12 months to resorb.295,334,335 
An in vivo study was carried out in 20 patients comparing Ti screws and 
Endofix® absorbable interference screws (Smith & Nephew, PGA-TMC) for 
femoral bone block fixation. Clinical assessments and computer tomography 
scans were conducted at 3, 6, 12 and 24 months. No complications were 
observed with the graft fixation in either group. At 12 months, complete screw 
degradation was observed; however, neo-bone formation was not observed with 
the polyglyconate screws up to three yrs post-surgery.335 Inion Hexalon® ACL 
screws (Inion Ltd., PDLLA-TMC) have been shown to retain 70-90% of their 
initial strength for up to 12 wks, with observable degradation from 18-36 wks and 
complete screw degradation within 2 yrs.471,492,493 MRI imaging at 2 yrs showed 
that the bone tunnels post-screw degradation were filled with fibrous-like tissue; 
however, the authors could not conclude the exact tissue type since histological 
sections were not taken. Complications occurred in only two out of 29 patients 
tested with tunnel enlargement or cyst observable 2 yrs post surgery.471 
The mechanical properties of Inion Hexalon® screws have been characterized 
using mature porcine cadaver tibiae (please refer to Chapter 52). add reference 
The initial fixation strength of the Inion Hexalon® interference screws were 
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measured in three separate experiments by comparing to 1) metal interference 
screw (via soft tissue graft fixation) 2) SR-PDLLA SmartScrew® (Conmed 
Linvatec) (via soft tissue graft fixation) 3) PLLA BioScrew® (Conmed Linvatec) 
(via bone-tendon-bone graft fixation). The yield loads for the Inion Hexalon® in 
each experiment were found to be 491 ± 154 N, 501 ± 122 N and 901 + 262 N, 
respectively while the maximum failure loads were 548 ± 130 N, 563 ± 109 N and 
926 ±259 N, respectively.471 The authors found fixation strengths of the Inion 
Hexalon® to be similar to the other tested metallic and polymer screws. In a 
previous study, torsional strength of the Inion Hexalon® was also characterized 
using a previously established protocol.494 Briefly, screws were mounted in a 
polyurethane resin to mimic screw failure observed in vivo. The mean maximum 
insertion torque was found to be 2.4 ± 0.3 Nm. Additionally screw failure was not 
observed up to 5 Nm. Higher clinically irrelevant torques (> 5 Nm) did not cause 
screw breakage but resulted in bending of the metallic screw driver shaft.471 
Based on these results, the authors concluded that the Inion Hexalon® screws 
equaled or surpassed other commercially available screws in torsional 
strength.494 
Polymers with calcium carbonate (CC) 
CC is an inorganic component of bone that can be used to form other calcium 
salts found in bone. When combined with other polymers, an osteoconductive 
interface is achieved with enhanced screw degradation properties and quickened 
neo-bone regeneration.495 Calcium salts have also been shown to provide a pH 
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buffer for the acidic products released during polymer degradation.132 An 
example of this blend is the Calaxo® interference screw (Smith & Nephew), 
which is a polylactide carbonate (PLC) composed of 85:15 PDLLA-co-PGA 
(65%) and calcium carbonate (35%). 
A recent in vitro study investigating the MW and pH of Calaxo® screws in PBS 
(pH = 7.36) over 12 wks found an 83.5% drop in MW of Calaxo® with a drop in 
pH to 6.86.496 The authors noted that the rapid degradation of the screw possibly 
overwhelmed the buffering effect of calcium carbonate. The Calaxo® screw has 
also been tested in 41 sheep for ACL fixation. No inflammatory reactions were 
observed at 6, 12, 26 or 52 wks. At t = 26 wks, the screw was partially replaced 
with new bone and at t = 52 wks, complete screw degradation had occurred with 
total bone replacement. Ultimate tensile loads to failure at 6 and 12 wks were 
approximately 70 N and 225 N, respectively.495 In humans, one case report 
highlighted the presence of tibial cysts and intra-articular granuloma formations in 
a patient implanted with Calaxo® screws 6 months post-surgery.497 According to 
a recent review, "a vast number of Calaxo® screws have been implanted without 
incident"; however, the complication described in the case report was "not unique 
in human subjects" prompting product withdrawal from the market by the 
manufacturer.498 
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Polymers with P-tricalcium phosphate (P-TCP) 
Several companies manufacture screws with PLLA, PLGA or PDLLA as the base 
polymer and P-TCP as the osteoconductive material. p-TCP is a brittle ceramic 
with low fracture toughness, meaning cracks in the material have low ability to 
resist fracture. It exhibits osteoconductive properties and degrades via hydrolysis 
into phosphate and calcium ions.437 The addition of P-TCP into PLLA screws, 
results in enhanced mechanical properties and faster degradation, which quicken 
bone healing and regeneration. PLGA, which degrades faster than PLLA, in 
conjunction with P-TCP may provide an optimized degradation profile in addition 
to osteoconductive properties due to TCP. A description of the salient P-TCP 
based screws follows. 
Bio-lntrafix® system (DePuy Mitek, Inc., 30% p-TCP - 70% PLLA) consists of 
two bio-absorbable components, the expansion sheath and the tapered screw. 
The components are manufactured using Micro Particle Dispersion, a proprietary 
technology of DePuy Mitek, Inc., which allows for a homogeneous blend between 
PLLA and P-TCP.499 A study investigating the Bio-lntrafix® system in patients 
showed no complications in patients 2 yrs post surgery. Additionally, a pull-out 
strength of approximately 1067 N was determined for the system.500 
The Milagro® interference screw (DePuy Mitek, Inc., 30% p-TCP - 70% PLGA) 
is composed of Depuy Mitek's proprietary composite material Biocryl Rapide®, a 
homogeneous blend of PLGA and TCP particles. Pre-clinical in vivo studies in 
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beagles have shown that Biocryl Rapide® degrades completely when placed in a 
defect in cortical femoral bone and is replaced by new bone by 24 months.501 A 
recent in vitro study investigating the effects of PBS (pH = 7.36) on Milagro® 
screws showed that minor dimensional changes occurred to the screws 12 wks 
post-culture.496 MW was found to drop by 66.9% in that time period; however, the 
pH stayed relatively constant (pH = 7.34 at 6 and 12 wks) suggesting that P-TCP 
successfully created a buffering effect to acidic degradation products released as 
a result of screw breakdown.132 Milagro® screws have also been used to study 
tibial bone-tunnel enlargements during double-bundle ACL reconstruction in 
patients. Tibial fixation in 25 patients was achieved with two Milagro® screws and 
MRI images and radiographs were obtained approximately 1 yr post-surgery. A 
mean tunnel enlargement of 43% was observed in the tibia. The authors, 
however, did not provide details on the degradation profiles of the implanted 
screws.502 Another study in 70 patients, comparing single bundle and double 
bundle ACL reconstruction, utilized Milagro® screws for tibial fixation. However, 
radiographs taken an average of 19 months post-surgery in patients could not 
reliably detect the interference screws and sizes of bone tunnels. Two patients 
were treated with antibiotics for infections post-surgery and in two patients 
cyclops lesions were debrided using arthroscopy. The authors did not, however, 
attribute a possible cause for these complications.503 Another interference screw, 
Biocryl®, manufactured by Mitek utilizing PLLA instead of PLGA, (30% p-TCP-
70% PLLA) was studied in mature sheep and was shown to yield superior bone 
to tissue osseo-integration when compared to an HA-PLLA composite screw.504 
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Bilok® interference screws (ArthroCare Corporation, 25% (3-TCP- 75% non 
crystalline PLLA) have been tested in vitro for their degradation properties over 
12 wks in PBS (pH = 7.36). At t = 12 wks, minor morphological changes were 
observed with a 44.7% decrease in MW. The pH of solution was also found to be 
in the physiologic range (pH = 7.28 at 12 wks).496 A study in 41 patients, 
investigating the clinical effectiveness of Bilok® interference screws for patellar 
tendon autograft ACL fixations, showed that 3 yrs post-operatively the screws 
were completely replaced by bone with no observable osteolysis. A quicker 
degradation rate of Bilok® interference screws was observed when compared to 
degradation rates of PLLA interference screws.505, 506 In another study involving 
patellar tendon graft ACL fixation in 20 patients, Bilok® interference screws did 
not degrade completely 24 months after implantation.507 In a few cases, fracture 
of Bilok® interference screws has been observed during insertion into the tibial or 
femoral tunnel.505, 507, 508 However, in each study, the authors modified their 
technique of screw insertion to resolve the problem. 
Polymers with hydroxyapatite (HA) 
HA is an inorganic Component of bone which has high biocompatibility and bio-
affinity and has been used extensively in the past for bone regeneration.470 In 
addition, HA also acts as a buffer to the acidic byproducts of PLLA during 
degradation.132 Similar to (3-TCP, HA exhibits low fracture toughness upon 
loading and is highly brittle. The elastic modulus of HA can range from 80-100 
GPa with a compressive strength of 500-1000 MPa.509 When blended with PLLA, 
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the composite's mechanical properties can be substantially altered to mimic 
those of bone.435 In addition, HA also promotes bone regeneration by increasing 
osteoblast attachment and proliferation on the composites.510 
Biosteon® (Stryker, HA-PLLA) interference screws are composites of non-
crystalline PLLA and HA. In vitro studies on Biosteon® screws cultured in PBS 
(pH = 7.36) showed that no significant gross changes occurred to the screws 
over a period of 12 wks. In addition, the MW of the screws dropped by 22.9% 
with a minimal drop in pH from 7.36 to 7.32.496 Experiments by Stryker, 
comparing PLLA and Biosteon® screws have shown that the latter exhibited 
superior strength retention in vivo over 24 wks and mimicked the body's natural 
healing response. In addition, the modulus of Biosteon® implants was shown to 
be similar to that of bone circumventing the issue of possible stress shielding 
resulting in bone density reduction.511 BIORCI-HA® interference screws (Smith & 
Nephew, HA-PLLA) were used for patellar tendon graft fixation in 20 patients. 
Two yrs post-operatively, no inflammation was visible via MRI around the graft in 
patients; however, screw degradation was minimal with little observable bone 
integration. In one patient, screw breakage was observed during insertion.507 
Polymers with biphasic calcium phosphate (BCP) 
Biphasic calcium phosphate consists of a mixture of HA and (3-TCP in varying 
ratios.512 HA and |3-TCP are known osteoconductive materials and their 
combination has been shown to increase osteoblast adhesion and proliferation 
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over each individual material, as described on the Arthrex, Inc. website. By 
determining the appropriate ratios leading to a more stable phase of HA and a 
more soluble P-TCP, researchers have been able to achieve controlled 
degradation and promote osteogenesis.472, 512 Combining polymers such as 
PDLLA with BCP serves to improve the mechanical properties of the composite 
material. BioComposite interference screws (Arthrex Inc., 70/30 PDLLA-BCP) are 
manufactured by blending and binding the two materials together to form a 
homogeneous porous implant. The macro and micro-pores in the screws aid in 
promoting bone cell adhesion and proliferation. To maximize the insertion torque 
and prevent screw breakage during insertion, a stepped-taper design is 
employed. 
Conclusions and future directions 
Biodegradable polymeric interference screws are now commonly used in surgery 
in lieu of metallic interference screws. Several studies comparing the two have 
found that metals provide no significant mechanical advantage over their 
polymeric counterparts.513"516 In fact, metallic screws release metal ions into the 
joint space, cause stress shielding which lowers bone density and contraindicate 
imaging applications such as MRI.57 Screws made out of aliphatic polyesters, 
such as polylactides and polyglycolides, overcome these inherent problems that 
metals present; however, the majority of studies in humans have shown that 
these polymers are susceptible to delayed degradation in vivo and the absence 
of neo-bone formation post screw degradation.358, 359, 487 The inclusion of 
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osteoinductive materials, such as HA, CC, TMC, (3-TCP, and BCP, along with 
the base polymer appears to quicken screw degradation, enhance osseous 
screw replacement and result in few complications.471'502,505 
Other osteoconductive agents such as growth factors (TGF-(3 and IGF), and 
bone morphogenic proteins (BMP I-7), have also shown potential in enhancing 
bone formation.517 By incorporating these agents into the polymer matrix during 
the fabrication process, the interference screw could serve a dual role of fixation 
device and drug delivery vehicle. As screws degrade in vivo, the bioactive agents 
released into the surrounding area could aid in neo-bone formation. Injectable 
osteoconductive agents may also be used to enhance and accelerate bone 
growth and healing post ACL reconstruction. For example, calcium phosphate 
cement has been used in a rabbit model to augment tendon-bone healing.518,519 
A recent study in dogs using injectable TCP to fill tunnel parts that were not filled 
by the graft showed greater tendon-bone adherence and superior pullout 
strength 12 wks post surgery when compared to the controls.520 
Xenogenic implants have been used in the past for various bone-graft sites with 
varying clinical success.521 Regeneration Technologies Inc. has developed a 
novel bovine interference screw (Sterling® interference screw) which consists of 
decellularized cortical bone to prevent immune responses while still maintaining 
the bone's mechanical properties. Similar to osteoconductive agents discussed 
previously, the goal of this product is to increase bone regeneration at the 
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implant site. Tests conducted by Regeneration Technologies Inc. have shown 
that the/pull-out strengths of this screw (538 ± 268 N) were on par with that of 
metallic and biodegradable screws tested by other groups in the literature.331,513, 
522
 In addition, a study with 17 patients showed no inflammatory responses or 
screw rejection 7 months post-operatively, with neo-bone formation observed 
around the graft site. Allograft screws (Regeneration Technologies Inc., CorlS®) 
have also been studied for ACL fixation in patients. A study found that 24 months 
post-surgery, the screws were completely degraded and the defect was filled with 
neo-cancellous bone.507 
The geometric design of interference screws can also affect graft fixation and 
influence the mechanical properties of the ACL screw-graft. For example, screw 
size, screw tapering and thread angle have been shown to affect graft fixation 
and screw engagement with the bone tunnel.499,523~525 Although, the general rule 
of equal screw diameter and bone tunnel is advocated, several experiments have 
investigated using smaller tunnel diameters with larger screws to achieve 
enhanced graft-tunnel fixation.526 Indeed, it is expected that geometrically 
equivalent screws made from different biodegradable and bioactive materials will 
respond differently in vitro and in vivo owing to intrinsic differences in the material 
properties of the screws. Thus, to ensure use of an appropriate screw, more tests 
need to be conducted, both in vitro and in vivo, to determine potential differences 
in mechanical and degradation properties and prevent screw breakage upon 
insertion into the bone tunnel as has been observed in several clinical studies.505. 
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507, 508 |n addition state-of-the-art computer modeling programs and 
combinatorial polymer scaffold libraries that can predict the properties of the 
screws prior to implantation may also be used as a selection tool to identify 
configurations and combinations of polymers that may achieve the desired 
fixation levels required in wVo.453,461 
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Figures associated with appendix C 
Table 13. Salient polymer and co-polymer formulations used in ACL screws 
Polymer 
PLLA 
SR-PLLA 
PDLLA 
SR-PDLLA 
PLLA-co-PGA 
PLLA-co-PDLLA 
PGA-co-PDLLA 
Company 
Arthrex 
Conmed Linvatek 
Depuy Othropedic Technologies 
Mitek 
Scandius 
Smith and Nephew 
Stryker 
Bioscience 
Sulzer Medica 
Storz 
Conmed Linvatek 
Biomet 
Phusis 
Instrument Makar 
Commercially available screws 
Delta tapered bio-interference screw 
Round delta tapered bio-interference screw 
Full thread bio-interference screw 
Biocortical screw 
Retro screw 
Bioscrew 
Phantom absorbable screw 
Absolute screw 
Bio-straTis 
BIORCI 
Universal wedge interference acrew 
Biofix 
Sysorb 
MegaFix 
SmartScrew 
Gentle threads 
BioCore 
Phusline interference screw 
Biologically quiet interference screw 
Table 14. Novel osteoconductive ACL screws 
Filler 
P-Tri-calcium phosphate 
(p-TCP) 
Tri-methylene carbonate 
(TCP) 
Calcium carbonate 
Hydroxyapatite 
(HA) 
Polymer 
PLLA 
PGLA 
PDLLA 
SR-PDLLA 
PGA 
PDLLA 
PGA-co-PDLLA 
PLLA 
Company 
ArthroCare 
Mitek 
Mitek 
Conmed Linvatek 
Conmed Linvatek 
Smith and Nephew 
Inion 
Smith and Nephew 
Smith and Nephew 
Stryker 
Commercially available screws 
Bilok 
Bio-lntrafix 
Biocryl TCP/PLA 
Milagro 
Osteo ACL Screw 
Matryx Interference Screw 
EndoFix 
Inion Hexalon 
Calaxo 
BIORCl-HA 
Biosteon 
